FIFA ANTI-DOPING

REGULATIONS
2021 edition
Fédération Internationale de Football Association

President: Gianni Infantino

Secretary General: Fatma Samoura
Address: FIFA-Strasse 20
P.O. Box
8044 Zurich
Switzerland
Telephone: +41 (0)43 222 7777
Internet: FIFA.com
FIFA ANTI-DOPING
REGULATIONS
2021 edition
2
 3

1. Fédération Internationale de Football Association

President: Gianni INFANTINO
Secretary General: Fatma SAMOURA
FIFA-Strasse 20
CH-8044 Zurich, Switzerland
Telephone: +41 (0)43 222 7777
Internet: FIFA.com

2. Medical Committee
Chairman: D’HOOGHE Michel (Belgium)
Members: AHMED Hosny Abdelrahman (Egypt)
CHIAMPAS George (USA)
DOHI Michiko (Japan)
FORSSBLAD Magnus (Sweden)
FULCHER Mark (New Zealand)
HERRERO Helena (Spain)
MARTĺNEZ QUIJADA Gerinaldo (Panama)
SINGH Gurcharan Dato’ (Malaysia)
VILLANI Donato (Argentina)
ZERGUINI Yacine (Algeria)
4 Contents

Article Page

PREFACE/OBJECTIVE 9

PRELIMINARY TITLE
I. Definitions and interpretation 10
II. General provisions 25
1 Scope of application: substantive law 25
2 Obligations of Member Associations and Confederations 25
3 Special obligations of Players and teams, Player Support
Personnel and other Persons 26
4 Testing authority of FIFA 28
5 Definition of doping 29

FIRST TITLE: SUBSTANTIVE LAW

III. Anti-doping rule violations 30
6 Presence of a Prohibited Substance or its Metabolites
or Markers in a Player’s Sample 30
7 Use or Attempted Use by a Player of a Prohibited Substance
or a Prohibited Method 31
8 Evading, refusing or failing to submit to Sample collection 31
9 Whereabouts failures 31
10 Tampering or Attempted tampering with any part of Doping
Control by a Player or other Person 31
11 Possession of a Prohibited Substance or a Prohibited Method
by a Player or Player Support Person 32
12 Trafficking or Attempted Trafficking in any Prohibited Substance
or Prohibited Method by Player or other Person 32
13 Administration or Attempted Administration by a Player or other
Person to any Player In-Competition of any Prohibited Substance or
Prohibited Method, or Administration or Attempted Administration
to any Player Out-of-Competition of any Prohibited Substance or
any Prohibited Method that is prohibited Out-of-Competition 32
14 Complicity or Attempted Complicity by a Player or other Person 33
15 Prohibited association by a Player or other Person 33
16 Acts by a Player or other Person to discourage or retaliate
against reporting to authorities 34
 Contents 5

Article Page

IV. The Prohibited List and therapeutic use exemptions 35

17 Prohibited Substances and Prohibited Methods identified
on the Prohibited List 35
18 WADA’s determination of the Prohibited List 36
19 Therapeutic use exemptions (TUEs) 36

V. Sanctions on individuals 38
Section 1: Imposition of period of Ineligibility 38
20 Ineligibility for presence, Use or attempted Use, or Possession
of a Prohibited Substance or Prohibited Method 38
21 Ineligibility for other anti-doping rule violations 39

Section 2: Elimination, reduction or suspension of period

of Ineligibility 41
22 Elimination of the period of Ineligibility where there is
No Fault or Negligence 41
23 Reduction of the period of Ineligibility based on No Significant
Fault or Negligence 41
24 Elimination, reduction, or suspension of period of Ineligibility or
other consequences for reasons other than Fault 43

Section 3: Increasing the period of Ineligibility and multiple

violations 46
25 Multiple violations 46

Section 4: Common provisions regarding sanctions

on individuals 49
26 Disqualification of results 49
27 Forfeited prize money 50
28 Financial consequences 51
29 Commencement of period of Ineligibility 51
30 Status during Ineligibility or Provisional Suspension 53
31 Automatic publication of sanction 54

VI. Consequences for teams 55

32 Target Testing of the team 55
33 Sanction on the club or Association 55
6 Contents

Article Page

VII. Provisional Suspension 56

34 Jurisdiction 56
35 Mandatory Provisional Suspension 56
36 Optional Provisional Suspension based on an Adverse
Analytical Finding for Specified Substances, Specified Methods,
Contaminated Products, or other anti-doping rule violations 57
37 Voluntary acceptance of Provisional Suspension 58
38 Notification 59
39 “B” Sample proves negative 59

VIII. Statute of limitations 61

40 Statute of limitations 61

SECOND TITLE: TESTING AND PROCEDURAL RULES

IX. Testing 62
Section 1: Testing 62
41 General rules for Testing 62
42 Test distribution plan 63
43 Selection of Players for Testing 65
44 Sample collection personnel: FIFA Doping Control Officers,
assistants, Chaperones 66
45 Failure to comply with Doping Control 67
46 Whereabouts information 69

Section 2: Analysis of Samples 69

47 Use of accredited, approved and other laboratories 69
48 Standards for Sample analysis and reporting 70
49 Further analysis of Samples 70
50 Property 71
51 Guidance 71

Section 3: Results management 71

52 Management process 71
53 Initial review regarding Adverse Analytical/Atypical Findings
and notification 72
54 Analysis of the “B” Sample in Adverse Analytical Findings 75
55 Review of Atypical Passport Findings and Adverse
Passport Findings 76
56 Review of whereabouts failures 77
57 Review of other anti-doping rule violations 77
 Contents 7

Article Page

58 Letter of charge 78
59 Retirement from sport 80
60 Retired Players returning to Competition 80

X. Procedural rules 82
Section 1: General provisions 82
61 Jurisdiction 82
62 Addressees of decisions and other documents 82
63 Form of decisions 83

Section 2: Fair hearing 83

64 Right to a fair hearing 83
65 Hearing principles 84
66 Considerations of the FIFA Disciplinary Committee 85
67 Procedure at a Competition 86

Section 3: Proof of doping 86

68 Burdens and standards of proof 86
69 Methods of establishing facts and presumptions 87

Section 4: Confidentiality and reporting 89

70 Information concerning asserted anti-doping rule violations 89
71 Public Disclosure 91
72 Information concerning whereabouts and Testing 92
73 Data privacy 93

Section 5: Implementation of decisions 94

74 Implementation of decisions 94
75 Recognition by Associations and Confederations 95

Section 6: Appeals 96
76 Decisions subject to appeal 96
77 Appeals against decisions regarding anti-doping rule violations,
Consequences, Provisional Suspensions, implementation of
decisions and authority 96
78 Failure to render a timely decision 99
79 Appeals relating to TUEs 99
80 Notification of appeal decisions 100
81 Appeal against decisions pursuant to article 85
(Sanctions and costs assessed against sporting bodies) 100
8 Contents

Article Page

82 Time for filing appeals 100

83 FIFA not required to exhaust internal remedies 101
84 Appeals against decisions granting or denying a therapeutic
use exemption 102
85 Sanctions and costs assessed against sporting bodies 102

FINAL TITLE
86 Official languages 103
87 Additional regulations 103
88 Amendments to and interpretation of the Anti-Doping Regulations 103

ANNEXES
A. The Prohibited List 106
B. Therapeutic use exemption (TUE) 107
C. Whereabouts 111
D. Testing procedure 127
E. Forms 145
F. List of WADA-accredited laboratories 147
 Preface/Objective 9

International federations such as FIFA and the IOC have played a pioneering
role in the fight against doping in sport. FIFA introduced regular Doping
Controls in 1966 to ensure that the results of the Matches in its International
Competitions are a fair reflection of the strength of the contenders.

The fundamental aims of Doping Control are threefold. They are to:

a) safeguard the physical health and mental integrity of players;

b) uphold and preserve the ethics of sport;

c) ensure that all competitors have an equal chance.

FIFA and its Medical Committee acknowledge their responsibility in the

fight against doping through stringent anti-doping provisions, ongoing
data collection and support for the research promoted by experts.

The FIFA Medical Committee has overall responsibility for implementing

Doping Control at all FIFA Competitions and Out-of-Competition as well
as for approving applications for therapeutic use exemptions (TUEs). It
delegates the management and administration of doping tests to the FIFA
Anti-Doping Unit, which coordinates the FIFA Doping Control Officers. It
delegates the evaluation and the approval of TUEs to the FIFA TUE Advisory
Group. FIFA follows a strategy of basing any decisions and regulations
on the specifics of the game, scientific evidence and analysis of validated
doping statistics.

Any aspect of Doping Control or anti-doping Education may also be

delegated by FIFA to a Delegated Third Party. However, FIFA shall require
the Delegated Third Party to perform such aspects in compliance with the
Code, WADA’s International Standards, and these Regulations. FIFA and its
Medical Committee shall always remain fully responsible for ensuring that
any delegated aspects are performed in compliance with the Code.

FIFA has accepted the World Anti-Doping Code 2021 and implemented
the applicable provisions of this Code and the International Standards
in these Regulations. Thus, in the event of questions, the comments
annotating various provisions of the World Anti-Doping Code 2021 and the
International Standards shall be used to construe these Regulations where
applicable. The Code and the International Standards shall be considered
integral parts of these Regulations and shall prevail in the event of any
conflict.
10 I. Definitions and interpretation

PRELIMINARY TITLE

1. ADAMS: the Anti-Doping Administration and Management System is a

web-based database management tool for data entry, storage, sharing,
and reporting designed to assist stakeholders and WADA in their anti-
doping operations in conjunction with data protection legislation.

2. Administration: providing, supplying, supervising, facilitating, or

otherwise participating in the Use or Attempted Use by another
Person of a Prohibited Substance or Prohibited Method. However,
this definition shall not include the actions of bona fide medical
personnel involving a Prohibited Substance or Prohibited Method
used for genuine and legal therapeutic purposes or other acceptable
justification and shall not include actions involving Prohibited
Substances which are not prohibited in Out-of-Competition Testing
unless the circumstances as a whole demonstrate that such Prohibited
Substances are not intended for genuine and legal therapeutic
purposes or are intended to enhance sport performance.

3. Adverse Analytical Finding: a report from a WADA-accredited

laboratory or other WADA-approved laboratory that, consistent with
the International Standard for Laboratories establishes in a Sample the
presence of a Prohibited Substance or its Metabolites or Markers or
evidence of the Use of a Prohibited Method.

4. Adverse Passport Finding: a report identified as an Adverse Passport

Finding as described in the applicable International Standards.

5. Aggravating Circumstances: circumstances involving, or actions by,

a Player or other Person which may justify the imposition of a period
of Ineligibility greater than the standard sanction. Such circumstances
and actions shall include, but not be limited to: the Player or other
Person Using or Possessing multiple Prohibited Substances or Prohibited
Methods, Using or Possessing a Prohibited Substance or Prohibited
Method on multiple occasions or committing multiple other anti-
doping rule violations; a normal individual would be likely to enjoy
the performance-enhancing effects of the anti-doping rule violation(s)
beyond the otherwise applicable period of Ineligibility; the Player or
other Person engaging in deceptive or obstructing conduct to avoid
the detection or adjudication of an anti-doping rule violation; or the
Player or other Person engaging in Tampering during the Results
Management or hearing process. For the avoidance of doubt, the
 I. Definitions and interpretation 11

examples of circumstances and conduct described herein are not

exclusive and other similar circumstances or conduct may also justify
the imposition of a longer period of Ineligibility.

6. Anti-Doping Activities: anti-doping Education and information, test

distribution planning, maintaining a Registered Testing Pool, managing
Athlete Biological Passports, conducting Testing, organising the analysis
of Samples, gathering intelligence and conducting investigations,
processing of TUE applications, Results Management, hearings,
monitoring and enforcing compliance with any Consequences imposed,
and all other activities related to anti-doping to be carried out by or on
behalf of an Anti-Doping Organisation, as set out in the Code and/or
the International Standards.

7. Anti-Doping Organisation: WADA or a Signatory that is responsible

for adopting rules for initiating, implementing or enforcing any
part of the Doping Control process. This includes, for example, the
International Olympic Committee, the International Paralympic
Committee, other Major Event Organisations that conduct Testing at
their events, international federations and NADOs.

8. Association: a football Association recognised by FIFA. It is a member

of FIFA unless a different meaning is evident from the context.

9. Athlete Biological Passport: the programme and methods of

gathering and collating data as described in the International Standard
for Testing and Investigations and the International Standard for
Laboratories

10. Attempt: purposely engaging in conduct that constitutes a substantial

step in a course of conduct planned to culminate in the commission of
an anti-doping rule violation. However, there shall be no anti-doping
rule violation based solely on an Attempt to commit a violation if the
Person renounces the Attempt prior to it being discovered by a third
party not involved in the Attempt.

11. Atypical Finding: a report from a WADA-accredited laboratory or

other WADA-approved laboratory which requires further investigation
as provided by the International Standard for Laboratories or related
Technical Documents prior to the determination of an Adverse
Analytical Finding.
12 I. Definitions and interpretation

12. Atypical Passport Finding: a report described as an Atypical Passport

Finding as described in the applicable International Standards.

13. CAS: the Court of Arbitration for Sport, Lausanne, Switzerland.

14. Chain of Custody: the sequence of individuals or organisations who

have responsibility for the custody of a Sample from the provision of
the Sample until the Sample has been delivered to the laboratory for
analysis.

15. Chaperone: an official who is suitably trained and authorised by FIFA

to carry out specific duties including one or more of the following
(at FIFA’s discretion): notification of the Player selected for Sample
collection; accompanying and observing the Player until arrival at the
Doping Control room; accompanying and/or observing the Players
who are present in the Doping Control room and/or witnessing and
verifying the provision of the Sample where the training specifically
qualifies them to do so.

16. Code: the World Anti-Doping Code.

17. Competition: a series of football Matches conducted together

under one ruling body (e.g. the Olympic Games, FIFA World Cup™).
“Competition” in the official FIFA terminology corresponds to “event”
in the World Anti-Doping Code.

18. Competition Period: the time between the beginning and end of
a Competition, as established by the ruling body of the Competition.
“Competition Period” in the official FIFA terminology corresponds to
“event period” in the World Anti-Doping Code.

19. Competition Venues: venues designated by the ruling body for the
Competition, including, but not limited to, stadiums, team hotels,
hospitals and training sites. “Competition Venues” in the official FIFA
terminology corresponds to “event venues” in the World Anti-Doping
Code.

20. Confederation: a group of Associations recognised by FIFA that

belong to the same continent (or assimilable geographic region).
 I. Definitions and interpretation 13

21. Consequences of Anti-Doping Rule Violations (“Consequences”):

a Player’s or other Person’s violation of an anti-doping rule may result in
one or more of the following: (a) Disqualification, meaning the Player’s
results in a particular Competition are invalidated, with all the resulting
Consequences including the forfeiture of any medals, points and
prizes; (b) Ineligibility, meaning the Player or other Person is barred on
account of an anti-doping rule violation for a specified period of time
from participating in any Competition or other activity or funding as
provided in art. 20 (Ineligibility for presence, Use or Attempted Use,
or Possession of a Prohibited Substance or Prohibited Method);
(c) Provisional Suspension, meaning the Player or other Person is barred
temporarily from participating in any Competition or activity prior to
the final decision at a hearing conducted under art. 64 (Right to a fair
hearing); (d) Financial Consequences, meaning a financial sanction
imposed for an anti-doping rule violation or to recover costs associated
with an anti-doping rule violation; and (e) Public Disclosure, meaning
the dissemination or distribution of information to the general public
or Persons beyond those Persons entitled to earlier notification in
accordance with art. 71 (Public Disclosure). Teams may also be subject
to Consequences as provided in art. 33 (Sanction on the club or
Association).

22. Contaminated Product: a product that contains a Prohibited

Substance that is not disclosed on the product label or in information
available in a reasonable internet search.

23. Decision Limit: the value of the result for a threshold substance in a
Sample, above which an Adverse Analytical Finding shall be reported,
as defined in the International Standard for Laboratories.

24. Delegated Third Party: any Person to which FIFA delegates any aspect
of Doping Control or anti-doping Education programmes including,
but not limited to, third parties or other Anti-Doping Organisations
that conduct Sample collection or other Doping Control services or
anti-doping educational programmes for FIFA, or individuals serving
as independent contractors who perform Doping Control services for
FIFA (e.g. non-employee Doping Control Officers or Chaperones). This
definition does not include CAS.

25. Disqualification: see “Consequences of Anti-Doping Rule Violations”

above.
14 I. Definitions and interpretation

26. Doping Control: all steps and processes from test distribution planning
through to ultimate disposition of any appeal and the enforcement of
Consequences, including all steps and processes in between, including
but not limited to, Testing, investigations whereabouts, TUEs, Sample
collection and handling, laboratory analysis, Results Management,
hearings and appeals, and investigations or proceedings relating
to violations of art. 30 (Status during Ineligibility or Provisional
Suspension).

27. Education: the process of instilling values and developing behaviour

that foster and protect the spirit of sport, and to prevent intentional
and unintentional doping.

28. Fault: Fault is any breach of duty or any lack of care appropriate to a
particular situation. Factors to be taken into consideration in assessing
a Player’s or other Person’s degree of Fault include, for example, the
Player’s or other Person’s experience, whether the Player or other
Person is a Protected Person, special considerations such as impairment,
the degree of risk that should have been perceived by the Player and
the level of care and investigation exercised by the Player in relation
to what should have been the perceived level of risk. In assessing the
Player’s or other Person’s degree of Fault, the circumstances considered
must be specific and relevant to explain the Player’s or other Person’s
departure from the expected standard of behaviour. Thus, for example,
the fact that a Player would lose the opportunity to earn large sums
of money during a period of Ineligibility, or the fact that the Player
only has a short time left in his career, or the timing of the sporting
calendar, would not be relevant factors to be considered in reducing
the period of Ineligibility under art. 23 par. 1 or 2 (Reduction of the
period of Ineligibility based on No Significant Fault or Negligence).

29. FIFA Anti-Doping Unit: the functional body to which the FIFA Medical
Committee delegates the management and administration of Doping
Control.

30. FIFA Disciplinary Committee: a FIFA judicial body, embodied in

the FIFA Statutes, that is authorised to sanction any breach of FIFA
Regulations which does not come under the jurisdiction of another
body.

31. FIFA Doping Control Officer: a natural Person who carries out
Sample collections for FIFA. The FIFA Doping Control Officer must be a
 I. Definitions and interpretation 15

doctor. If national legislation allows professionals other than doctors

to collect Samples of bodily fluids (with all consequences including
medical confidentiality according to medical ethics and the Hippocratic
Oath), an exception may be made by the FIFA Anti-Doping Unit.

32. FIFA Regulations: the Statutes, regulations, guidelines, directives

and circulars of FIFA and the Beach Soccer and Futsal Laws of the
Game issued by FIFA as well as the Laws of the Game issued by The
International Football Association Board.

33. Financial Consequences: see “Consequences of Anti-Doping Rule

Violations” above.

34. In-Competition: the period commencing at 23:59 on the day before

a Match in which the Player is scheduled to participate through to the
end of said Match and including the Sample collection process relating
to said Match.

35. Independent Observer Programme: a team of observers and/or

auditors, under the supervision of WADA, who observe and provide
guidance on the Doping Control process prior to or during certain
Competitions and report on their observations as part of WADA’s
compliance monitoring programme.

36. Independent Witness: a person invited by FIFA, the laboratory

or WADA to witness parts of the analytical testing process. The
Independent Witness shall be independent of the Player and his
representative(s), the laboratory, FIFA, the Confederations, Member
Associations or WADA, as applicable. The Independent Witness may be
compensated for his service.

37. Ineligibility: see “Consequences of Anti-Doping Rule Violations”

above.

38. Institutional Independence: hearing panels on appeal shall be

fully independent institutionally of the Anti-Doping Organisation
responsible for Results Management. They must not, therefore, in
any way be administered by, connected or subject to the Anti-Doping
Organisation which is responsible for Results Management.

39. International Competition: a Competition where the International

Olympic Committee, the International Paralympic Committee, an
16 I. Definitions and interpretation

international federation, a Major Event Organisation, or another

international sports organisation is the ruling body for the Competition
or appoints the technical officials for the Competition (“International
Competition” in the official FIFA terminology corresponds to
“international event” in the World Anti-Doping Code).

40. International-Level Player: a Player designated by FIFA or a

Confederation as being within FIFA’s or the Confederation’s Registered
Testing Pool and/or a Player who participates regularly in International
Competitions (as defined in these Regulations) and/or Competitions
under the jurisdiction of a Confederation.

41. International Standard: a standard adopted by WADA in support of

the Code. Compliance with an International Standard (as opposed to
another alternative standard, practice or procedure) shall be sufficient
to conclude that the procedures addressed by the International
Standard were performed properly. International Standards shall
include any Technical Documents issued pursuant to the International
Standard.

42. Major Event Organisations: the continental associations of National

Olympic Committees and other international multi-sport organisations
that function as the ruling body for any continental, regional or other
International Competition.

43. Marker: a compound, group of compounds or biological variable(s)

that indicates the Use of a Prohibited Substance or Prohibited Method.

44. Match: a single football Match. “Match” in the official FIFA

terminology corresponds to “Competition” in the World Anti-Doping
Code.

45. Match Officials: the referee, assistant referees, fourth official, Match
Commissioner, referee inspector, the Person in charge of safety, and
any other Persons appointed by FIFA to assume responsibility in
connection with a Match.

46. Medical Committee: the FIFA standing committee, embodied in the

FIFA Statutes, that deals with all medical aspects of football, including
any doping-related matters.
 I. Definitions and interpretation 17

47. Member Association: an Association that has been admitted into

membership of FIFA by the FIFA Congress.

48. Metabolite: any substance produced by a biotransformation process.

49. Minimum Reporting Level: the estimated concentration of a

Prohibited Substance or its Metabolite(s) or Marker(s) in a Sample
below which WADA-accredited laboratories should not report that
Sample as an Adverse Analytical Finding.

50. Minor: a natural Person who has not reached the age of 18 years.

51. National Anti-Doping Organisation (NADO): the entity(ies)

designated by each country as possessing the primary authority and
responsibility to adopt and implement anti-doping rules, direct the
collection of Samples, the management of test results, and the conduct
of hearings at national level. If this designation has not been made by
the competent public authority(ies), the entity shall be the country’s
National Olympic Committee or its designee.

52. National Competition: a sports Competition that may involve

National- or International-Level Players and that is not an International
Competition.

53. National-Level Player: a Player who competes in sport at national

level, as defined by each NADO, consistent with the International
Standard for Testing and Investigations.

54. National Olympic Committee: the organisation recognised by

the International Olympic Committee. The term National Olympic
Committee shall also include the national sport confederation in those
countries where the national sport confederation assumes typical
National Olympic Committee responsibilities in the anti-doping area.

55. No Fault or Negligence: the Player or other Person’s establishing

that he or she did not know or suspect, and could not reasonably have
known or suspected even with the exercise of utmost caution, that
he or she had Used or been administered the Prohibited Substance or
Prohibited Method or otherwise violated an anti-doping rule. Except in
the case of a Protected Person or Recreational Player, for any violation
of art. 6 (Presence of a Prohibited Substance or its Metabolites or
18 I. Definitions and interpretation

Markers in a Player’s Sample), the Player must also establish how the
Prohibited Substance entered the Player’s system.

56. No Significant Fault or Negligence: the Player or other Person’s

establishing that any Fault or negligence, when viewed in the totality
of the circumstances and taking into account the criteria for No Fault
or negligence, was not significant in relationship to the anti-doping
rule violation. Except in the case of a Protected Person or Recreational
Player, for any violation of art. 6 (Presence of a Prohibited Substance
or its Metabolites or Markers in a Player’s Sample), the Player must also
establish how the Prohibited Substance entered the Player’s system.

57. Official: every board member, committee member, referee and

assistant referee, coach, trainer and any other Person responsible for
technical, medical and administrative matters in FIFA, a Confederation,
Association, League or club as well as all other Persons obliged to
comply with the FIFA Statutes (except Players).

58. Operational Independence: this means that (1) board members, staff
members, commission members, consultants and Officials of FIFA or its
affiliates, as well as any Person involved in the investigation and pre-
adjudication of a matter, cannot be appointed as members and/or clerks
(to the extent that such clerk is involved in the deliberation process and/
or drafting of any decision) of hearing panels of FIFA and (2) hearing
panels shall be in a position to conduct the hearing and decision-making
process without interference from FIFA or any third party. The objective
is to ensure that members of the hearing panel or individuals otherwise
involved in the decision of the hearing panel, are not involved in the
investigation of, or decisions to proceed with, the case.

59. Out-of-Competition: any period which is not In-Competition.

60. Participant: any Player or Player Support Personnel.

61. Person: a natural Person or an organisation or other entity.

62. Player: any football Player licensed by an Association.

63. Player Support Personnel: any coach, trainer, manager, agent, team
staff, official, medical or paramedical personnel, parent or any other
Person working with, treating or assisting a Player participating in or
preparing for sports competition.
 I. Definitions and interpretation 19

64. Possession: the actual, physical possession, or the constructive

possession (which shall be found only if the Person has exclusive
control or intends to exercise control over the Prohibited Substance or
Prohibited Method or the premises in which a Prohibited Substance or
Prohibited Method exists); provided, however, that if the Person does
not have exclusive control over the Prohibited Substance or Prohibited
Method or the premises in which a Prohibited Substance or Prohibited
Method exists, constructive Possession shall only be found if the Person
knew about the presence of the Prohibited Substance or Prohibited
Method and intended to exercise control over it. However, there shall
be no anti-doping rule violation based solely on Possession if, prior
to receiving notification of any kind that the Person has committed
an anti-doping rule violation, the Person has taken concrete action
demonstrating that the Person never intended to have Possession
and has renounced Possession by explicitly declaring it to an Anti-
Doping Organisation. Notwithstanding anything to the contrary in this
definition, the purchase (including by any electronic or other means) of
a Prohibited Substance or Prohibited Method constitutes Possession by
the Person who makes the purchase.

65. Prohibited List: the list identifying the Prohibited Substances and
Prohibited Methods.

66. Prohibited Method: any method so described on the Prohibited List.

67. Prohibited Substance: any substance, or class of substances, so

described on the Prohibited List.

68. Protected Person: a Player or other natural Person who at the time
of the anti-doping rule violation: (i) has not reached the age of 16
years; (ii) has not reached the age of 18 years and is not included in any
Registered Testing Pool and has never competed in any International
Competition in an open category; or for whom (iii) for reasons other
than age, it has been determined lacks legal capacity under the
applicable national legislation.

69. Provisional Hearing: for the purposes of art. 64 (Right to a fair

hearing), an expedited abbreviated hearing occurring prior to a
hearing under these Regulations that provides the Player with notice
and an opportunity to be heard in either written or oral form.
20 I. Definitions and interpretation

70. Provisional Suspension: see “Consequences of Anti-Doping Rule

Violations” above.

71. Public Disclosure or Publicly Disclose: see “Consequences of Anti-

Doping Rule Violations” above.

72. Recreational Player: a natural Person who is so defined by the

relevant NADO; provided, however, the term shall not include any
Person who, within the five years prior to committing any anti-
doping rule violation, has been an International-Level Player (as
defined by FIFA or a Confederation) or a National-Level Player (as
defined by the relevant NADO), has represented any country in an
International Competition in an open category or has been included
in any Registered Testing Pool or other whereabouts information pool
maintained by FIFA, a Confederation or a NADO.

73. Regional Anti-Doping Organisation: a regional entity designated by

member countries to coordinate and manage delegated areas of their
national anti-doping programmes, which may include the adoption
and implementation of anti-doping rules, the planning and collection
of Samples, the management of results, the review of TUEs, the
conduct of hearings and the conduct of Educational programmes at a
regional level.

74. Registered Testing Pool: a pool of high-priority Players established

separately at international level by FIFA, and national level by NADOs,
who are subject to focused In-Competition and Out-of-Competition
Testing as part of FIFA’s or the NADO’s test distribution plan and
therefore are required to provide whereabouts information as
provided in Annexe C of these Regulations and the International
Standard for Testing and Investigations.

75. Results Management: the process encompassing the timeframe

between notification in accordance with art. 5 of the International
Standard for Results Management, or in certain cases (e.g. Atypical
Finding, Athlete Biological Passport, whereabouts failure), such pre-
notification steps expressly provided for in art. 5 of the International
Standard for Results Management, through the charge until the final
resolution of the matter, including the end of the hearing process at
first instance or on appeal (if an appeal was lodged).
 I. Definitions and interpretation 21

76. Sample or Specimen: any biological material collected for the

purposes of Doping Control.

77. Sample Collection Session: all of the sequential activities that

directly involve the Player from the point that initial contact is made
until the Player leaves the Doping Control room after having provided
his Sample(s).

78. Signatories: those entities accepting the Code and agreeing to

implement the Code, as provided in art. 23 of the WADA Code 2021.

79. Specified Method: see art. 17 par. 3 (Prohibited Substances and

Prohibited Methods identified on the Prohibited List).

80. Specified Substance: see art. 17 par. 3 (Prohibited Substances and

Prohibited Methods identified on the Prohibited List).

81. Strict Liability: the rule which provides that under art. 6 (Presence
of a Prohibited Substance or its Metabolites or Markers in a Player’s
Sample) and art. 7 (Use or Attempted Use by a Player of a Prohibited
Substance or a Prohibited Method), it is not necessary that intent, Fault,
negligence, or knowing Use on the Player’s part be demonstrated by
the Anti-Doping Organisation in order to establish an anti-doping rule
violation.

82. Substance of Abuse: see art. 17 par. 4 (Substances of Abuse).

83. Substantial Assistance: for the purposes of art. 24 par. 1 (Substantial

Assistance in discovering or establishing Code violations), a Person
providing Substantial Assistance must: (1) fully disclose in a signed
written statement or recorded interview all information he or she
possesses in relation to anti-doping rule violations or other proceeding
described in art. 24 par. 1 (Substantial Assistance in discovering
or establishing Code violations), and (2) fully cooperate with the
investigation and adjudication of any case or matter related to that
information, including, for example, presenting testimony at a hearing
if requested to do so by an Anti-Doping Organisation or hearing panel.
Further, the information provided must be credible and must comprise
an important part of any case or proceeding which is initiated or, if no
case or proceeding is initiated, must have provided a sufficient basis on
which a case or proceeding could have been brought.
22 I. Definitions and interpretation

84. Suitable Specific Gravity for Analysis: for Samples with a minimum
volume of 90ml and less than 150ml, this shall be specific gravity
measured at 1.005 with a refractometer, or 1.010 or higher with lab
sticks. For Samples with a volume of 150ml and above, it shall be
specific gravity measured at 1.003 or higher with a refractometer only.

85. Tampering: intentional conduct which subverts the Doping Control

process but which would not otherwise be included in the definition
of Prohibited Methods. Tampering shall include, without limitation,
offering or accepting a bribe to perform or fail to perform an act,
preventing the collection of Sample, affecting or making impossible
the analysis of a Sample, falsifying documents submitted to an Anti-
Doping Organisation or TUE committee or hearing panel, procuring
false testimony from witnesses, committing any other fraudulent act
upon the Anti-Doping Organisation or hearing body to affect Results
Management or the imposition of Consequences, and any other similar
intentional interference or Attempted interference with any aspect of
Doping Control.

86. Target Testing: selection of specific Players for Testing based on

criteria set forth in the International Standard for Testing and
Investigations.

87. Team Activity: all sporting activities (e.g. training, travelling, tactical
sessions) on a collective basis with the Player’s team or other activities
under the supervision of the team (e.g. treatment by a team doctor).

88. Technical Document: a document adopted and published by WADA

from time to time that contains mandatory technical requirements on
specific anti-doping topics as set forth in an International Standard.

89. Testing: the parts of the Doping Control process involving test
distribution planning, Sample collection, Sample handling, and Sample
transport to the laboratory.

90. Therapeutic Use Exemption (TUE): a therapeutic use exemption

allows a Player with a medical condition to use a Prohibited Substance
or Prohibited Method, but only if the conditions set out in art. 19
(Therapeutic use exemptions (TUEs)) and the International Standard for
Therapeutic Use Exemptions are met.
 I. Definitions and interpretation 23

91. Trafficking: selling, giving, transporting, sending, delivering or

distributing (or Possessing for any such purpose) a Prohibited Substance
or Prohibited Method (either physically or by any electronic or other
means) by a Player, Player Support Personnel or any other Person
subject to the authority of an Anti-Doping Organisation to any third
party; provided, however, this definition shall not include the actions
of “bona fide” medical personnel involving a Prohibited Substance
Used for genuine and legal therapeutic purposes or other acceptable
justification, and shall not include actions involving Prohibited
Substances which are not prohibited in Out-of-Competition Testing
unless the circumstances as a whole demonstrate such Prohibited
Substances are not intended for genuine and legal therapeutic
purposes or are intended to enhance sport performance.

92. UNESCO Convention: the International Convention against Doping in

Sport adopted by the 33rd session of the UNESCO General Conference
on 19 October, 2005, including any and all amendments adopted by the
States Parties to the Convention and the Conference of Parties to the
International Convention against Doping in Sport.

93. Unsuccessful Attempt Report: a detailed report of an unsuccessful

Attempt to collect a Sample from a Player in a Registered Testing
Pool or Testing pool setting out the date of the Attempt, the location
visited, the exact arrival and departure times at the location, the steps
taken at the location to try to find the Player (including details of any
contact made with third parties), and any other relevant details about
the Attempt.

94. Use: the utilisation, application, ingestion, injection or consumption

by any means whatsoever of any Prohibited Substance or Prohibited
Method.

95. WADA: the World Anti-Doping Agency.

Reference to the competent FIFA bodies in these Regulations applies to the

equivalent body at Association or Confederation level.

Words importing the singular include the plural and vice versa.

References to “include” or “in particular”, “e.g.” or similar are to be

construed as being inclusive and without limitation to the listed examples.

References to “days” mean actual (calendar) days, not business days.

24 I. Definitions and interpretation

References to “chapters”, “sections”, “articles” and/or “paragraphs” are,

unless expressly stated otherwise, references to the chapters, sections,
articles or paragraphs of these Regulations.

References to the male gender in these Regulations are for simplification

and apply to both men and women.

All Annexes attached to these Regulations form an integral part of these

Regulations.

The various headings and sub-headings used in these Regulations are for
convenience only and shall not be deemed part of the substance of these
Regulations or to affect in any way the language of the provisions to which
they refer.

All capitalised terms shall have the meanings as defined in this Chapter I.
 II. General provisions 25

1 Scope of application: substantive law

1.
These Regulations shall apply to FIFA, its Member Associations and the
Confederations, including their board members, directors, officers, and to
specified employees, and to Delegated Third Parties and their employees,
any of whom are involved in any aspect of Doping Control, and to Players,
clubs, Player Support Personnel, Match Officials, Officials and other Persons
who participate in activities, Matches or Competitions organised by FIFA
or its Associations by virtue of their agreement, membership, affiliation,
authorisation, accreditation or participation.

Each of the above-mentioned Persons is deemed, as a condition of his

participation or involvement in the sport, to have agreed to and be bound
by these Regulations, and to have submitted to the authority of FIFA to
enforce these Regulations, including any Consequences for the breach
thereof, and to the jurisdiction of the hearing panels specified in these
Regulations and the FIFA Disciplinary Code to hear and determine cases
and appeals brought under these Regulations.

2.
These Regulations shall apply to all Doping Controls over which FIFA and,
respectively, its Associations have jurisdiction.

2 Obligations of Member Associations and Confederations

1.
All Associations shall undertake to comply with the Code, the International
Standards and these Regulations. These Regulations shall be incorporated
either directly, or by reference, into the rules of each Association. Each
Association shall include in its rules the procedural regulations necessary to
implement these Regulations and any changes that may be made to them.
In the event of a discrepancy between these Regulations and the rules of a
Member Association or Confederation, these Regulations shall prevail and
apply to the case at hand.

2.
In respect of the Confederations’ remit, reference in these Regulations to
the Associations shall, where appropriate, be understood as meaning the
Confederations.
26 II. General provisions

3.
The rules of each Association shall specifically provide that all Players, clubs,
Player Support Personnel, Officials and other Persons under the jurisdiction
of the Association shall be bound by these Regulations and the Results
Management authority of FIFA.

4.
Taking into account the Associations’ responsibilities introduced under
these Regulations and the Code, it is the particular responsibility of each
Association to collect Samples for Doping Control at National Competitions
and to initiate and direct Out-of-Competition Testing on its Players, conduct
anti-doping educational programmes in accordance with the International
Standard for Education, and to ensure that all national level Testing on its
Players and the Results Management from such tests comply with these
Regulations. In respect of this schedule of responsibilities, reference in
these Regulations to FIFA shall, where appropriate, be understood as
meaning the Association concerned.

5.
It is recognised that in some countries the Association will conduct the
Testing, Results Management process and educational anti-doping
programmes itself whilst, in others, some or all of the Association’s
responsibilities may be delegated or assigned to a NADO. In respect of
these countries, reference in these Regulations to the Association shall,
where appropriate, be understood as meaning the NADO. Irrespective of
the different situation in every country, the Association remains ultimately
responsible for every aspect of the process. The Confederation and/or
National Association shall provide FIFA with any information relating to an
anti-doping rule violation and decisions taken by the NADO duly translated
into an official FIFA language.

3 Special obligations of Players and teams, Player Support

Personnel and other Persons
1.
Players, Player Support Personnel and other Persons subject to these
Regulations shall be responsible for knowing what constitutes an anti-
doping rule violation, the substances and methods that have been included
in the Prohibited List and for familiarising themselves and complying with
these Regulations.
 II. General provisions 27

2.
In the context of anti-doping, Players shall be responsible for what they
ingest and Use and to make sure that any medical treatment received does
not violate these Regulations. Players are obliged to undergo Testing as set
forth in these Regulations. In particular, every Player designated to undergo
a doping test by a responsible Official, whether as a result of Target Testing
or drawing by lots, is obliged to provide a urine Sample and, if requested,
a blood Sample, to undergo any medical examination that the responsible
Official deems necessary and to cooperate with the latter in this respect.

3.
The Player’s rights include the right to:

a) have the team doctor or other representative present;

b) be informed and ask for additional information about the Sample

collection process.

4.
The Player’s obligations include the requirement to:

a) remain within direct observation of the FIFA Doping Control Officer, his
assistant or the Chaperone at all times from the point of notification
until completion of the Sample collection;

b) comply with Sample collection procedures (the Player shall be advised of

the possible consequences of failure to comply);

c) report immediately for a test, unless there are valid reasons for a delay,
as determined in accordance with Annexe D;

d) disclose the identity of their Player Support Personnel upon request by

any Anti-Doping Organisation with authority over the Player.

5.
The obligations of the Player, the Player Support Personnel and other
Persons include the requirement to:

a) disclose to their NADO, Confederation, Association and FIFA any decision

by any organisation that is not a Signatory to the Code that finds that they
committed an anti-doping rule violation within the previous ten years;
28 II. General provisions

b) cooperate with any Anti-Doping Organisation investigating anti-doping

rule violations.

Failure by any Player, Player Support Personnel or other Person to cooperate

in full with FIFA when it investigates potential anti-doping rule violation(s)
may result in a disciplinary measure under the FIFA Disciplinary Code.

Offensive conduct towards a Doping Control Officer or other Person

involved in Doping Control by any Player, Player Support Personnel or other
Person, which does not otherwise constitute Tampering, may result in a
disciplinary measure under the FIFA Disciplinary Code.

Player Support Personnel and other Persons subject to these Regulations

shall not Use any Prohibited Substance or Prohibited Method without valid
justification. Any such Use may result in a disciplinary measure under the
FIFA Disciplinary Code.

6.
Every Player/team that has been identified for inclusion in a national or
international Registered Testing Pool is obliged to provide whereabouts
information as set forth in Annexe C. Players may delegate the
whereabouts provision to a designated team representative. Regardless
of such delegation, Players remain personally responsible for duly filing
complete and accurate whereabouts information. Failure to do so may lead
to the consequences mentioned in art. 9 of these Regulations as well as
their Annexe C.

4 Testing authority of FIFA

1.
FIFA has testing authority over all clubs and their Players who are affiliated
to a Member Association or who participate in any Match or Competition
organised by FIFA.

2.
FIFA shall focus its Testing under these Regulations on Players in the FIFA
International Registered Testing Pool (IRTP) and on Players who compete,
or who are preparing to compete, in Matches or Competitions organised by
FIFA.
 II. General provisions 29

5 Definition of doping

1.
Doping is strictly forbidden under these Regulations.

2.
Doping is defined as the occurrence of one or more of the anti-doping rule
violations set forth in these Regulations.
30 III. Anti-doping rule violations

FIRST TITLE: SUBSTANTIVE LAW

The purpose of arts 6 to 16 is to specify the circumstances and conduct

which constitute anti-doping rule violations. Hearings in doping cases will
proceed based on the assertion that one or more of these specific rules
have been violated.

6 Presence of a Prohibited Substance or its Metabolites

or Markers in a Player’s Sample
1.
It is the Player’s personal duty to ensure that no Prohibited Substance
enters his body. Players are responsible for any Prohibited Substance or its
Metabolites or Markers found to be present in their Samples. Accordingly,
it is not necessary that intent, Fault, negligence or knowing Use on the
Player’s part be demonstrated in order to establish an anti-doping rule
violation under art. 6.

2.
Sufficient proof of an anti-doping rule violation under art. 6 is established
by any of the following: presence of a Prohibited Substance or its
Metabolites or Markers in the Player’s “A” Sample where the Player waives
analysis of the “B” Sample and the “B” Sample is not analysed; or where the
Player’s “B” Sample is analysed and the analysis of the Player’s “B” Sample
confirms the presence of the Prohibited Substance or its Metabolites or
Markers found in the Player’s “A” Sample; or where the Player’s “A” or “B”
Sample is split into two parts and the analysis of the confirmation part of
the split Sample confirms the presence of the Prohibited Substance or its
Metabolites or Markers found in the first part of the split Sample or the
Player waives analysis of the confirmation part of the split Sample.

3.
Excepting those substances for which a Decision Limit is specifically
identified in the Prohibited List or a Technical Document, the presence
of any reported quantity of a Prohibited Substance or its Metabolites or
Markers in a Player’s Sample shall constitute an anti-doping rule violation.

4.
As an exception to the general rule of art. 6, the Prohibited List,
International Standards or Technical Documents may establish special
criteria for the reporting or the evaluation of certain Prohibited Substances.
 III. Anti-doping rule violations 31

7 Use or Attempted Use by a Player of a Prohibited Substance

or a Prohibited Method

1.
It is the Player’s personal duty to ensure that no Prohibited Substance
enters his body and that no Prohibited Method is Used. Accordingly, it is
not necessary that intent, Fault, negligence or knowing Use on the Player’s
part be demonstrated in order to establish an anti-doping rule violation for
Use of a Prohibited Substance or a Prohibited Method.

2.
The success or failure of the Use or Attempted Use of a Prohibited
Substance or Prohibited Method is not material. It is sufficient that the
Prohibited Substance or Prohibited Method was Used or Attempted to be
Used for an anti-doping rule violation to be committed.

8 Evading, refusing of failing to submit to Sample collection

Evading Sample collection; or refusing or failing to submit to Sample
collection without compelling justification after notification by a duly
authorised Person.

9 Whereabouts failures
Any combination of three missed tests and/or filing failures, as defined in
the International Standard for Results Management, within a 12-month
period by a Player in a Registered Testing Pool.

10 Tampering or Attempted Tampering with any part of

Doping Control by a Player or other Person
Tampering or Attempted Tampering with any part of Doping Control by a
Player or other Person.
32 III. Anti-doping rule violations

11 Possession of a Prohibited Substance or a Prohibited

Method by a Player or Player Support Person

1.
Possession by a Player In-Competition of any Prohibited Substance or any
Prohibited Method, or Possession by a Player Out-of-Competition of any
Prohibited Substance or any Prohibited Method which is prohibited Out-of-
Competition unless the Player establishes that the Possession is consistent
with a therapeutic use exemption (TUE) granted in accordance with art. 18
(Therapeutic use exemptions (TUEs)) or other acceptable justification.

2.
Possession by a Player Support Person In-Competition of any Prohibited
Substance or any Prohibited Method, or Possession by a Player Support
Person Out-of-Competition of any Prohibited Substance or any Prohibited
Method which is prohibited Out-of-Competition in connection with a
Player, Match or training, unless the Player Support Person establishes that
the Possession is consistent with a TUE granted to a Player in accordance
with art. 18 (Therapeutic use exemptions (TUEs)) or other acceptable
justification.

12 Trafficking or Attempted Trafficking in any Prohibited

Substance or Prohibited Method by a Player or other
Person
Trafficking or Attempted Trafficking in any Prohibited Substance or
Prohibited Method by a Player or other Person.

13 Administration or Attempted Administration by a

Player or other Person to any Player In-Competition
of any Prohibited Substance or Prohibited Method, or
Administration or Attempted Administration to any Player
Out-of-Competition of any Prohibited Substance or any
Prohibited Method that is prohibited Out-of-Competition
Administration or Attempted Administration by a Player or other Person
to any Player In-Competition of any Prohibited Substance or Prohibited
Method, or Administration or Attempted Administration to any Player
Out-of-Competition of any Prohibited Substance or any Prohibited Method
that is prohibited Out-of-Competition.
 III. Anti-doping rule violations 33

14 Complicity or Attempted Complicity by a Player or

other Person

Assisting, encouraging, aiding, abetting, conspiring, covering up or any

other type of intentional complicity or Attempted Complicity involving
an anti-doping rule violation, Attempted anti-doping rule violation or
violation of art. 30 par. 1 (Prohibition of participation during Ineligibility
or Provisional Suspension) by another Person.

15 Prohibited association by a Player or other Person

Association by a Player or other Person subject to the authority of FIFA or
other Anti-Doping Organisation in a professional or sport-related capacity
with any Player Support Personnel who:

1.
If subject to the authority of an Anti-Doping Organisation, is serving a
period of Ineligibility; or

2.
If not subject to the authority of an Anti-Doping Organisation and
where Ineligibility has not been addressed in a Results Management
process pursuant to the Code, has been convicted or found in a criminal,
disciplinary or professional proceeding to have engaged in conduct which
would have constituted a violation of anti-doping rules if Code-compliant
rules had been applicable to such Person. The disqualifying status of
such Person shall be in force for the longer of six years from the criminal,
professional or disciplinary decision or the duration of the criminal,
disciplinary or professional sanction imposed; or

3.
Is serving as a front or intermediary for an individual described in art. 15
par. 1 or par. 2 (Prohibited association by a Player or other Person).

To establish a violation of art. 15, an Anti-Doping Organisation must

establish that the Player or other Person knew of the Player Support
Person’s disqualifying status.

The burden shall be on the Player or other Person to establish that any
association with a Player Support Person described in art. 15 par. 1 or par. 2
34 III. Anti-doping rule violations

is not in a professional or sport-related capacity and/or that such association

could not have been reasonably avoided.

If FIFA is aware of any Player Support Personnel who meet the criteria
described in art. 15 pars 1, 2 or 3, FIFA shall submit that information to
WADA.

16 Acts by a Player or other Person to discourage or

retaliate against reporting to authorities

Where such conduct does not otherwise constitute a violation of art. 10:

a) Any act which threatens or seeks to intimidate another Person with

the intent of discouraging the Person from the good-faith reporting
of information that relates to an alleged anti-doping rule violation
or alleged non-compliance with these Regulations and/or the Code
to WADA, FIFA, a NADO or other Anti-Doping Organisation, a law
enforcement, regulatory or professional disciplinary body, a hearing
body or a Person conducting an investigation for WADA, FIFA, a NADO
or other Anti-Doping Organisation.

b) Retaliation against a Person who, in good faith, has provided evidence

or information that relates to an alleged anti-doping rule violation
or alleged non-compliance with these Regulations and/or the Code
to WADA, FIFA, NADO or other Anti-Doping Organisation, a law
enforcement, regulatory or professional disciplinary body, a hearing
body or a Person conducting an investigation for WADA, FIFA, NADO or
other Anti-Doping Organisation.

For the purposes of this article, retaliation, threatening and intimidation

include an act taken against such Person either because the act lacks a
good faith basis or is a disproportionate response.
 IV. The prohibited list and therapeutic use exemptions 35

17 Prohibited Substances and Prohibited Methods identified

on the Prohibited List

1.
Prohibited Substances and Prohibited Methods
The Prohibited list shall identify those Prohibited Substances and Prohibited
Methods which are prohibited as doping at all times (both In-Competition
and Out-of-Competition) because of their potential to enhance performance
in future Matches or their masking potential, and those substances and
methods which are prohibited In-Competition only.

2.
Publication and revision of the Prohibited List
Unless otherwise communicated by FIFA, the Prohibited List and its revisions
shall come into effect under these Regulations three months after publication
of the Prohibited List by WADA without requiring any further action by FIFA
or its Member Associations. All Players and other Persons shall be bound by
the Prohibited List, and any revisions thereto, from the date they go into
effect, without further formality. It is the responsibility of all Players and
other Persons to familiarise themselves with the most up-to- date version of
the Prohibited List and all revisions thereto.

3.
Specified Substances or Specified Methods
For the purpose of the application of chapter V (Sanctions on individuals), all
Prohibited Substances shall be Specified Substances except those identified in
the Prohibited List. No Prohibited Method shall be a Specified Method unless
it is specifically identified as a Specified Method on the Prohibited List.

4.
Substances of Abuse
For the purposes of the application of chapter V (Sanctions on individuals),
Substances of Abuse shall include those Prohibited Substances which are
specifically identified as Substances of Abuse on the Prohibited List because
they are frequently abused in society outside the context of sport.
36 IV. The prohibited list and therapeutic use exemptions

18 WADA’s determination of the Prohibited List

WADA’s determination of the Prohibited Substances and Prohibited

Methods that will be included on the Prohibited List, the classification
of substances into categories on the Prohibited List, the classification of
a substance as prohibited at all times or In-Competition only, and the
classification of a substance or method as a Specified Substance, Specified
Method or Substance of Abuse is final and shall not be subject to any
challenge by a Player or other Person, including, but not limited to, any
challenge based on an argument that the substance or method was not
a masking agent or did not have the potential to enhance performance,
represent a health risk or violate the spirit of sport.

19 Therapeutic use exemptions (TUEs)

1.
The presence of a Prohibited Substance or its Metabolites or Markers, and/
or the Use or Attempted Use, Possession or Administration or Attempted
Administration of a Prohibited Substance or Prohibited Method, shall
not be considered an anti-doping rule violation if it is consistent with the
provisions of a TUE granted in accordance with the International Standard
for Therapeutic Use Exemptions.

2.
Any Player who consults a doctor and is prescribed treatment or medication
for therapeutic reasons shall enquire whether the prescription contains
Prohibited Substances and/or Prohibited Methods. If so, the Player shall
request alternative treatment.

3.
If there is no alternative treatment, the Player with a documented medical
condition requiring the use of a Prohibited Substance and/or a Prohibited
Method must first obtain a TUE. However, TUEs will only be granted in
cases of clear and compelling clinical need where no competitive advantage
can be gained by the Player.

4.
The application for and approval of a TUE strictly follow the procedure laid
out in the International Standard for Therapeutic Use Exemption and in the
FIFA TUE policy in force.
 IV. The prohibited list and therapeutic use exemptions 37

5.
Players who are International-Level Players must obtain TUEs in accordance
with the rules stipulated by FIFA in its TUE policy document. FIFA publishes
a list of those International Competitions for which a TUE from FIFA is
required. Details of the application procedure shall be found in Annexe
B. TUEs granted by FIFA under these rules shall be reported to the Player’s
Association and to WADA.

6.
Players who are not International-Level Players must obtain a TUE from
their NADO. NADOs shall in all cases be responsible for promptly reporting
the granting of any TUEs under these Regulations to FIFA and WADA.

7.
If FIFA chooses to collect a Sample from a Player who is not an
International-Level Player or a National-Level Player, and that Player is
Using a Prohibited Substance or Prohibited Method for therapeutic reasons,
FIFA shall permit that Player to apply for a retroactive TUE.

8.
Expiration, cancellation, withdrawal or reversal of a TUE

a) A TUE granted pursuant to these Regulations: (a) shall expire

automatically at the end of any term for which it was granted,
without the need for any further notice or other formality; (b) may
be withdrawn if the Player does not promptly comply with any
requirements or conditions imposed by the FIFA TUE Advisory Group
upon grant of the TUE; (c) may be withdrawn by the FIFA TUE Advisory
Group if it is subsequently determined that the criteria for grant of a
TUE are not in fact met; or (d) may be reversed on review by WADA or
on appeal.

b) In such event, the Player shall not be subject to any Consequences based
on his Use or Possession or Administration of the Prohibited Substance
or Prohibited Method in question in accordance with the TUE prior
to the effective date of expiry, withdrawal or reversal of the TUE. The
review pursuant to these Regulations and to the International Standard
for Results Management of any subsequent Adverse Analytical Finding,
reported shortly after the TUE’s expiration, withdrawal or reversal, shall
include consideration of whether such finding is consistent with Use of
the Prohibited Substance or Prohibited Method prior to that date, in
which event no anti-doping rule violation shall be asserted.
38 V. Sanctions on individuals

Section 1: Imposition of a period of Ineligibility

20 Ineligibility for presence, Use or Attempted Use, or

Possession of a Prohibited Substance or Prohibited Method
The period of Ineligibility for a violation of arts 6 (Presence of a Prohibited
Substance or its Metabolites or Markers in a Player’s Sample), 7 (Use or
Attempted Use by a Player of a Prohibited Substance or a Prohibited
Method) or 11 (Possession of a Prohibited Substance or a Prohibited Method
by a Player or Player Support Person) shall be as follows, subject to potential
elimination, reduction or suspension pursuant to arts 22 (Elimination of the
Period of Ineligibility where there is No Fault or Negligence), 23 (Reduction
of the period of Ineligibility based on No Significant Fault or Negligence) or
24 (Elimination, reduction, or suspension of period of Ineligibility or other
consequences for reasons other than Fault):

1.
Subject to art. 20 par. 4 of these Regulations, the period of Ineligibility shall
be four years where:

a) the anti-doping rule violation does not involve a Specified Substance,

unless the Player or other Person can establish that the anti-doping rule
violation was not intentional;

b) the anti-doping rule violation involves a Specified Substance and FIFA

can establish that the anti-doping rule violation was intentional.

2.
If art. 20 par. 1 does not apply, the period of Ineligibility shall be two years,
subject to art. 20 par. 4 of these Regulations.

3.
As used in art 20 (Ineligibility for presence, Use or Attempted Use, or
Possession of a Prohibited Substance or Prohibited Method), the term
“intentional” is meant to identify those Players or other Persons who
engage in conduct which they knew constituted an anti-doping rule
violation or knew that there was a significant risk that the conduct
might constitute or result in an anti-doping rule violation and manifestly
disregarded that risk. An anti-doping rule violation resulting from an
Adverse Analytical Finding for a substance which is only prohibited
 V. Sanctions on individuals 39

In-Competition shall be rebuttably presumed to be not intentional

if the substance is a Specified Substance and the Player can establish
that the Prohibited Substance was Used Out-of-Competition. An anti-
doping rule violation resulting from an Adverse Analytical Finding for a
substance which is only prohibited In-Competition shall not be considered
“intentional” if the substance is not a Specified Substance and the Player
can establish that the Prohibited Substance was Used Out-of-Competition
in a context unrelated to sport performance.

4.
Notwithstanding any other provision in art. 20, where the anti-doping rule
violation involves a Substance of Abuse:

a) If the Player can establish that any ingestion or Use occurred Out-of-
Competition and was unrelated to sport performance, then the period
of Ineligibility shall be three months’ Ineligibility. In addition, the period
of Ineligibility calculated under this paragraph may be reduced to one
month’s Ineligibility if the Player or other Person satisfactorily completes a
Substance of Abuse treatment programme approved by FIFA. The period
of Ineligibility established in this paragraph is not subject to any reduction
based on any provision in art. 23.

b) If the ingestion, Use or Possession occurred In-Competition, and the Player

can establish that the context of the ingestion, Use or Possession was
unrelated to sport performance, then the ingestion, Use or Possession
shall not be considered intentional for the purposes of art. 20 par. 1 and
shall not provide a basis for a finding of Aggravating Circumstances.

21 Ineligibility for other anti-doping rule violations

The period of Ineligibility for anti-doping rule violations other than as
provided in art. 20 (Ineligibility for presence, Use or Attempted Use, or
Possession of a Prohibited Substance or Prohibited Method) shall be as
follows, unless arts 23 (Reduction of the period of Ineligibility based on No
Significant Fault or Negligence) or 24 (Elimination, reduction, or suspension
of period of Ineligibility or other consequences for reasons other than
Fault) are applicable:
40 V. Sanctions on individuals

1.
For violations of art. 8 (Evading, refusing or failing to submit to Sample
collection) or art. 10 (Tampering or Attempted Tampering with any part
of Doping Control by a Player or other Person), the period of Ineligibility
shall be four years except: (i) in the case of failing to submit to Sample
collection, if the Player can establish that the commission of the anti-
doping rule violation was not intentional, the period of Ineligibility shall
be two years; (ii) in all other cases, if the Player or Person can establish
exceptional circumstances that justify a reduction of the period of
Ineligibility, the period of Ineligibility shall be in a range from two years
to four years, depending on the Players or Person’s degree of Fault; or (iii)
in a case involving a Protected Person or Recreational Player, the period of
Ineligibility shall be in a range between a maximum of two years and, at
a minimum, a reprimand and no period of Ineligibility, depending on the
Protected Person’s or Recreational Player’s degree of Fault.

2.
For violations of art. 9 (Whereabouts failures), the period of Ineligibility
shall be two years, subject to reduction down to a minimum of one year,
depending on the Player’s degree of Fault. The flexibility between two years
and one year of Ineligibility in this article is not available to Players where a
pattern of last-minute whereabouts changes or other conduct raises a serious
suspicion that the Player was trying to avoid being available for Testing.

3.
For violations of art. 12 (Trafficking or Attempted Trafficking in any
Prohibited Substance or Prohibited Method by a Player or other Person)
or art. 13 (Administration or Attempted Administration by a Player or
other Person to any Player In-Competition of any Prohibited Substance or
Prohibited Method, or Administration or Attempted Administration to any
Player Out-of-Competition of any Prohibited Substance or any Prohibited
Method that is prohibited Out-of-Competition), the period of Ineligibility
shall be a minimum of four years up to lifetime Ineligibility, depending on
the seriousness of the violation. An art. 12 or art. 13 violation involving a
Protected Person shall be considered a particularly serious violation and,
if committed by Player Support Personnel for violations other than for
Specified Substances, shall result in lifetime Ineligibility for Player Support
Personnel. In addition, significant violations of art. 12 or art. 13 which may
also violate non-sporting laws and regulations shall be reported to the
competent administrative, professional or judicial authorities.
 V. Sanctions on individuals 41

4.
For violations of art. 14 (Complicity or Attempted Complicity by a Player
or other Person), the period of Ineligibility imposed shall be a minimum of
two years, up to lifetime Ineligibility, depending on the seriousness of the
violation.

5.
For violations of art. 15 (Prohibited association by a Player or other Person),
the period of Ineligibility shall be two years, subject to reduction down to
a minimum of one year, depending on the Player’s or other Person’s degree
of Fault and other circumstances of the case.

6.
For violations of art. 16 (Acts by a Player or other Person to discourage or
retaliate against reporting to authorities), the period of Ineligibility shall
be a minimum of two years, up to lifetime Ineligibility, depending on the
seriousness of the violation by the Player or other Person.

Section 2: Elimination, reduction or suspension of period of

Ineligibility

22 Elimination of the period of Ineligibility where there is

No Fault or Negligence
If a Player or other Person establishes in an individual case that he bears No
Fault or Negligence, the otherwise applicable period of Ineligibility shall be
eliminated.

23 Reduction of the period of Ineligibility based on No

Significant Fault or Negligence
1.
Reduction of sanctions in particular circumstances for violations
of art. 6 (Presence of a Prohibited Substance or its Metabolites
or Markers in a Player’s Sample), 7 (Use or Attempted Use by a
Player of a Prohibited Substance or a Prohibited Method) or 11
(Possession of a Prohibited Substance or a Prohibited Method by
a Player or Player Support Person)
42 V. Sanctions on individuals

All reductions under this paragraph 1 are mutually exclusive and not
cumulative.

a) Specified Substances or Specified Methods

Where the anti-doping rule violation involves a Specified Substance
(other than a Substance of Abuse) or Specified Method, and the Player
or other Person can establish No Significant Fault or Negligence, then
the period of Ineligibility shall be, at a minimum, a reprimand and no
period of Ineligibility, and at a maximum, two years of Ineligibility,
depending on the Player’s or other Person’s degree of Fault.

b) Contaminated Products
In cases where the Player or other Person can establish both No
Significant Fault or Negligence and that the detected Prohibited
Substance (other than Substance of Abuse) came from a Contaminated
Product, then the period of Ineligibility shall be, at a minimum, a
reprimand and no period of Ineligibility, and at a maximum, two years’
Ineligibility, depending on the Player’s or other Person’s degree of Fault.

c) Protected Persons or Recreational Players

Where the anti-doping rule violation not involving a Substance of
Abuse is committed by a Protected Person or Recreational Player
and the Protected Person or Recreational Player can establish No
Significant Fault or Negligence, then the period of Ineligibility shall
be, at a minimum, a reprimand and no period of ineligibility, and at a
maximum, two years Ineligibility, depending on the Protected Person’s
or Recreational Player’s degree of Fault.

2.
Application of No Significant Fault or Negligence beyond the
application of art. 23 par. 1
If a Player or other Person establishes in an individual case where art. 23
par. 1 is not applicable that he bears No Significant Fault or Negligence,
then, subject to further reduction or elimination as provided in art. 24,
the otherwise applicable period of Ineligibility may be reduced based
on the Player or other Person’s degree of Fault, but the reduced period
of Ineligibility may not be less than one half of the period of Ineligibility
otherwise applicable. If the otherwise applicable period of Ineligibility is
a lifetime, the reduced period under this article may be no less than eight
years.
 V. Sanctions on individuals 43

24 Elimination, reduction, or suspension of period of

Ineligibility or other consequences for reasons other
than Fault

1.
Substantial Assistance in discovering or establishing Code
violations
a) FIFA may, prior to an appellate decision under art. 76 (Decisions
subject to appeal) or the expiration of the time to appeal, suspend a
part of the Consequences (other than Disqualification and mandatory
Public Disclosure) imposed in an individual case in which it has Results
Management authority where the Player or other Person has provided
Substantial Assistance to an Anti-Doping Organisation, criminal
authority or professional disciplinary body which results in: (i) the Anti-
Doping Organisation discovering or bringing forward an anti-doping
rule violation by another Person, or (ii) which results in a criminal or
disciplinary body discovering or bringing forward a criminal offence or
the breach of professional rules committed by another Person and the
information provided by the Person providing Substantial Assistance is
made available to FIFA or other Anti-Doping Organisation with Results
Management responsibility; or (iii) which results in WADA initiating
a proceeding against a Signatory, WADA-accredited laboratory or
Player passport management unit (as defined in the International
Standard for Testing and Investigations) for non-compliance with the
Code, International Standard or Technical Document; or (iv) with the
approval by WADA, which results in a criminal or disciplinary body
bringing forward a criminal offence or the breach of professional or
sport rules arising out of a sport integrity violation other than doping.
After an appellate decision under art. 76 (Decisions subject to appeal)
or the expiration of time to appeal, FIFA may only suspend a part of
the otherwise applicable Consequences with the approval of WADA.
The extent to which the otherwise applicable period of Ineligibility may
be suspended shall be based on the seriousness of the anti-doping rule
violation committed by the Player or other Person and the significance
of the Substantial Assistance provided by the Player or other Person
to the effort to eliminate doping in sport, non-compliance with the
Code and/or sport integrity violations. No more than three quarters of
the otherwise applicable period of Ineligibility may be suspended. If
the otherwise applicable period of Ineligibility is a lifetime, the non-
suspended period under this article must be no less than eight years.
44 V. Sanctions on individuals

For the purposes of this paragraph, the otherwise applicable period of

Ineligibility shall not include any period of Ineligibility that could be
added under art. 25 par. 4 b) of these Regulations. If so requested by
a Player or other Person who seeks to provide Substantial Assistance,
FIFA shall allow the Player or other Person to provide the information
to the Anti-Doping Organisation subject to a without-prejudice
agreement. If the Player or other Person fails to continue to cooperate
and to provide the complete and credible Substantial Assistance upon
which a suspension of the Consequences was based, FIFA shall reinstate
the original Consequences. If FIFA decides to reinstate suspended
Consequences or decides not to reinstate suspended Consequences, that
decision may be appealed by any Person entitled to appeal under art.
77 par. 3 of these Regulations.

b) To further encourage Players and other Persons to provide Substantial

Assistance to Anti-Doping Organisations, at the request of FIFA or the
Anti-Doping Organisation conducting Results Management or at the
request of the Player or other Person who has, or has been asserted
to have, committed an anti-doping rule violation or other violation of
the Code, WADA may agree at any stage of the Results Management
process, including after an appellate decision under art. 76 (Decisions
subject to appeal), to what it considers to be an appropriate
suspension of the otherwise-applicable period of Ineligibility and other
Consequences. In exceptional circumstances, WADA may agree to
suspensions of the period of Ineligibility and other Consequences for
Substantial Assistance greater than those otherwise provided in this
article, or even no period of Ineligibility, no mandatory Public Disclosure
and/or no return of prize money or payment of fines or costs. WADA’s
approval shall be subject to reinstatement of the Consequences, as
otherwise provided in this article. Notwithstanding section 6 of chapter
X (Appeals), WADA’s decisions in the context of this paragraph may not
be appealed.

c) If FIFA suspends any part of an otherwise applicable sanction because

of Substantial Assistance, then notice providing justification for the
decision shall be provided to the other Anti-Doping Organisations
with a right to appeal under art. 77 par. 3 of these Regulations. In
unique circumstances where WADA determines that it would be in
the best interests of anti-doping, WADA may authorise FIFA to enter
into appropriate confidentiality agreements limiting or delaying the
disclosure of the Substantial Assistance agreement or the nature of
Substantial Assistance being provided.
 V. Sanctions on individuals 45

2.
Admission of an anti-doping rule violation in the absence of other
evidence
Where a Player or other Person voluntarily admits to the FIFA Disciplinary
Committee that he has committed an anti-doping rule violation before
having received notice of a Sample collection which could establish an
anti-doping rule violation (or, in the case of an anti-doping rule violation
other than art. 6 (Presence of a Prohibited Substance or its Metabolites or
Markers in a Player’s Sample), before receiving first notice of the admitted
violation pursuant to section 3 of chapter IX (Results Management)) and
that admission is the only reliable evidence of the violation at the time of
admission, the period of Ineligibility may be reduced, but not below one
half of the period of Ineligibility otherwise applicable.

3.
Application of multiple grounds for reduction of a sanction
Where a Player or other Person establishes entitlement to a reduction
in sanction under more than one provision of art. 22 (Elimination of
the period of Ineligibility where there is No Fault or Negligence), art. 23
(Reduction of the period of Ineligibility based on No Significant Fault or
Negligence) or art. 24 (Elimination, reduction, or suspension of period
of Ineligibility or other consequences for reasons other than Fault),
before applying any reduction or suspension under art. 24, the otherwise
applicable period of Ineligibility shall be determined in accordance with
arts 20 (Ineligibility for presence, Use or Attempted Use, or Possession of a
Prohibited Substance or Prohibited Method), 21 (Ineligibility for other anti-
doping rule violations), 22, and 23. If the Player or other Person establishes
entitlement to a reduction or suspension of the period of Ineligibility under
art. 24, the period of Ineligibility may be reduced or suspended, but not
below one fourth of the otherwise applicable period of Ineligibility.

4.
Results Management agreement
Where a Player or other Person, after being notified by FIFA of a potential
anti-doping rule violation that carries an asserted period of Ineligibility
of four or more years (including any period of Ineligibility asserted under
Aggravating Circumstances), admits the violation and accepts the asserted
period of Ineligibility no later than 20 days after receiving notice of an anti-
doping rule violation charge, the Player or Person may receive a one-year
reduction in the period of Ineligibility asserted by FIFA. Where the Player
or other Person receives the one-year reduction in the asserted period of
Ineligibility under this article, no further reduction in the asserted period of
Ineligibility shall be allowed under any other article.
46 V. Sanctions on individuals

5.
Case resolution agreement
Where the Player or other Person admits an anti-doping rule violation after
being confronted with the anti-doping rule violation by FIFA and agrees to the
Consequences acceptable to FIFA and WADA, at their sole discretion, then:

a) the Player or other Person may receive a reduction in the period

of Ineligibility based on an assessment by FIFA and WADA of the
application of chapter V section 2 of these Regulations to the asserted
anti-doping rule violation, the seriousness of the violation, the Player
or other Person’s degree of Fault and how promptly the Player or other
Person admitted the violation; and

b) the period of Ineligibility may start as early as the date of Sample

collection or the date on which another anti-doping rule violation last
occurred. In each case, however, where this article is applied, the Player
or other Person shall serve at least one half of the agreed-upon period
of Ineligibility going forward from the earlier of the date the Player
or other Person accepted the imposition of a sanction or Provisional
Suspension which was subsequently respected by the Player or other
Person. The decision by FIFA and WADA to enter or not to enter into
a case resolution agreement, and the amount of the reduction to,
and the starting date of, the period of Ineligibility are not matters
for determination or review by a hearing body and are not subject to
appeal under chapter X section 6 of these Regulations. If so requested
by a Player or other Person who seeks to enter into a case resolution
agreement under this article, FIFA shall allow the Player or other Person
to discuss an admission of the anti-doping rule violation with the Anti-
Doping Organisation subject to a without-prejudice agreement.

Section 3: Increasing the period of Ineligibility and multiple

violations

25 Multiple violations
1.
Second or third anti-doping rule violation
For a Player or other Person’s second anti-doping rule violation, the period
of Ineligibility shall be the greater of:
 V. Sanctions on individuals 47

a) A six-month period of Ineligibility; or

b) A period of Ineligibility in the range between:

• the sum of the period of Ineligibility imposed for the first anti-
doping rule violation plus the period of Ineligibility otherwise
applicable to the second anti-doping rule violation treated as if it
were a first violation, and

• twice the period of Ineligibility otherwise applicable to the second

anti-doping rule violation treated as if it was a first violation.

The period of Ineligibility within this range shall be determined based

on the entirety of the circumstances and the Player or other Person’s
degree of Fault with respect to the second violation.

The period of Ineligibility established above may then be further reduced

by the application of art. 24.

2.
A third anti-doping rule violation will always result in a lifetime period of
Ineligibility, except if the third violation fulfils the condition for elimination
or reduction of the period of Ineligibility under art. 22 (Elimination of
the period of Ineligibility where there is No Fault or Negligence) or 23
(Reduction of the period of Ineligibility based on No Significant Fault or
Negligence), or involves a violation of art. 9 (Whereabouts failures). In
these particular cases, the period of Ineligibility shall be from eight years to
lifetime Ineligibility.

The period of Ineligibility established above may then be further reduced

by the application of art. 24.

3.
An anti-doping rule violation for which a Player or other Person has
established No Fault or Negligence shall not be considered a violation
for the purposes of this art. 25. In addition, an anti-doping rule violation
sanctioned under art. 20 par. 4 of these Regulations shall not be considered
a violation for purposes of this art. 25.
48 V. Sanctions on individuals

4.
Additional rules for certain potential multiple violations

a) For the purpose of imposing sanctions under art. 25 (Multiple

violations), except as provided in art. 25 par. 4 of these Regulations, an
anti-doping rule violation will only be considered a second violation
if FIFA can establish that the Player or other Person committed
the additional anti-doping rule violation after the Player or other
Person received notice pursuant to Section 3 of chapter IX (Results
Management) or after FIFA made reasonable efforts to give notice of
the first anti-doping rule violation. If FIFA cannot establish this, the
violations shall be considered together as one single first violation,
and the sanction imposed shall be based on the violation that carries
the more severe sanction, including the application of Aggravating
Circumstances. Results in all Matches dating back to the earlier
anti-doping rule violation will be Disqualified as provided in art. 26
(Disqualification of results).

b) If FIFA establishes that a Player or other Person committed an additional

anti-doping rule violation prior to notification, and that the additional
violation occurred 12 months or more before or after the first-noticed
violation, then the period of Ineligibility for the additional violation
shall be calculated as if the additional violation were a stand-alone first
violation and this period of Ineligibility is served consecutively, rather
than concurrently, with the period of Ineligibility imposed for the
earlier-noticed violation. Where this paragraph applies, the violations
taken together shall constitute a single violation for the purposes of art.
25 (Multiple violations).

c) If FIFA establishes that a Player or other Person committed a violation

of art. 10 (Tampering or Attempted Tampering with any part of
Doping Control by a Player or other Person) in connection with the
Doping Control process for an underlying asserted anti-doping rule
violation, the violation of art. 10 shall be treated as a standalone
first violation and the period of Ineligibility for such violation shall
be served consecutively, rather than concurrently, with the period
of Ineligibility, if any, imposed for the underlying anti-doping rule
violation. Where this paragraph is applied, the violations taken
together shall constitute a single violation for the purposes of art. 25
(Multiple violations).
 V. Sanctions on individuals 49

d) If FIFA establishes that a Person has committed a second or third anti-

doping rule violation during a period of Ineligibility, the periods of
Ineligibility for the multiple violations shall run consecutively, rather
than concurrently.

5.
Multiple anti-doping rule violations during ten-year period
For the purpose of art. 25 (Multiple violations), each anti-doping rule
violation must take place within the same ten-year period in order to be
considered multiple violations.

6.
Aggravating circumstances which may increase the period of
ineligibility
If FIFA establishes in an individual case involving an anti-doping rule
violation other than violations under art. 12 (Trafficking or Attempted
Trafficking in any Prohibited Substance or Prohibited Method by a Player
or other Person), art. 13 (Administration or Attempted Administration by
a Player or other Person to any Player In-Competition of any Prohibited
Substance or Prohibited Method, or Administration or Attempted
Administration to any Player Out-of-Competition of any Prohibited
Substance or any Prohibited Method that is prohibited Out-of-Competition),
art. 14 (Complicity or Attempted Complicity by a Player or other Person)
and art. 16 (Acts by a Player or other Person to discourage or retaliate
against reporting to authorities) that Aggravating Circumstances are
present which justify the imposition of a period of Ineligibility greater than
the standard sanction, then the period of Ineligibility otherwise applicable
shall be increased by an additional period of Ineligibility of up to two
years depending on the seriousness of the violation and the nature of the
Aggravating Circumstances, unless the Player or other Person can establish
that he not knowingly commit the anti-doping rule violation.

Section 4: Common provisions regarding sanctions on individuals

26 Disqualification of results
1.
Automatic disqualification of individual awards
An anti-doping rule violation in connection with an In-Competition test
automatically leads to Disqualification of any awards received by individual
Players in that Match.
50 V. Sanctions on individuals

2.
Disqualification of results in the Competition during which an anti-
doping rule violation occurs
An anti-doping rule violation occurring during or in connection with a
Competition may, upon the decision of the ruling body of the Competition,
lead to Disqualification of all of the Player’s individual results obtained in
that Competition with all Consequences, including forfeiture of all awards,
except as provided in paragraph 3 of this article.

Factors to be included in considering whether to Disqualify other results in

a Competition might include, for example, the seriousness of the Player’s
anti-doping rule violation and whether the Player tested negative in the
other Matches.

3.
If the Player establishes that he bears No Fault or Negligence for the
violation, the Player’s individual results in the other Matches shall not be
Disqualified, unless the Player’s results in Matches other than the Match
in which the anti-doping rule violation occurred were likely to have been
affected by the Player’s anti-doping rule violation.

4.
Disqualification of results in Matches subsequent to Sample
collection or commission of an anti-doping rule violation
In addition to the automatic Disqualification of the results in the Match
which produced the positive Sample under paragraph 1 of this article, all
other competitive results of the Player obtained from the date a positive
Sample was collected (whether In-Competition or Out-of-Competition),
or other anti-doping rule violation occurred, through the commencement
of any Provisional Suspension or Ineligibility period, shall, unless fairness
requires otherwise, be Disqualified with all of the resulting Consequences.

27 Forfeited prize money

If FIFA has recovered prize money forfeited as a result of an anti-doping
rule violation, it shall take reasonable measures to allocate and distribute
this prize money to the Players who would have been entitled to it had the
forfeiting Player not competed.
 V. Sanctions on individuals 51

28 Financial consequences

1.
On account of anti-doping rule violations, financial sanctions may be imposed
in accordance with the FIFA Disciplinary Code.

2.
However, no financial sanction may be considered as grounds for reducing
the period of Ineligibility or other sanction that would otherwise be
applicable under these Regulations.

3.
Repayment of prize money or other financial support
As a condition of regaining eligibility after being found to have committed
an anti-doping rule violation, the Player may first be obliged to repay all
prize money or other financial support obtained from sports organisations,
and from the date a positive Sample was collected or other anti-doping
rule violation occurred, until the commencement of any Provisional
Suspension or period of Ineligibility.

4.
After being found to have committed an anti-doping rule violation, the
Player or other person may be requested to reimburse the proportionate
expenses of the Sample collection and the Results Management of his case.

29 Commencement of period of Ineligibility

Where a Player is already serving a period of Ineligibility for an anti-doping
rule violation any new period of Ineligibility shall commence on the first day
after the current period of Ineligibility has been served. Otherwise, except as
provided below, the period of Ineligibility shall start on the date of the final-
hearing decision providing for Ineligibility or, if the hearing is waived or there
is no hearing, on the date the Ineligibility is accepted or otherwise imposed.

1.
Delays not attributable to the Player or other Person
Where there have been substantial delays in the hearing process or other
aspects of Doping Control and the Player or other Person can establish that
such delays are not attributable to the Player or other Person, the FIFA
52 V. Sanctions on individuals

Disciplinary Committee may decide that the period of Ineligibility shall start
at an earlier date, commencing as early as the date of Sample collection
or the date on which another anti-doping rule violation last occurred. All
competitive results achieved during the period of Ineligibility, including
retroactive Ineligibility, shall be Disqualified.

2.
Credit for Provisional Suspension or period of Ineligibility served
a) If a Provisional Suspension is respected by the Player or other Person,
then the Player or other Person shall receive a credit for such period
of Provisional Suspension against any period of Ineligibility which may
ultimately be imposed. If the Player or other Person does not respect a
Provisional Suspension, then the Player or other Person shall receive no
credit for any period of the Provisional Suspension served. If a period
of Ineligibility is served pursuant to a decision that is subsequently
appealed, the Player or other Person shall receive a credit for such
period of Ineligibility served against any period of Ineligibility which
may ultimately be imposed on appeal.

b) If a Player or other Person voluntarily accepts a Provisional Suspension

in writing from FIFA and thereafter respects the Provisional Suspension,
the Player or other Person shall receive a credit for such period of
voluntary Provisional Suspension against any period of Ineligibility
which may ultimately be imposed. A copy of the Player or other Person’s
voluntary acceptance of a Provisional Suspension shall be provided
promptly to each party entitled to receive notice of an asserted
anti-doping rule violation as provided in these Regulations (art. 70:
Information concerning asserted anti-doping rule violations).

c) No credit against a period of Ineligibility shall be given for any time

period before the effective date of the Provisional Suspension or
voluntary Provisional Suspension regardless of whether the Player
elected not to compete or was suspended by a team.

d) Where a period of Ineligibility is imposed upon a team, unless fairness

requires otherwise, the period of Ineligibility shall start on the date of
the final hearing decision providing for Ineligibility or, if the hearing is
waived, on the date Ineligibility is accepted or otherwise imposed. Any
period of team Provisional Suspension (whether imposed or voluntarily
accepted) shall be credited against the total period of Ineligibility to be
served.
 V. Sanctions on individuals 53

30 Status during Ineligibility or Provisional Suspension

1.
Prohibition of participation during Ineligibility or Provisional
Suspension
No Player or other Person who has been declared Ineligible or is subject to
a Provisional Suspension may, during a period of Ineligibility or Provisional
Suspension, participate in any capacity in a Match or activity (other
than authorised anti-doping Education or rehabilitation programmes)
authorised or organised by FIFA, any Association, any other Signatory of
the Code, a club or other member organisation of an Association or of
any Signatory to the Code, or In-Competitions authorised or organised by
any professional league or any international or national-level Competition
organisation or any elite or national-level sporting activity funded by a
governmental agency.

A Player or other Person subject to a period of Ineligibility longer than

four years may, after completing four years of the period of Ineligibility,
participate as a Player in local sports competitions not approved or
otherwise under the authority of FIFA, the Associations or Confederations,
or any other Signatory to the Code or its member, but only so long as the
local sports competition is not at a level that could otherwise qualify such
Player or other Person directly or indirectly to compete in (or accumulate
points towards) a national championship or International Competition, and
does not involve the Player or other Person working in any capacity with
Protected Persons.

A Player or other Person subject to a period of Ineligibility shall remain

subject to Testing and any possible requirement by FIFA or other Anti-
Doping Organisation to provide whereabouts information.

2.
Return to training
As an exception to art. 30 par. 1, a Player may return to train with a team
or to use the facilities of a club or other member organisation of a FIFA
Member Association or any other Signatory to the Code during the shorter
of: (1) the last two months of the Player’s period of Ineligibility, or (2) the
last one quarter of the period of Ineligibility imposed.
54 V. Sanctions on individuals

3.
Violation of the prohibition of participation during Ineligibility or
Provisional Suspension
Where a Player or other Person who has been declared ineligible violates
the prohibition against participation during Ineligibility as described in
art. 30 par. 1, the results of such participation shall be Disqualified and
a new period of Ineligibility equal in length up to the original period of
Ineligibility shall be added to the end of the original period of Ineligibility.
The new period of Ineligibility, including a reprimand and no period
of Ineligibility, may be adjusted based on the Player or other Person’s
degree of Fault and other circumstances of the case. The determination
of whether a Player or other Person has violated the prohibition against
participation, and whether an adjustment is appropriate, shall be made
by FIFA or the Anti-Doping Organisation whose Results Management led
to the imposition of the initial period of Ineligibility. This decision may be
appealed as provided in these Regulations.

A Player or other Person who violates the prohibition against participation

during a Provisional Suspension described in this article shall receive no
credit for any period of Provisional Suspension served and the results of
such participation shall be Disqualified. Where a Player Support Person
or other Person assists a Person in violating the prohibition against
participation during Ineligibility or a Provisional Suspension, FIFA shall
impose sanctions for a violation of art. 14 (Complicity or Attempted
Complicity by a Player or other Person) for such assistance.

4.
Withholding of financial support during Ineligibility
In addition, for any anti-doping rule violation not involving a reduced
sanction as described in art. 22 (Elimination of the period of Ineligibility
where there is No Fault or Negligence) or art. 23 (Reduction of the period
of Ineligibility based on No Significant Fault or Negligence), some or all
sport-related financial support or other sport-related benefits received
by such Person will be withheld by FIFA, its Member Associations or the
Confederations.

31 Automatic publication of sanction

A mandatory part of each sanction shall include automatic publication
(Public Disclosure), as provided in art. 71 (Public Disclosure).
 VI. Consequences for teams 55

32 Target Testing of the team

Where more than one member of a team has been notified of an anti-
doping rule violation under Section 3 of chapter IX (Results Management)
in connection with a Competition, the ruling body for the Competition
shall conduct appropriate Target Testing of the team during the
Competition Period.

33 Sanction on the club or Association

1.
If a Member Association’s NADO is declared to be non-compliant according
to the International Standard for Code Compliance by Signatories, the FIFA
Disciplinary Committee shall recognise the effects of the asserted non-
compliance and apply them to the relevant Member Association, including
but not limited to the possibility of excluding all or some members of that
Member Association from specified future Competitions or all Competitions
conducted within a specified period of time in line with the International
Standard for Code Compliance by Signatories.

2.
If more than two members of a team are found to have committed an anti-
doping rule violation during a Competition Period, the FIFA Disciplinary
Committee, if FIFA is the ruling body, or otherwise the Association
concerned, shall impose an appropriate sanction on the team and on the
Association or club to which the members of the team belong in addition
to any consequences imposed upon the individual Player(s) committing the
anti-doping rule violation.

3.
The sanctions provided for under the FIFA Disciplinary Code in force are
applicable.
56 VII. Provisional Suspension

34 Jurisdiction

1.
Where it is asserted that an anti-doping rule has been violated in
connection with any test conducted by FIFA, the chairman of the FIFA
Disciplinary Committee shall be responsible for imposing the relevant
Provisional Suspension.

2.
For the purposes of this chapter, references hereafter to the chairman of
the FIFA Disciplinary Committee shall, where appropriate, be understood as
meaning the relevant Person or body of the Association, and references to
the Player shall, where appropriate, be understood as meaning any Player
Support Personnel or other Person.

35 Mandatory Provisional Suspension

1.
When an Adverse Analytical Finding or Adverse Passport Finding (upon
the completion of the Adverse Passport Finding review process) is received
for a Prohibited Substance or a Prohibited Method, other than a Specified
Substance or Specified Method, a Provisional Suspension shall be imposed
promptly upon or after the review and notification required under art.
53 (Initial review regarding Adverse Analytical/Atypical Findings and
notification).

2.
The mandatory Provisional Suspension may be eliminated if (i) the Player
demonstrates to the FIFA Disciplinary Committee that the violation is likely
to have involved a Contaminated Product, or (ii) the violation involves a
Substance of Abuse and the Player establishes entitlement to a reduced
period of Ineligibility under art. 20 par. 4 of these Regulations. The FIFA
Disciplinary Committee’s decision not to eliminate a mandatory Provisional
Suspension on account of the Player’s assertion regarding a Contaminated
Product shall not be appealable.

3.
A mandatory Provisional Suspension may not be imposed unless the Player
or other Person is given: (a) an opportunity for a Provisional Hearing, either
 VII. Provisional Suspension 57

before imposition of the mandatory Provisional Suspension or on a timely

basis after imposition of the mandatory Provisional Suspension; or (b) an
opportunity for an expedited hearing in accordance with art. 64 (Right to a
fair hearing) on a timely basis after imposition of a mandatory Provisional
Suspension. The imposition of a mandatory Provisional Suspension, or
the decision not to impose a mandatory Provisional Suspension, may be
appealed in an expedited process in accordance with art. 77 (Appeals
against decisions regarding anti-doping rule violations, Consequences,
Provisional Suspensions, implementation of decisions and authority).

4.
A mandatory Provisional Suspension shall start on the date on which it is
notified (or deemed to be notified) by the FIFA Disciplinary Committee
to the Player or other Person and shall end with the final decision of the
FIFA Disciplinary Committee, unless earlier lifted in accordance with the
rules under this section. However, the period of the mandatory Provisional
Suspension shall not exceed the maximum length of the period of
Ineligibility that may be imposed on the Player or other Person based on
the relevant anti-doping rule violation(s).

36 Optional Provisional Suspension based on an Adverse

Analytical Finding for Specified Substances, Specified
Methods, Contaminated Products, or other anti-doping
rule violations
1.
In the case of an Adverse Analytical Finding for a Specified Substance,
Specified Method, Contaminated Products or other anti-doping rule
violations not covered by art. 35, a Provisional Suspension may be imposed
prior to analysis of the Player’s “B” Sample or final hearing as described in
art. 64 (Right to a fair hearing).

2.
A Provisional Suspension may not be imposed unless the Player or other
Person is given: (a) an opportunity for a Provisional Hearing, either
before imposition of the Provisional Suspension or on a timely basis after
imposition of the Provisional Suspension; or (b) an opportunity for an
expedited hearing in accordance with art. 64 (Right to a fair hearing) on
a timely basis after imposition of a Provisional Suspension. The imposition
of a Provisional Suspension, or the decision not to impose a Provisional
Suspension, may be appealed in an expedited process in accordance with
58 VII. Provisional Suspension

art. 77 (Appeals against decisions regarding anti-doping rule violations,

Consequences, Provisional Suspensions, implementation of decisions and
authority).

3.
A Provisional Suspension shall start on the date on which it is notified (or
deemed to be notified) by the FIFA Disciplinary Committee to the Player or
other Person and shall end with the final decision of the FIFA Disciplinary
Committee, unless earlier lifted in accordance with the rules under this
section. However, the period of the Provisional Suspension shall not exceed
the maximum length of the period of Ineligibility that may be imposed on the
Player or other Person based on the relevant anti-doping rule violation(s).

37 Voluntary acceptance of Provisional Suspension

1.
Players may, on their own initiative, voluntarily accept a Provisional
Suspension if done so prior to the later of: (i) the expiration of ten days
from the report of the “B” Sample (or waiver of the “B” Sample) or ten
days from the notice of any other anti-doping rule violation, or (ii) the date
on which the Player first competes after such report or notice.

Other Persons on their own initiative may voluntarily accept a Provisional

Suspension if done so within ten days from the notice of the anti-doping
rule violation.

Upon such voluntary acceptance, the Provisional Suspension shall have

the full effect and be treated in the same manner as if the Provisional
Suspension had been imposed under art. 35 or art. 36 of these Regulations
provided, however, at any time after voluntarily accepting a Provisional
Suspension, the Player or other Person may withdraw such acceptance, in
which event the Player or other Person shall not receive any credit for time
previously served during the Provisional Suspension.

2.
The Player or other Person may accept a voluntary Provisional Suspension
provided that this is confirmed in writing to the FIFA Disciplinary
Committee.
 VII. Provisional Suspension 59

3.
A voluntary Provisional Suspension shall be effective only from the date
of receipt of the Player’s or other Person’s written confirmation of such
by FIFA. Therefore, the Association concerned has to promptly submit a
copy of the Player’s or other Person’s voluntary acceptance of a Provisional
Suspension if it was addressed to the relevant Person or body of the
Association.

38 Notification
1.
A Player or other Person who has been Provisionally Suspended, or whose
Provisional Suspension has been lifted, shall be notified immediately, as
set forth in the International Standard for Results Management, the FIFA
Disciplinary Code and in these Regulations.

2.
In any case where an Association imposes or declines to impose a
Provisional Suspension or a Player or other Person accepts a voluntary
suspension, the Association shall inform the FIFA Disciplinary Committee of
this fact immediately.

39 “B” Sample proves negative

1.
If a Provisional Suspension is imposed based on an “A” Sample Adverse
Analytical Finding and a subsequent “B” Sample analysis (if requested
by the Player or FIFA) does not confirm the “A” Sample analysis, then
the Player shall not be subject to any further Provisional Suspension on
account of a violation of art. 6 (Presence of a Prohibited Substance or its
Metabolites or Markers in a Player’s Sample).

2.
In circumstances where the Player or team has been removed from a
Competition based on a violation of art. 6 (Presence of a Prohibited
Substance or its Metabolites or Markers in a Player’s Sample) and the
subsequent “B” Sample analysis does not confirm the “A” Sample finding,
60 VII. Provisional Suspension

where, without otherwise affecting the Competition, it is still possible for

the Player or team to be reinstated, the Player or team may continue to
take part in the Competition.

3.
With reference to par. 2, in any other case where a reinstatement affects
the Competition, the Player or team shall not continue to take part in the
Competition and shall not make any claim for damages or compensation.
 VIII. Statute of limitations 61

40 Statute of limitations

No anti-doping rule violation proceeding may be commenced against

a Player or other Person unless he has been notified of the anti-doping
rule violation as provided in these Regulations, or notification has been
reasonably Attempted, within ten years of the date the violation is asserted
to have occurred.
62 IX. Testing

SECOND TITLE: TESTING AND PROCEDURAL RULES

Section 1: Testing

41 General rules for Testing

1.
Under these Regulations, every Player may be subject to In-Competition
Testing at the Matches in which he competes and to Out-of-Competition
Testing at any time and place by FIFA or the relevant Association. Testing
shall include, but shall not be limited to, urine tests and blood tests.

2.
Within its jurisdiction, FIFA may delegate Testing under these Regulations
to any Association, Confederation, WADA, governmental agency, NADO
or Delegated Third Party that it deems to be suitably qualified for the
purpose. In this case, reference to the FIFA Anti-Doping Unit or the
FIFA Doping Control Officer shall, where appropriate, be understood as
meaning the mandated party or Person. Irrespective of the foregoing, the
overall responsibility remains with FIFA.

3.
Only a single organisation shall have the authority to conduct In-Competition
Testing.

a) At International Competitions, FIFA or another international

organisation that is the ruling body for the Match/Competition shall
have authority to conduct Testing.

b) At National Competitions, the designated NADO of that country shall

have authority to conduct Testing.

c) If an Anti-Doping Organisation is not responsible for initiating and

directing Testing at a Competition, but would otherwise have Testing
authority and desires to conduct Testing of Players at the Competition
Venues during the Competition Period, it shall first contact FIFA or the
other ruling body of the Match/Competition to obtain the appropriate
permission. If the Anti-Doping Organisation is not satisfied with
the response of FIFA or the other ruling body, it may ask WADA for
permission to conduct Testing and to determine how to coordinate
such Testing. WADA shall not grant any such approval before it has
 IX. Testing 63

consulted with and informed FIFA or the other ruling body for the
Match/Competition. WADA’s decision shall be final and not subject
to appeal. Unless otherwise provided in the authorisation to conduct
Testing, such tests shall be considered Out-of-Competition tests. Results
Management for any such test shall be the responsibility of the Anti-
Doping Organisation initiating the test, unless provided otherwise in
the rules of the ruling body of the Match/Competition.

4.
In addition to FIFA and the relevant Association, the following organisations
shall be responsible for initiating and directing Out-of-Competition Testing:

a) the IOC in connection with the Olympic Games;

b) the NADO of the country or territory of which the Player is a national or

resident and/or in which the Player is present;

5.
WADA shall have In-Competition and Out-of-Competition Testing authority
as set out in article 20.7.10 of the Code.

6.
Testing of individual Players shall be performed in line with the
International Standard for Testing and Investigations. Testing shall be
performed with no advance notice. For In-Competition Testing, place
holder selection may be known in advance, but shall not be revealed to the
Player until notification.

42 Test distribution plan

1.
The FIFA Anti-Doping Unit shall develop a test distribution plan for efficient
and effective In-Competition and Out-of-Competition Testing for all Players
over whom FIFA has jurisdiction, including but not limited to Players in the
FIFA IRTP.

2.
In developing the test distribution plan, the FIFA Anti-Doping Unit shall
consider the risk of doping in football based on:
64 IX. Testing

a) the FIFA Doping Control database on positive tests and the respective
substances detected;

b) the WADA statistics;

c) which Prohibited Substances and/or Prohibited Methods a Player would

consider most likely to enhance performance in football;

d) the history of doping in football as well as the outcomes of previous

test distribution planning cycles including past Testing strategies;

e) the Competition calendar, including seasonal breaks which enables

identification of the time(s) during the year the Player would be most
likely to benefit from Prohibited Substances and/or Prohibited Methods;

f) the number of Players;

g) the physical and other demands of football;

h) available statistics and research on doping trends;

i) information received/intelligence developed on possible doping

practices in football (e.g. laboratory recommendations; reports; Player
testimony; information from criminal investigations);

j) at what points during a Player’s career he would be most likely to

benefit from Prohibited Substances and/or Prohibited Methods;

k) the rewards and/or potential incentives for doping available at different

levels of football and the nations participating in football.

3.
The FIFA Anti-Doping Unit shall also take the anti-doping activities of the
Member Associations and Confederations and the strength of the national
anti-doping programme of the particular nation into account. The plan shall
be updated, if necessary, on the basis of this regular review, particularly with
regard to the relative merits of Out-of-Competition and In-Competition
Testing in football.

4.
The timing of Testing and the number of Sample collections shall be
determined by the type of Sample collection, including Out-of-Competition,
 IX. Testing 65

In-Competition, blood and urine Sample collection, in order to ensure

optimum deterrence and detection of doping in football.

5.
Player Support Personnel and/or any other Person with a conflict of interest
shall not be involved in test distribution planning for their Players or in the
process of selecting Players for Testing.

6.
The FIFA Anti-Doping Unit shall maintain a record of test distribution
planning data in order to coordinate Testing activities with other
Anti-Doping Organisations.

7.
The Chain of Custody of the Samples shall ensure that Samples and the
respective documentation forms arrive together at the laboratory.

43 Selection of Players for Testing

1.
In implementing the test distribution plan, the FIFA Anti-Doping Unit shall
select Players for Sample collection using random selection methods and
Target Testing, as applicable, in line with the International Standard for
Testing and Investigations. Following the respective risk assessment, Target
Testing shall be prioritised, where possible and reasonable.

2.
Target Testing shall be based on an intelligent assessment of the risks
of doping and the most effective use of resources to ensure optimum
detection and deterrence. Target Testing shall be a priority, i.e. a significant
amount of the Testing undertaken as part of FIFA’s test distribution plan
shall be Target Testing of Players within its overall pool. If more than one
Player in a team has been tested positive, Target Testing shall be performed
on all Players in the team. For individual Players, Target Testing may be
performed as a consequence of behaviour indicating doping, abnormal
biological parameters (blood parameters, steroid profiles, etc.), injury,
repeated failure to meet whereabouts requirements, Player test history and
when a Player is reinstated after a period of Ineligibility.
66 IX. Testing

3.
Testing that is not Target Testing shall be determined by random selection
in accordance with the International Standard for Testing and Investigation.
In-Competition, the FIFA Doping Control Officer shall be authorised to
select additional Players for Sample collection, e.g. for behaviour indicating
doping. Out-of-Competition, the FIFA Doping Control Officer shall follow
the instructions for the selection of the Player(s) as given on the respective
authorisation form by the FIFA Anti-Doping Unit.

44 Sample collection personnel: FIFA Doping Control

Officers, assistants, Chaperones
1.
The FIFA Anti-Doping Unit shall designate an accredited FIFA Doping
Control Officer to carry out In-Competition tests at the Matches in question
and for Out-of-Competition doping tests as defined in the test distribution
plan.

2.
The FIFA Doping Control Officer must have undergone specific training as
a FIFA Doping Control Officer. He shall be responsible for the entire doping
test procedure, including blood sampling and the immediate dispatch of
urine Samples to the relevant laboratory and of copies of the forms to FIFA.
FIFA shall provide him with the material required to carry out the tests.

3.
The FIFA Anti-Doping Unit may also appoint one or several assistants to
the FIFA Doping Control Officer, if necessary, e.g. in the case of double
headers. Furthermore, the FIFA Doping Control Officer may be supported
by Chaperones.

4.
The FIFA Doping Control Officer may delegate the urine sampling
procedure or parts thereof to his assistant. The blood sampling procedure
may not be delegated unless the assistant is a doctor. Nevertheless, if
national legislation allows professionals other than doctors to collect
Samples of bodily fluids (with all consequences including medical
confidentiality according to medical ethics and the Hippocratic Oath), an
exception may be made regarding the assistant by the FIFA Anti-Doping
Unit. In the case of delegation, reference to the FIFA Doping Control
Officer shall, where appropriate, be understood as meaning the assistant.
 IX. Testing 67

5.
All other Sample collection personnel, in addition to the FIFA Doping
Control Officer, shall have been trained for their assigned responsibilities,
shall not have a conflict of interest in the outcome of the Sample collection
for which they are appointed and shall not be Minors.

6.
All Sample collection personnel shall have official identification that is
provided either by FIFA or the FIFA-authorised Anti-Doping Organisation/
relevant competent body. The minimum identification requirement is
official documentation naming FIFA or the FIFA-authorised Anti-Doping
Organisation by which the Person has been authorised. In the case of FIFA
Doping Control Officers, this documentation shall include their name and
photograph and an expiry date.

45 Failure to comply with Doping Control

1.
When any member of the Sample collection personnel becomes aware of
any matters occurring before, during or after a Sample Collection Session
that may lead to a determination of a failure to comply, he must inform
the FIFA Doping Control Officer immediately.

2.
The FIFA Doping Control Officer shall then:

a) inform the Player or other Person of the Consequences of a possible

failure to comply;

b) complete the Player’s Sample Collection Session, if possible;

c) provide a detailed written report of any possible failure to comply to

the FIFA Anti-Doping Unit.

3.
The FIFA Anti-Doping Unit shall then:

a) inform the Player or other Person and WADA of the possible failure to
comply in writing and grant an opportunity to respond;
68 IX. Testing

b) instigate a review of the possible failure to comply based on all relevant

information and documentation and without unnecessary delay;

c) document the evaluation process;

d) make the final determination available to other Anti-Doping

Organisations in accordance with section 4 of chapter X (Confidentiality
and reporting).

4.
If the FIFA Anti-Doping Unit determines that there has been a potential
failure to comply, it shall:

a) promptly notify the Player or other Person in writing of the possible

Consequences, i.e. that a potential failure to comply will be investigated
by the FIFA Disciplinary Committee or its equivalent at Association level
and that appropriate follow-up action will be taken in accordance with
these Regulations and the FIFA Disciplinary Code;

b) notify the FIFA Disciplinary Committee of all relevant facts.

5.
Any additional necessary information about the potential failure to comply
shall be obtained from all relevant sources, including the Player or other
Person, as soon as possible and recorded.

6.
The FIFA Disciplinary Committee shall investigate the potential failure to
comply and take appropriate follow-up action in accordance with these
Regulations and the FIFA Disciplinary Code.

7.
The FIFA Anti-Doping Unit shall establish a system for ensuring that the
outcomes of its reviews into the potential failure to comply are considered
for the purposes of Results Management and, if applicable, for further
planning and Target Testing.
 IX. Testing 69

46 Whereabouts information

The provisions to be respected by the Players governing whereabouts

information are set forth under Annexe C of these Regulations.

Section 2: Analysis of Samples

47 Use of accredited, approved and other laboratories

1.
For the purpose of directly establishing an Adverse Analytical Finding under
art. 6 (Presence of a Prohibited Substance or its Metabolites or Markers in
a Player’s Sample), analysis of the Samples shall be carried out in WADA-
accredited laboratories or laboratories otherwise approved by WADA
(see Annexe F). The choice of the WADA accredited or WADA approved
laboratory used for the Sample analysis shall be determined exclusively by
the FIFA Anti- Doping Unit.

Facts related to anti-doping rule violations may be established by any

reliable means. This would include, for example, reliable laboratory or
other forensic testing not conducted in WADA-accredited or approved
laboratories.

2.
Samples and related analytical data or Doping Control information shall
be analysed to detect Prohibited Substances and Prohibited Methods
identified on the Prohibited List and other substances as may be directed by
WADA pursuant to its monitoring programme; or to assist FIFA in profiling
relevant parameters in a Player’s urine, blood or other matrix, including
for DNA or genomic profiling; or for any other legitimate anti- doping
purpose.

3.
Samples, related analytical data and Doping Control information may be
used for anti-doping research purposes, although no Sample may be used
for research without the Player’s written consent. Moreover, Samples and
related analytical data or Doping Control information used for research
purposes shall first be processed in such a manner as to prevent Samples
and related analytical data or Doping Control information being traced
back to a particular Player. Any research involving Samples and related
70 IX. Testing

analytical data or Doping Control information shall adhere to the principles

set out in article 19 of the Code.

48 Standards for Sample analysis and reporting

1.
Laboratories shall analyse Samples and report results in conformity with
the International Standard for Laboratories. The head of the laboratory
shall send the test results immediately by encrypted email to the FIFA
Anti-Doping Unit.

2.
The FIFA Anti-Doping Unit may request that laboratories analyse its
Samples using more extensive menus than those described in the Technical
Document of WADA.

3.
The FIFA Anti-Doping Unit may request that laboratories analyse its
Samples using less extensive menus than those described in the Technical
Document of WADA only if the FIFA Anti-Doping Unit has satisfied WADA
that, because of the particular circumstances as set out in a test distribution
plan, less extensive analysis would be appropriate.

4.
Laboratories may, at their own initiative and expense, analyse Samples for
Prohibited Substances or Prohibited Methods not included on the standard
Sample analysis menu. If additional analyses not included on the standard
sample analysis menu are requested by FIFA, FIFA shall bear the respective
costs. Results from any such analysis shall be reported to FIFA and have the
same validity and Consequences as any other analytical result.

49 Further analysis of Samples

Any Sample may be stored and subjected to further analysis for the purpose
of detection of Prohibited Substances and/or Prohibited Methods and other
substances as described in this chapter prior to FIFA notifying a Player that
the Sample is the basis for an anti-doping rule violation charge. If after
such notification FIFA wishes to conduct an additional analysis of that
 IX. Testing 71

Sample, it may do so only with the consent of the Player or the approval of
a hearing body. Other circumstances and conditions for further analysis of
Samples shall conform to the requirements of the International Standard for
Laboratories and the International Standard for Testing and Investigations.

50 Property
All Samples provided by Players in Doping Controls conducted under the
responsibility of FIFA shall immediately become the property of FIFA.

51 Guidance
If, at any stage, any question or issue arises concerning the analysis or
interpretation of the results of a Sample, the Person responsible for the
analysis at the laboratory may consult the FIFA Anti-Doping Unit for guidance.

Section 3: Results Management

52 Management process
1.
FIFA’s Results Management process is set forth below and in the
International Standard for Results Management.

2.
In the case of a Player tested by FIFA or where a Player has to file
whereabouts information pursuant to Annexe C of these Regulations
to FIFA, the Results Management process shall be conducted by the FIFA
Anti-Doping Unit as the Results Management authority. In all other cases, it
shall be conducted by the relevant Person or body of the Player’s Association.
Requests for assistance in conducting, or information about, the Results
Management process may be made to the FIFA Anti-Doping Unit at any time.

3.
For the purposes of this chapter, references hereafter to the FIFA Anti-
Doping Unit shall, where appropriate, be understood as meaning the
72 IX. Testing

relevant Person or body of the Association and references to the Player

shall, where appropriate, be understood as meaning any Player Support
Personnel or other Person.

53 Initial review regarding Adverse Analytical/Atypical

Findings and notification
1.
Upon receipt of an Adverse Analytical or an Atypical Finding in an “A”
Sample, the FIFA Anti-Doping Unit shall conduct a review to determine
whether:

a) an applicable TUE has been granted or will be granted to the Player for
the Prohibited Substance;

b) there is any apparent departure from the International Standard for

Laboratories, the International Standard for Testing and Investigations
or other applicable provision in these Regulations that caused the
Adverse Analytical Finding/Atypical Finding such as to undermine the
validity of the finding.

c) it is apparent that the Adverse Analytical Finding or Atypical Finding

was caused by ingestion of the relevant Prohibited Substance through a
permitted route.

2.
If the initial review of an Adverse Analytical Finding does not reveal an
applicable TUE or entitlement to a TUE or departure from the International
Standards that caused the Adverse Analytical Finding or ingestion through
a permitted route, the FIFA Anti-Doping Unit shall at once confidentially
notify the Player, the FIFA Disciplinary Committee, the Player’s Association,
the Player’s Confederation, the NADO with testing authority over the
Player and/or club and WADA, in the manner set forth under this article.

3.
If the initial review of an Atypical Finding does not reveal an applicable
TUE or an apparent departure from the International Standards that
caused the Atypical Finding or ingestion through a permitted route, the
FIFA Anti-Doping Unit shall conduct the required investigation. If, after the
investigation has been completed, the FIFA Anti-Doping Unit decides to
 IX. Testing 73

bring forward the Atypical Finding as an Adverse Analytical Finding, the

Player (in the manner provided below), his club, the Confederation, the
Association concerned, the NADO with testing authority over the Player
and WADA shall be notified in the manner set forth under this article.

4.
If, at any point during the Results Management process up until the charge,
the FIFA Anti-Doping Unit decides not to move forward with a matter, it
must notify the Player or other Person (provided the Player or other Person
has already been informed of the ongoing Results Management) and give
notice (with reasons) to the Anti-Doping Organisation(s) with a right of
appeal under art. 77 par. 3 (Persons entitled to appeal).

5.
In the case of an Adverse Analytical Finding, the Player shall be promptly
notified of the following (see art. 62 (Addressees of decisions and other
documents) and chapter X section 4 (Confidentiality and reporting)):

a) the Adverse Analytical Finding;

b) the fact that the Adverse Analytical Finding may result in an anti-
doping rule violation of art. 6 (Presence of a Prohibited Substance or its
Metabolites or Markers in a Player’s Sample) and/or 7 (Use or Attempted
Use by a Player of a Prohibited Substance or a Prohibited Method) and
the applicable Consequences;

c) his right to promptly request the analysis of the “B” Sample and, failing
such request within the time limit set by these Regulations, of the fact
that the “B” Sample analysis may be deemed irrevocably waived. The
Player shall be advised at the same time that, if the “B” Sample analysis
is requested, all related laboratory costs shall be borne by the Player,
unless the “B” Sample fails to confirm the “A” Sample, in which case
the costs shall be borne by FIFA;

d) the fact that analysis of the “B” Sample may be conducted at the
request of FIFA regardless of the Player’s decision in this respect;

e) the scheduled date, time and place for the “B” Sample analysis if the
Player or FIFA chooses to request an analysis of the “B” Sample. These
items may also be promptly communicated in a subsequent letter after
the Player (or FIFA) has requested the “B” Sample analysis;
74 IX. Testing

f) the opportunity for the Player and/or the Player’s representative to

attend the “B” Sample opening and analysis in accordance with the
International Standard for Laboratories;

g) the Player’s right to request copies of the “A” Sample laboratory

documentation package, which includes information as required by the
International Standard for Laboratories.

h) the fact that the case will be handed over to the FIFA Disciplinary
Committee for further evaluation of the case;

i) that the Player will be informed by the FIFA Disciplinary Committee

about his opportunity to provide an explanation within a short
deadline;

j) that the Player has an opportunity to provide Substantial Assistance,

admit the anti-doping rule violation and potentially benefit from a
one-year reduction in the period of Ineligibility as set out in art. 24
(Elimination, reduction, or suspension of period of Ineligibility or other
consequences for reasons other than Fault) or to seek to enter into a
case resolution agreement;

k) any matters relating to a Provisional Suspension (including the

possibility for the Player to accept a voluntary suspension as set out in
art. 37 (Voluntary acceptance of Provisional Suspension).

6.
Notice of an Atypical Finding will not be provided before completion of the
investigation under this article and before the decision as to whether to
bring forward the Atypical Finding as an Adverse Analytical Finding unless
one of the following circumstances exists:

a) If the FIFA Anti-Doping Unit determines that the “B” Sample should be
analysed prior to the conclusion of its investigation under art. 53 par. 4,
the FIFA Anti-Doping Unit may conduct the “B” Sample analysis after
notifying the Player accordingly, such notice to include a description of
the Atypical Finding and the information described in art. 53 par. 4 c) to j).

b) If FIFA receives a request, either from a Major Event Organisation

shortly before one of its international events or from a sports
organisation responsible for meeting an imminent deadline for
selecting team members for an international event, to disclose whether
 IX. Testing 75

any Player identified on a list provided by the Major Event Organisation

or sports organisation has a pending Atypical Finding, FIFA shall so
identify any such Player after first providing notice of the Atypical
Finding to the Player; or if the Atypical Finding is, in the opinion of
qualified medical or expert personnel, likely to be connected to a
serious pathology that requires urgent medical attention.

54 Analysis of the “B” Sample in Adverse Analytical

Findings
1.
The Player has the right to request the analysis of the “B” Sample, within
12 (In-Competition)/48 (Out-of-Competition) hours of being notified. The
request of the analysis of the “B” Sample has no impact on a Provisional
Suspension of the Player.

If the Player requests the “B” Sample analysis but claims that he and/or
his representative will not be available on the scheduled date, the FIFA
Anti-Doping Unit shall liaise with the laboratory and propose at least two
alternative dates.

2.
A Player may accept an ”A” Sample analytical result by waiving his right to
the ”B” Sample analysis. The FIFA Anti-Doping Unit may, however, request
the analysis of the “B” Sample at any time if it believes that such analysis
will be relevant for consideration of the Player‘s case.

3.
The FIFA Anti-Doping Unit shall communicate the request for analysis of
the “B” Sample immediately to the head of the laboratory where the “B”
Sample is being kept. The analysis of the “B” Sample should be carried out
within 48 hours of FIFA’s request or as soon as possible.

a) The laboratory is required to be ready to perform the “B” Sample

analysis within this time frame, as laid down in the agreement between
FIFA and the respective laboratory prior to the Match/Competition
where controls are being conducted;

b) If the laboratory is unable to perform the “B” Sample analysis within

this time frame for technical or logistical reasons, the analysis shall
take place at the next available date for the laboratory. This shall
76 IX. Testing

not be considered as a deviation from the International Standard for

Laboratories susceptible to invalidate the analytical procedure and
analytical results. No other reason shall be accepted for changing the
date of the “B” Sample analysis.

4
The Player and/or his representative shall be allowed to be present at the
opening of the “B” Sample analysis and to attend the analysis throughout.
A representative of the Player’s Association or club may also be present and
attend throughout, as may a representative of FIFA.

If the Player and his representative claim not to be available on the

alternative dates proposed, the FIFA Anti-Doping Unit shall instruct the
laboratory to proceed regardless and appoint an Independent Witness to
verify that the “B” Sample container shows no signs of Tampering and that
the identifying numbers match those on the collection documentation.

5.
The results of the “B” Sample analysis shall be sent immediately by
encrypted email to the FIFA Anti-Doping Unit. If the results of the “B”
Sample confirm the results of the “A” Sample analysis, the Player shall be
promptly notified of such results and be provided with an opportunity
to give an explanation or supplement his explanations within a short
deadline. The Player shall also be afforded the possibility to admit
the anti-doping rule violation in order to potentially benefit from a
one-year reduction in the period of Ineligibility under art. 24 par. 4
(Results Management agreement), if applicable, and/or to voluntarily
accept a Provisional Suspension as per art. 37 (Voluntary acceptance of
Provisional Suspension). Any communication provided to the Player shall
simultaneously be provided to the Player’s NADO, Association and WADA.

55 Review of Atypical Passport Findings and Adverse

Passport Findings
A review of Atypical Passport Findings and Adverse Passport Findings shall
take place as provided in Annexe C to the International Standard for Results
Management. At such time as FIFA is satisfied that an anti-doping rule
violation has occurred, it shall promptly give the Player (and simultaneously
the Player’s NADO, Association and WADA) notice of the anti-doping rule
violation asserted and the basis of that assertion.
 IX. Testing 77

56 Review of whereabouts failures

FIFA shall review potential filing failures and missed tests, as defined in
the International Standard for Results Management, in respect of Players
who are in the FIFA IRTP and file their whereabouts information with FIFA,
in accordance with Annexe B to the International Standard for Results
Management. At such time as FIFA is satisfied that an anti-doping rule
violation has occurred under art. 9 (Whereabouts failures), it shall promptly
give the Player (and simultaneously the Player’s NADO, Association and
WADA) notice that it is asserting a violation of art. 9 and the basis of that
assertion.

57 Review of other anti-doping rule violations

1.
In the case of any possible anti-doping rule violation where there is no
Adverse Analytical Finding and no Atypical Finding, the FIFA Anti-Doping
Unit shall conduct any investigation based on the facts of the case that it
deems to be necessary.

2.
At such time as the FIFA Anti-Doping Unit has reason to believe that an
anti-doping rule violation might have occurred, it shall promptly notify
the Player or other Person, the Player’s or other Person’s NADO, club and
Association, the FIFA Disciplinary Committee and WADA of:

a) the anti-doping rule that appears to have been violated and the
applicable Consequences;

b) the relevant factual circumstances upon which the allegations are based;

c) the relevant evidence in support of those facts that the FIFA Anti-Doping
Unit considers to demonstrate that the Player or other Person may have
committed (an) anti-doping rule violation(s);

d) the fact that the case will be handed over to the FIFA Disciplinary
Committee for further evaluation of the case;
78 IX. Testing

e) the fact that the Player or other Person will be informed by the FIFA
Disciplinary Committee about his opportunity to provide an explanation
within a short deadline;

f) the opportunity for the Player or other Person to provide Substantial

Assistance, admit the anti-doping rule violation and potentially benefit
from a one-year reduction in the period of Ineligibility as set out in art.
24 (Elimination, reduction, or suspension of period of Ineligibility or
other consequences for reasons other than Fault) or to seek to enter into
a case resolution agreement;

g) any matters relating to Provisional Suspension (including the possibility

for the Player or other Person to accept a voluntary Provisional
Suspension as per art. 37 (Voluntary acceptance of Provisional
Suspension).

58 Letter of charge
1.
If, after receipt of the Player’s or other Person’s explanation or expiry of
the deadline to provide such explanation, the FIFA Disciplinary Committee
is (still) satisfied that the Player or other Person has committed (an) anti-
doping rule violation(s), the FIFA Disciplinary Committee shall promptly
charge the Player or other Person with the anti-doping rule violation(s) they
are asserted to have breached. In this letter of charge, the FIFA Disciplinary
Committee shall:

a) set out the provision(s) of its anti-doping rules asserted to have been
violated by the Player or other Person;

b) provide a detailed summary of the relevant facts upon which the

assertion is based, enclosing any additional underlying evidence
not already provided in the notification under art. 53 (Initial review
regarding Adverse Analytical/Atypical Findings and notification);

c) indicate the specific Consequence(s) being sought in the event that

the asserted anti-doping rule violation(s) is/are upheld and that such
Consequence(s) shall have a binding effect on all Confederations and
Member Associations, as well as all Signatories to the Code in all sports
and countries;
 IX. Testing 79

d) grant a deadline of 20 days from receipt of the letter of charge (which

may be extended in exceptional cases) to the Player or other Person to
admit the anti-doping rule violation asserted and to accept the proposed
Consequences by signing, dating and returning an acceptance of
Consequences form, which shall be enclosed with the letter;

e) in the event that the Player or other Person does not accept the proposed
Consequence(s), it shall grant a deadline of 20 days from receipt of the
letter of charge (which may be extended in exceptional cases) to challenge
in writing the FIFA Disciplinary Committee’s assertion of an anti-doping
rule violation and/or proposed Consequence(s) and/or make a written
request for a hearing before the relevant hearing panel;

f) indicate that if the Player or other Person does not challenge the FIFA
Disciplinary Committee’s assertion of an anti-doping rule violation or
proposed Consequence(s) nor request a hearing within the prescribed
deadline, the FIFA Disciplinary Committee shall be entitled to deem
that the Player or other Person has waived his right to a hearing and be
entitled to issue a decision based on the evidence on file;

g) indicate that the Player or other Person may be able to obtain a

suspension of the Consequence(s) if he provides Substantial Assistance
under art. 24 par. 1 (Substantial Assistance in discovering or establishing
Code violations), may admit the anti-doping rule violation(s) within 20
days from receipt of the letter of charge and potentially benefit from a
one-year reduction in the period of Ineligibility under art. 24 par. 4 (Results
Management agreement) (if applicable) and/or seek to enter into a case
resolution agreement by admitting the anti-doping rule violation(s) under
art. 24 par. 5 (Case resolution agreement);

h) set out any matters relating to Provisional Suspension.

2.
The letter of charge notified to the Player or other Person shall simultaneously
be notified to the Player’s or other Person’s Confederation, Association, NADO
and WADA.

3.
In the event that the Player or other Person either (i) admits the anti doping
rule violation and accepts the proposed Consequence(s) or (ii) is deemed
to have admitted the violation and accepted the Consequence(s), the FIFA
Disciplinary Committee shall promptly issue the decision and notify it to the
80 IX. Testing

Player or other Person and to other Persons with a right to appeal as set out
in art. 77 (Appeals against decisions regarding anti-doping rule violations,
Consequences, Provisional Suspensions, implementation of decisions and
authority).

59 Retirement from sport

1.
If a Player or other Person retires while FIFA is conducting the Results
Management process, FIFA retains the authority to complete its Results
Management process.

2.
If a Player or other Person retires before any Results Management process
has begun, and FIFA would have had Results Management authority over
the Player or other Person at the time the Player or other Person committed
an anti-doping rule violation, FIFA has the authority to conduct Results
Management in respect of that anti-doping rule violation.

60 Retired Players returning to Competition

1.
If an International- or National-Level Player in a Registered Testing Pool
retires and then wishes to return to active participation in sport, the Player
shall not compete in International Competitions or National Competitions
until the Player has made himself available for Testing, by giving six months’
prior written notice to FIFA and his NADO. WADA, in consultation with FIFA
and the relevant NADO, may grant an exemption to the six-month written
notice rule where the strict application of that rule would be unfair to a
Player. This decision may be appealed under art. 77 (Appeals against decisions
regarding anti-doping rule violations, Consequences, Provisional Suspensions,
implementation of decisions and authority).

2.
If a Player retires from sport while subject to a period of Ineligibility, the
Player must notify FIFA or other Anti-Doping Organisation that imposed
the period of Ineligibility in writing of such retirement. If the Player then
 IX. Testing 81

wishes to return to active competition in sport, the Player shall not compete
in International Competitions or National Competitions until the Player has
made himself available for Testing by giving six months’ prior written notice
(or notice equivalent to the period of Ineligibility remaining as of the date
the Player retired, if that period was longer than six months) to FIFA and the
Player’s NADO. FIFA may grant an exemption to the six-month written notice
rule where the strict application of that rule would be unfair to a Player. This
decision may not be appealed.
82 X. Procedural rules

Section 1: General provisions

61 Jurisdiction
1.
Where it is asserted that an anti-doping rule has been violated in connection
with any test conducted by FIFA, the case shall be submitted to the FIFA
Disciplinary Committee. In all other cases, it shall be submitted to the
relevant hearing panel of a Confederation or Association.

2.
The FIFA Disciplinary Committee shall decide appropriate sanctions in
compliance with these Regulations and the FIFA Disciplinary Code.

3.
In the case of a Player tested by FIFA, FIFA has the exclusive right to publish
the test results and the relevant measures thereof.

4.
For the purpose of chapter X, references hereafter to the FIFA Disciplinary
Committee shall, where appropriate, be understood as meaning the
relevant hearing panel of the Association and references to the Player
shall, where appropriate, be understood as meaning any Player Support
Personnel or other person.

62 Addressees of decisions and other documents

Decisions and other documents intended for Players, clubs, Match Officials,
Officials and other Persons are addressed to the Association concerned
on the condition that it forwards the documents to the parties concerned
without delay and that it confirms to FIFA that it has performed this step.

In the event that the documents were not also or solely sent to the party
concerned, these documents are considered to have been communicated
properly to the ultimate addressee the day after receipt of the document
by the respective Association.
 X. Procedural rules 83

63 Form of decisions

1.
Decisions rendered pursuant to these Regulations shall include the full
reasons for the decision, including the basis of jurisdiction and applicable
rules, detailed factual background, the anti-doping rule violation(s)
committed or Provisional Suspension imposed, the applicable Consequences
and, if applicable, justification for why the maximum potential Consequences
were not imposed as well as the appeal routes and deadlines to appeal for
the Player or other Person. Where the decision is not in one of the four
official FIFA languages (English, French, Spanish or German), the relevant
hearing panel of the Association or Confederation shall provide a short
summary of the decision and the supporting reasons in English, French,
Spanish or German.

2.
Decisions communicated by registered letter or electronic mail shall be
legally binding.

3.
In exceptional circumstances, the parties may be informed solely of the
terms of the decision. The motivated decision will be communicated in full,
written form. The time limit to lodge an appeal, where applicable, begins
upon receipt of this motivated decision.

Section 2: Fair hearing

64 Right to a fair hearing

1.
For every Player or other Person who is asserted to have committed an
anti-doping rule violation, FIFA shall ensure, at a minimum, that the Player
or other Person receives a fair hearing in front of the FIFA Disciplinary
Committee within a reasonable period of time in accordance with these
Regulations, the FIFA Disciplinary Code and the International Standard for
Results Management.
84 X. Procedural rules

2.
Anti-doping rule violations asserted against International-Level Players,
National-Level Players or other Persons may, with the consent of the Player
or other Person, FIFA and WADA, be heard in a single hearing directly at
CAS under CAS procedures. Nothing set out in this paragraph precludes
the Player or other Person and FIFA (where it has Results Management
responsibility) to waive their right to appeal by agreement. Such waiver,
however, only binds the parties to such agreement and not any other entity
with a right of appeal under the Code.

3.
A Player or other Person against whom an anti-doping rule violation is
asserted may waive a hearing expressly and accept the Consequences
proposed by FIFA.

However, if the Player or other Person against whom an anti-doping rule

violation is asserted fails to dispute that assertion within the deadline
specified in the letter of charge sent by FIFA, then they shall be deemed to
have waived a hearing.

In the above cases, a hearing before the FIFA Disciplinary Committee

shall not be required. Instead, FIFA shall promptly issue a written decision
that conforms with article 9 of the International Standard for Results
Management and that includes the full reasons for the decision, the
period of Ineligibility imposed, the Disqualification of results under art. 26
(Disqualification of results), and if applicable, a justification for why the
greatest potential Consequences were not imposed.

FIFA shall notify that decision to the Player or other Person and to other
Anti-Doping Organisations with a right to appeal under art. 77 par. 3 of
these Regulations and shall promptly enter it in ADAMS. FIFA shall Publicly
Disclose that decision in accordance with art. 71 (Public Disclosure).

65 Hearing principles
The FIFA Disciplinary Committee shall be fair, impartial and Operationally
Independent and the hearing process shall respect the following rights of
the Player or other Person:
 X. Procedural rules 85

a) the right to be assisted by counsel and an interpreter at the Player’s or

other Person’s own expense;

b) the right to be informed in a fair and timely manner of the asserted

anti-doping rule violation;

c) the right to respond to the asserted anti-doping rule violation and

resulting consequences;

d) the right of access to and to present evidence, including the right to call
and question witnesses;

e) the right to a timely, written and reasoned decision, specifically

including an explanation of the reason(s) for any period of Ineligibility;

f) the right of the Player or other Person to request a public hearing.

66 Considerations of the FIFA Disciplinary Committee

1.
At the hearing, the FIFA Disciplinary Committee shall consider first whether
or not an anti-doping rule violation has been committed.

2.
The FIFA Disciplinary Committee may draw an adverse inference against the
Player or other Person who is asserted to have committed an anti-doping
rule violation based on the Player’s or other Person’s refusal, after a request
made in a reasonable time in advance of the hearing, to appear at the
hearing (either in person or by telephone or video conference as directed
by the FIFA Disciplinary Committee) and to answer questions from the FIFA
Disciplinary Committee.

3.
If the FIFA Disciplinary Committee considers that an anti-doping rule
violation has been committed, it shall consider the appropriate measures
applicable under arts 20 (Ineligibility for presence, Use or Attempted Use,
or Possession of a Prohibited Substance or Prohibited Method) and 21
(Ineligibility for other anti-doping rule violations) prior to the imposition
of any period of Ineligibility. The Player and other Person shall have the
opportunity to establish that there are specific or exceptional circumstances
86 X. Procedural rules

in his case that justify a reduction or elimination of the sanction otherwise

applicable.

4.
Where no hearing occurs, the FIFA Disciplinary Committee shall consider
whether an anti-doping rule violation was committed and, if so, the
appropriate measures to take based on the content of the file, and render
a reasoned decision explaining the actions taken.

67 Procedure at a Competition
The chairman of the FIFA Disciplinary Committee may expedite the
procedure at a Competition. He may conduct the hearing on his own or
take other measures at his discretion, especially where the resolution of an
anti-doping rule violation may affect the participation of a Player in the
Competition.

Section 3: Proof of doping

68 Burdens and standards of proof

1.
FIFA shall have the burden of establishing that an anti-doping rule violation
has occurred. The standard of proof shall be whether FIFA has established
an anti-doping rule violation to the comfortable satisfaction of the FIFA
Disciplinary Committee, bearing in mind the seriousness of the allegation
which is made. In all cases, this standard of proof is greater than a mere
balance of probability but less than proof beyond a reasonable doubt.

2.
Where the Code or these Regulations place the burden of proof upon
the Player or other Person alleged to have committed an anti-doping
rule violation to rebut a presumption or establish specified facts or
circumstances, except as provided in art. 69 par. 2 b) and c), the standard of
proof shall be by a balance of probability.
 X. Procedural rules 87

69 Methods of establishing facts and presumptions

1.
Facts related to anti-doping rule violations may be established by any
reliable means, including admissions.

2.
The following rules of proof shall be applicable in doping cases:

a) Analytical methods or Decision Limits approved by WADA after

consultation within the relevant scientific community or which have
been the subject of peer review are presumed to be scientifically valid.
Any Player or other Person seeking to challenge whether the conditions
for such presumption have been met or to rebut this presumption of
scientific validity shall, as a condition precedent to any such challenge,
first notify WADA of the challenge and the basis of the challenge. The
initial hearing body, appellate body or CAS, on its own initiative, may
also inform WADA of any such challenge. Within ten days of WADA’s
receipt of such notice, and the case file related to such challenge,
WADA shall also have the right to intervene as a party, appear as
amicus curiae, or otherwise provide evidence in such proceeding. In
cases before CAS, at WADA’s request, the CAS panel shall appoint an
appropriate scientific expert to assist the panel in its evaluation of the
challenge.

b) WADA-accredited laboratories, and other laboratories approved

by WADA, are presumed to have conducted Sample analysis and
custodial procedures in accordance with the International Standard for
Laboratories. The Player or other Person may rebut this presumption
by establishing that a departure from the International Standard for
Laboratories occurred which could reasonably have caused the Adverse
Analytical Finding. If the Player or other Person rebuts the preceding
presumption by showing that a departure from the International
Standard for Laboratories occurred which could reasonably have
caused the Adverse Analytical Finding, then FIFA shall have the burden
to establish that such departure did not cause the Adverse Analytical
Finding.

c) Departures from any other International Standard or other anti-doping

rule or policy set forth in the Code or in these Regulations shall not
88 X. Procedural rules

invalidate analytical results or other evidence of an anti-doping rule

violation, and shall not constitute a defence to an anti-doping rule
violation; provided, however, that if the Player or other Person establishes
that a departure from one of the specific International Standard
provisions listed below could reasonably have caused an anti-doping rule
violation based on an Adverse Analytical Finding or whereabouts failure,
then FIFA shall have the burden to establish that such departure did not
cause the Adverse Analytical Finding or whereabouts failure:

i. a departure from the International Standard for Testing and

Investigations related to Sample collection or Sample handling
which could reasonably have caused an anti-doping rule violation
based on an Adverse Analytical Finding, in which case FIFA shall
have the burden to establish that such departure did not cause the
Adverse Analytical Finding;

ii. a departure from the International Standard for Results

Management or International Standard for Testing and
Investigations related to Adverse Passport Findings which could
reasonably have caused an anti-doping rule violation, in which case
FIFA shall have the burden to establish that such departure did not
cause the anti-doping rule violation;

iii. a departure from the International Standard for Results

Management related to the requirement to provide notice to the
Player of the “B” Sample opening which could reasonably have
caused an anti-doping rule violation based on an Adverse Analytical
Finding, in which case FIFA shall have the burden to establish that
such departure did not cause the Adverse Analytical Finding;

iv. a departure from the International Standard for Results

Management related to Player notification which could reasonably
have caused an anti-doping rule violation based on a whereabouts
failure, in which case FIFA shall have the burden to establish that
such departure did not cause the whereabouts failure

d) The facts established by a decision of a court or professional disciplinary

tribunal of competent jurisdiction which is not the subject of a pending
appeal shall be irrebuttable evidence against the Player or other Person
to whom the decision pertained of those facts unless the Player or
other Person establishes that the decision violated principles of natural
justice.
 X. Procedural rules 89

e) The hearing panel in a hearing on an anti-doping rule violation may

draw an inference adverse to the Player or other Person who is asserted
to have committed an anti-doping rule violation based on the Player’s
or other Person’s refusal, after a request made in a reasonable time in
advance of the hearing, to appear at the hearing (either in person or
via video conference as directed by the hearing panel) and to answer
questions from the hearing panel or FIFA.

Section 4: Confidentiality and reporting

70 Information concerning asserted anti-doping rule

violations
1.
The Player or other Person shall be notified of an anti-doping rule
violation asserted against him as provided in section 3 of chapter IX
(Results Management).

2.
FIFA or the Anti-Doping Organisation that is responsible for managing the
results shall notify the Player’s Association, NADO, FIFA and WADA by no
later than completion of the process described under arts 53 (Initial review
regarding Adverse Analytical/Atypical Findings and notification), 55 (Review
of Atypical Passport Findings and Adverse Passport Findings), 56 (Review of
whereabouts failures) and 57 (Review of other anti-doping rule violations),
simultaneously with the notification of the Player or other Person.

3.
Notification of an anti-doping rule violation shall include: the Player’s or
other Person’s name, country, sport, club, the Player’s competitive level,
whether the test was In-Competition or Out-of-Competition, the date of
Sample collection, the analytical result reported by the laboratory, and
other information as required by the International Standard for Testing and
Investigations and the International Standard for Results Management or,
for anti-doping rule violations other than art. 6 (Presence of a Prohibited
Substance or its Metabolites or Markers in a Player’s Sample), the rule
violated and the basis of the asserted violation.

4.
Except with respect to investigations which have not resulted in a notice
of an anti-doping rule violation as described above, the same Persons and
90 X. Procedural rules

Anti-Doping Organisations shall be regularly updated on the status and

findings of any review or proceedings conducted pursuant to section 3
of chapter IX (Results Management), chapter VII (Provisional Suspension),
sections 2 and 6 of chapter X (Fair hearing and Appeals respectively) and
shall be provided with a prompt written reasoned explanation or decision
explaining the resolution of the matter.

5.
FIFA shall be notified in accordance with art. 38 (Notification) of the
decision of the hearing panel pursuant to sections 2 and 6 of chapter X
(Fair hearing and Appeals respectively).

6.
The recipient organisations shall not disclose this information beyond
those Persons with a need to know (which would include the appropriate
personnel at the applicable National Olympic Committee, Association, club
and team) until FIFA or the Association concerned, according to the Results
Management responsibility, has made Public Disclosure as permitted under
art. 71 (Public Disclosure).

7.
An Anti-Doping Organisation that declares, or that receives notice of, a
whereabouts-related failure in respect of a Player shall not disclose that
information beyond those Persons with a need to know unless and until
that Player is found to have committed an anti-doping rule violation under
art. 9 (Whereabouts failures) based on such whereabouts-related failure.
Such Persons who need to know shall also maintain the confidentiality of
such information until the same point.

8.
FIFA shall ensure that information concerning Adverse Analytical Findings,
Atypical Findings, and other asserted anti-doping rule violations remains
confidential until such information is Publicly Disclosed in accordance
with art. 71 (Public Disclosure). FIFA shall ensure that its employees
(whether permanent or otherwise), contractors, agents, consultants, and
Delegated Third Parties are subject to a fully enforceable contractual duty
of confidentiality and to fully enforceable procedures for the investigation
and disciplining of improper and/or unauthorised disclosure of such
confidential information.
 X. Procedural rules 91

71 Public Disclosure

1.
Except as provided in pars 2 and 4 below, no Anti-Doping Organisation,
Member Association or WADA-accredited laboratory, or any official of
any such body, shall publicly comment on the specific facts of any pending
case (as opposed to a general description of process and science) except
in response to public comments attributed to, or based on information
provided by, the Player, other Person or their entourage or other
representatives.

2.
After notice has been provided to the Player or other Person in accordance
with the International Standard for Results Management, and to the
applicable Anti-Doping Organisations in accordance with art. 53 (Initial
review regarding Adverse Analytical/Atypical Findings and notification), the
identity of any Player or other Person who is notified of a potential anti-
doping rule violation, the Prohibited Substance or Prohibited Method and
nature of the violation involved, and whether the Player or other Person
who is subject to a Provisional Suspension may be Publicly Disclosed by FIFA.

3.
No later than 20 days after it has been determined in an appellate decision
under art. 77 pars 1 and 2 of these Regulations or such appeal has been
waived, or a hearing in accordance with art. 64 (Right to a fair hearing)
has been waived, or the assertion of an anti-doping rule violation has
not been timely challenged or the matter has been resolved under art. 24
par. 6 of these Regulations, or a new period of Ineligibility, or reprimand,
has been imposed under art. 30 par. 1 of these Regulations, FIFA or the
Association concerned, depending on who has responsibility for managing
the results, must Publicly Disclose the disposition of the anti-doping matter
including the anti-doping rule violated, the name of the Player or other
Person committing the violation, the Prohibited Substance or Prohibited
Method involved (if any) and the Consequences imposed, according to their
communication policy. FIFA or the Association concerned must also Publicly
Disclose within 20 days the results of appelate decisions concerning anti-
doping rule violations, including the information described above.

4.
After an anti-doping rule violation has been determined to have been
committed in an appellate decision under art. 77 (Appeals against
92 X. Procedural rules

decisions regarding anti-doping rule violations, Consequences, Provisional

Suspensions, implementation of decisions and authority) or such appeal
has been waived, or in a hearing in accordance with art. 64 (Right to a fair
hearing) or where such hearing has been waived, or the assertion of an
anti-doping rule violation has not otherwise been timely challenged, or the
matter has been resolved under art. 24 par. 6 of these Regulations, FIFA or
the Association concerned may make public such determination or decision
and may comment publicly on the matter.

5.
In any case where it is determined, after a hearing or appeal, that the
Player or other Person did not commit an anti-doping rule violation,
the fact that the decision has been appealed may be Publicly Disclosed.
However, the decision itself and the underlying facts may not be Publicly
Disclosed except with the consent of the Player or other Person who is
the subject of the decision. FIFA or the Association shall make reasonable
efforts to obtain such consent, and if consent is obtained, shall Publicly
Disclose the decision in its entirety or in such revised form as the Player or
other Person may approve.

6.
For the purposes of this article, publication shall be accomplished at a
minimum by placing the required information on the FIFA or the
Association’s website and leaving the information up for the longer of
one month or the duration of any period of Ineligibility.

7.
The mandatory Public Disclosure described in this article shall not be
required where the Player or other Person who has been found to have
committed an anti-doping rule violation is a Minor, Protected Person or
Recreational Player. Any optional Public Disclosure in a case involving a
Minor, Protected Person or Recreational Player shall be proportionate to
the facts and circumstances of the case.

72 Information concerning whereabouts and Testing

1.
The current whereabouts information of Players who have been identified
by FIFA for inclusion in its IRTP shall be provided to WADA and to other
 X. Procedural rules 93

Anti-Doping Organisations having the authority to test the Player through

ADAMS, as provided in article 5 of the Code. Whereabouts information
shall be maintained in strict confidence at all times; shall be used exclusively
for the purposes of planning, coordinating or conducting Doping Controls;
shall provide information relevant to the Athlete Biological Passport or
other analytical results to support an investigation into a potential anti-
doping rule violation or to support proceedings alleging an anti-doping
rule violation; and shall be destroyed after it is no longer relevant for
these purposes in accordance with the International Standards for the
Protection of Privacy and Personal Information. FIFA may, in accordance
with the International Standard for Testing and Investigations, collect
whereabouts information from Players who are not included within the
IRTP. If FIFA chooses to collect whereabouts information from such Players,
a Player’s failure to provide requested whereabouts information on or
before the date required by FIFA or the Player’s failure to provide accurate
whereabouts information shall result in FIFA including the Player in FIFA’s
IRTP.

2.
FIFA shall report all In-Competition and Out-of-Competition tests to WADA
by entering the Doping Control forms in ADAMS in accordance with the
requirements and timelines contained in the International Standard for
Testing and Investigations. This information will be made accessible, where
appropriate and in accordance with the applicable rules, to the Player,
the Player’s Association, the National Olympic Committee, the NADO,
and the International Olympic Committee, and any other Anti-Doping
Organisations with Testing authority over the Player.

3.
FIFA shall, at least annually, publish a general statistical report of its Doping
Control activities, with a copy provided to WADA.

73 Data privacy
Handling of the personal information relating to Players, other Persons
or third parties that is collected, stored, processed or disclosed when
performing the obligations under these Regulations has to comply with
the applicable data protection and privacy laws and FIFA Data Protection
Regulations, as well as the International Standard for the Protection of
Privacy and Personal Information issued by WADA.
94 X. Procedural rules

Section 5: Implementation of decisions

74 Implementation of decisions
1.
A decision regarding an anti-doping rule violation made by a Signatory
Anti-Doping Organisation, an appellate body or CAS shall, after the parties
to the proceeding are notified, automatically be binding beyond the
parties to the proceeding and upon FIFA and its Associations, as well as
every Signatory in every sport with the effects described below:

1.1 A decision by any of the above-mentioned bodies imposing a Provisional

Suspension (after a Provisional Hearing has occurred or the Player or
other Person has either accepted the Provisional Suspension or has
waived the right to a Provisional Hearing, expedited hearing or
expedited appeal offered in accordance with art. 35 (Mandatory
Provisional Suspension) and art. 36 (Optional Provisional Suspension
based on an Adverse Analytical Finding for Specified Substances,
Specified Methods, Contaminated Products, or other anti-doping rule
violations) automatically prohibits the Player or other Person from
participation in all sports within the authority of any Signatory during
the Provisional Suspension.

1.2 A decision by any of the above-mentioned bodies imposing a

period of Ineligibility (after a hearing has occurred or been waived)
automatically prohibits the Player or other Person from participation
in all sports within the authority of any Signatory for the period of
Ineligibility.

1.3 A decision by any of the above-mentioned bodies accepting an anti-

doping rule violation automatically binds all Signatories.

1.4 A decision by any of the above-mentioned bodies to Disqualify

results under art. 26 (Disqualification of results) for a specified period
automatically Disqualifies all results obtained within the authority of
any Signatory during the specified period.

2.
FIFA and its Associations shall recognise and implement a decision and its
effects as required by this article, without any further action required, on
the earlier of the date FIFA receives actual notice of the decision or the
date the decision is entered in ADAMS.
 X. Procedural rules 95

3.
A decision by an Anti-Doping Organisation, a national appellate body or
CAS to suspend, or lift, Consequences shall be binding upon FIFA and its
Associations without any further action required, on the earlier of the
date FIFA receives actual notice of the decision or the date the decision is
entered in ADAMS.

4.
Notwithstanding any provision in this article, however, a decision of an
anti-doping rule violation by a Major Event Organisation made in an
expedited process during a Competition shall not be binding on FIFA or
its Associations unless the rules of the Major Event Organisation provide
the Player or other Person with an opportunity to an appeal under non-
expedited procedures.

5.
FIFA and its Associations may decide to implement other anti-doping
decisions rendered by Anti-Doping Organisations not described in
paragraphs 1-4 above, such as a Provisional Suspension prior to a
Provisional Hearing or acceptance by the Player or other Person.

6.
An anti-doping decision by a body that is not a Signatory to the Code shall
be implemented by FIFA and its Associations if they find that the decision
purports to be within the authority of that body and the anti-doping rules
of that body are otherwise consistent with the Code.

75 Recognition by Associations and Confederations

1.
Where Doping Controls have been carried out by FIFA, an Association or a
Confederation in accordance with these Regulations, every Association and
Confederation shall recognise the results of such Doping Controls.

2.
Where decisions have been taken by FIFA or an Association regarding a
breach of these Regulations, every Association and Confederation shall
recognise such decisions and shall take all necessary action to render such
decisions effective.
96 X. Procedural rules

Section 6: Appeals

76 Decisions subject to appeal

Decisions made under these Regulations may be appealed as set forth
below in arts 77 to 82 or as otherwise provided in these Regulations, the
Code or International Standards. Such decisions shall remain in effect while
under appeal unless the appellate body orders otherwise.

1.
Scope of review not limited
The scope of review on appeal includes all issues relevant to the matter
and is expressly not limited to the issues or scope of review before the
initial decision-maker. Any party to the appeal may submit evidence, legal
arguments and claims that were not raised in the first-instance hearing so
long as they arise from the same cause of action or same general facts or
circumstances raised or addressed in the first-instance hearing.

2.
CAS shall not defer to the findings being appealed
In making its decision, CAS does not need to give deference to the
discretion exercised by the body whose decision is being appealed.

3.
WADA not required to exhaust internal remedies
Where WADA has a right to appeal under arts 76 to 82 and no other party
has appealed a final decision within FIFA’s process, WADA may appeal such
decision directly to CAS without having to exhaust other remedies in FIFA’s
process.

77 Appeals against decisions regarding anti-doping rule

violations, Consequences, Provisional Suspensions,
implementation of decisions and authority
A decision that an anti-doping rule violation was committed, a decision
imposing Consequences or not imposing Consequences for an anti-
doping rule violation, or a decision that no anti-doping rule violation
was committed; a decision that an anti-doping rule violation proceeding
cannot go forward for procedural reasons (including, for example,
 X. Procedural rules 97

prescription); a decision by WADA not to grant an exception to the six

months’ notice requirement for a retired Player to return to Competition
under art. 60 (Retired Players returning to Competition); a decision by
WADA assigning Results Management under art. 7.1 of the Code; a
decision by FIFA not to bring forward an Adverse Analytical Finding or an
Atypical Finding as an anti-doping rule violation, or a decision not to go
forward with an anti-doping rule violation after an investigation under
these Regulations and in accordance with the International Standard for
Results Management; a decision to impose, or lift, a Provisional Suspension
as a result of a Provisional Hearing; FIFA’s failure to comply with chapter
VII; a decision that FIFA lacks authority to rule on an alleged anti-doping
rule violation or its Consequences; a decision to suspend, or not suspend,
Consequences or to reinstate, or not reinstate, Consequences under art. 24
par. 1 (Substantial assistance in discovering or establishing Code violations);
failure to comply with art. 24 par. 4 of these Regulations, failure to comply
with art. 24 par. 5 of these Regulations; a decision under art. 30 par. 3
(Violation of the prohibition of participation during Ineligibility); and a
decision by FIFA not to implement another Anti-Doping Organisation’s
decision under art. 74 (Implementation of decisions), and a decision under
art. 88 par. 5 d) of these Regulations may be appealed exclusively as
provided in arts 77 to 82.

1.
Appeals involving International-Level Players or International
Competitions
In cases arising from participation in an International Competition or in
cases involving International-Level Players, the decision may be appealed
exclusively to CAS.

2.
Appeals involving other Players or other Persons
In cases where art. 77 par. 1 (Appeals involving International-Level Players
or International Competitions) is not applicable, the decision may be
appealed to an appellate body in accordance with rules adopted by the
NADO having jurisdiction over the Player or other Person. The rules for
such appeal shall respect the following principles: a timely hearing; a fair,
impartial and operationally and institutionally independent hearing panel;
the right to be represented by counsel at the Player’s or other Person’s
own expense; and a timely, written, reasoned decision. If no such body as
described above is in place and available at the time of appeal, the Player
or other Person shall have a right to appeal to CAS.
98 X. Procedural rules

3.
Persons entitled to appeal
In cases under art. 77 par. 1 (Appeals involving International-Level Players
or International Competitions), the following parties shall have the right
to appeal to CAS: (a) the Player or other Person who is the subject of
the decision being appealed; (b) the other party to the case in which the
decision was rendered; (c) FIFA; (d) the NADO of the Person’s country of
residence or countries where the Person is a national or licence holder;
(e) the International Olympic Committee or International Paralympic
Committee, as applicable, where the decision may have an effect in relation
to the Olympic Games or Paralympic Games, including decisions affecting
eligibility for the Olympic Games or Paralympic Games; and (f) WADA.

In cases under art. 77 par. 2 (Appeals involving other Players or other

Persons), the parties having the right to appeal to the national-level appeal
body shall be as provided in the NADO’s rules but, at a minimum, shall
include the following parties: (a) the Player or other Person who is the
subject of the decision being appealed; (b) the other party to the case in
which the decision was rendered; (c) FIFA; (d) the NADO of the Person’s
country of residence or countries where the Person is a national or licence
holder; (e) the International Olympic Committee or International Paralympic
Committee, as applicable, where the decision may have an effect in relation
to the Olympic Games or Paralympic Games, including decisions affecting
eligibility for the Olympic Games or Paralympic Games; and (f) WADA. For
cases under art. 77 par. 2 (Appeals involving other Players or other Persons),
WADA, the International Olympic Committee, the International Paralympic
Committee, and FIFA shall also have the right to appeal to CAS with respect
to the decision of the national-level appeal body. Any party filing an appeal
shall be entitled to assistance from CAS to obtain all relevant information
from the Anti-Doping Organisation whose decision is being appealed and
the information shall be provided if CAS so directs.

Notwithstanding any other provision herein, the only Person who may
appeal against the imposition of a Provisional Suspension is the Player or
other Person upon whom the Provisional Suspension is imposed.

4.
Duty to notify
All parties to any CAS appeal must ensure that FIFA, WADA and all other
parties with a right to appeal have been given timely notice of the appeal.
 X. Procedural rules 99

5.
Cross-appeals and other subsequent appeals allowed
Cross-appeals and other subsequent appeals by any respondent named in
cases brought to CAS under the Code are specifically permitted. Any party
with a right to appeal under the Appeals section of these Regulations must
file a cross-appeal or subsequent appeal with the party’s answer at the
latest.

78 Failure to render a timely decision

1.
Where, in a particular case, FIFA fails to render a decision with respect to
whether an anti-doping rule violation was committed within a reasonable
deadline set by WADA, WADA may elect to appeal directly to CAS as if
FIFA had rendered a decision finding no anti-doping rule violation. If the
CAS hearing panel determines that an anti-doping rule violation was
committed and that WADA acted reasonably in electing to appeal directly
to CAS, WADA’s costs and attorney fees in prosecuting the appeal shall be
reimbursed to WADA by FIFA.

2.
Where, in a particular case, a Member Association or Confederation fails
to render a decision with respect to whether an anti-doping rule violation
was committed within a reasonable deadline set by FIFA, FIFA may elect
to appeal directly to CAS as if the Member Association or Confederation
had rendered a decision finding no anti-doping rule violation. If the CAS
hearing panel determines that an anti-doping rule violation was committed
and that FIFA acted reasonably in electing to appeal directly to CAS, FIFA’s
costs and attorney fees in prosecuting the appeal shall be reimbursed to
FIFA by a Member Association or Confederation.

79 Appeals relating to TUEs

TUE decisions may be appealed exclusively as provided in art. 19 (Therapeutic
use exemptions (TUEs)) and art. 84 (Appeals against decisions granting or
denying a therapeutic use exemption).
100 X. Procedural rules

80 Notification of appeal decisions

Any Anti-Doping Organisation that is a party to an appeal shall promptly

provide the appeal decision to the Player or other Person and to the
other Anti-Doping Organisations that would have been entitled to appeal
under art. 77 par. 3 (Persons entitled to appeal) as provided under art. 70
(Information concerning asserted anti-doping rule violations).

81 Appeal against decisions pursuant to article 85

(Sanctions and costs assessed against sporting bodies)
Decisions by FIFA pursuant to art. 85 (Sanctions and costs assessed against
sporting bodies) may be appealed exclusively to CAS by a Member
Association.

82 Time for filing appeals

1.
Appeals to CAS
a) The time to file an appeal to CAS shall be 21 days from the date of
receipt of the motivated decision in an official FIFA language by the
appealing party. The above notwithstanding, the following shall apply in
connection with appeals filed by a party entitled to appeal but which was
not a party to the proceedings that led to the decision being appealed:

i) Within 15 days from notice of the decision, such party/ies shall have
the right to request a copy of the case file translated in an official
FIFA language from the body that issued the decision;

ii) If such a request is made within the 15-day period, the party making
such request shall have 21 days from receipt of the file to file an
appeal to CAS.

b) Notwithstanding the above, the filing deadline for an appeal

filed by WADA shall be the later of:

i) Twenty-one days after the last day on which any other party having
a right to appeal could have appealed; or
 X. Procedural rules 101

ii) Twenty-one days after WADA’s receipt of the complete file relating
to the decision.

2.
Appeals under art. 77 par. 2
(Appeals involving other Players or other Persons)
The time to file an appeal to an independent and impartial body in accordance
with rules established by the National Anti-Doping Organisation shall be
indicated by the same rules of the National Anti Doping Organisation.

Notwithstanding the above, the filing deadline for an appeal filed by WADA
shall be the later of:

a) Twenty-one days after the last day on which any other party having a
right to appeal could have appealed, or

b) Twenty-one days after WADA’s receipt of the complete file relating to

the decision.

3.
a) Where FIFA appeals against a decision of an Association, Anti-Doping
Organisation or Confederation to CAS under this chapter, the applicable
law for the proceeding shall be the FIFA regulations, in particular the FIFA
Statutes, the FIFA Anti-Doping Regulations and the FIFA Disciplinary Code.

b) Where FIFA appeals against a decision of an Association, Anti-Doping

Organisation or Confederation to CAS under this chapter, FIFA’s time limits
stipulated in art. 82 par. 1 a) shall start with the receipt of the relevant
document(s) by the FIFA Anti-Doping Unit ([email protected]).

4.
The time limits set out above shall start from the day following receipt of
the relevant document.

83 FIFA not required to exhaust internal remedies

Where FIFA has a right to appeal under this chapter and no other party has
appealed a final decision within the Anti-Doping Organisation’s process, FIFA
may appeal such a decision directly to CAS without having to exhaust other
remedies in the Anti-Doping Organisation process.
102 X. Procedural rules

84 Appeals against decisions granting or denying a

therapeutic use exemption

1.
WADA, at the request of a Player or on its own initiative, may review the
granting or denial of any TUE by FIFA. Decisions by WADA reversing the
granting or denial of a TUE may be appealed exclusively to CAS by the
Player or FIFA.

2.
Decisions by FIFA, Associations or NADOs denying TUEs, which are not
reversed by WADA, may be appealed by Players to CAS or to the national
level reviewing body as described under these Regulations. If the national
level reviewing body reverses the decision to deny a TUE, that decision may
be appealed to CAS by WADA.

3.
When FIFA, an Association or NADO fails to take action on a properly
submitted application for a TUE within a reasonable time, this failure to
decide may be considered a denial for the purpose of the appeal rights
provided in this article.

85 Sanctions and costs assessed against sporting bodies

1.
FIFA has the authority to withhold some or all funding or other
non-financial support to Member Associations that are not in compliance
with these Regulations.

2.
Member Associations shall be obligated to reimburse FIFA for all costs
(including but not limited to laboratory fees, hearing expenses and travel)
related to a violation of these Regulations committed by a Player or other
Person affiliated with that Member Association.
 Final title 103

86 Official languages

1.
These Regulations exist in the four official FIFA languages (English, French,
Spanish and German).

2.
In case of any discrepancy in the interpretation of the English, French,
Spanish or German texts of these Regulations, the English text will be
authoritative.

87 Additional regulations
In addition, the provisions of the FIFA Disciplinary Code and all other FIFA
Regulations shall apply.

88 Amendments to and interpretations of the Anti-Doping

Regulations
1.
Matters not provided for in these Regulations and cases of force majeure
shall be settled by the final decision of the relevant FIFA committee.

2.
These Regulations shall be implemented and construed according to Swiss
law and the FIFA Statutes, FIFA Disciplinary Code and FIFA Regulations.

3.
These Regulations may be amended from time to time by FIFA.

4.
These Regulations shall be interpreted as an independent and autonomous
text and not by reference to existing law or statutes.

5.
These Regulations were adopted by the FIFA Council on 25 June 2020 and
come into force on 1 January 2021 (the “Effective Date”). They repeal the
FIFA Anti-Doping Regulations that came into effect on 14 January 2019.
104 Final title

They shall not apply retroactively to matters pending before the Effective
Date; provided, however, that:

a) Anti-doping rule violations taking place prior to the Effective Date

count as “first violations” or “second violations” for the purpose of
determining sanctions under arts 6 to 16 for violations taking place
after the Effective Date.

b) Any anti-doping rule violation case which is pending on the Effective

Date and any anti-doping rule violation case brought after the Effective
Date based on an anti-doping rule violation which occurred prior to
the Effective Date shall be governed by the substantive anti-doping
rules in effect at the time that the alleged anti-doping rule violation
occurred, and not by the substantive anti-doping rules set out in these
Regulations, unless the panel hearing the case determines that the
principle of lex mitior appropriately applies under the circumstances
of the case. The retrospective periods in which prior violations can be
considered multiple violations under art. 25 par. 5 (Multiple anti-doping
rule violations during ten-year period) and the statute of limitations
set forth in art. 40 (Statute of limitations) are procedural rules, not
substantive rules, and should be applied retroactively along with all of
the other procedural rules in these Regulations (provided, however, that
art. 40 shall only be applied retroactively if the statute of limitations
period has not already expired by the Effective Date).

c) Any whereabouts failure under art. 9 (whether a filing failure or a

missed test, as those terms are defined in the International Standard
for Results Management) prior to the Effective Date shall be carried
forward and may be relied upon, prior to expiry, in accordance with the
International Standard for Results Management, but it shall be deemed
to have expired 12 months after it occurred.

d) With respect to cases where a final decision finding an anti-doping

rule violation has been rendered prior to the Effective Date, but the
Player or other Person is still serving the period of Ineligibility as of the
Effective Date, the Player or other Person may apply to FIFA or the
Anti-Doping Organisation which had Results Management responsibility
for the anti-doping rule violation to consider a reduction in the period
of Ineligibility in light of these Regulations. Such application must
be made before the period of Ineligibility has expired. The decision
 Final title 105

rendered may be appealed pursuant to art. 77 (Appeals against

decisions regarding anti-doping rule violations, Consequences,
Provisional Suspensions, implementation of decisions and authority).
These Regulations shall have no application to any case where a final
decision finding an anti-doping rule violation has been rendered and
the period of Ineligibility has expired.

e) For the purpose of assessing the period of Ineligibility for a second

violation under art. 25 par. 1 (Multiple violations), where the sanction
for the first violation was determined based on rules in force prior to
the Effective Date, the period of Ineligibility which would have been
assessed for that first violation had these Regulations been applicable,
shall be applied.

f) Changes to the Prohibited List and Technical Documents relating to

substances on the Prohibited List shall not, unless they specifically
provide otherwise, be applied retroactively. As an exception, however,
when a Prohibited Substance has been removed from the Prohibited
List, a Player or other Person currently serving a period of Ineligibility
on account of the formerly Prohibited Substance may apply to FIFA
or other Anti-Doping Organisation which had Results Management
responsibility for the anti-doping rule violation to consider a reduction
in the period of Ineligibility in light of the removal of the substance
from the Prohibited List.

Zurich, 25 June 2020

For the FIFA Council

President: Secretary General:

Gianni Infantino Fatma Samoura
106 Annexe A: The Prohibited List

Reference is made to the Prohibited List published by WADA, which is

available at www.wada-ama.org.
 Annexe B: Therapeutic use exemption (TUE) 107

1.
An application for a TUE will be reviewed by the FIFA Medical Committee
represented by the FIFA TUE Advisory Group.

2.
A Player may be granted a TUE (if and only if) he can show, on the balance
of probabilities, that he has met each of the following conditions, which
may be revised by the FIFA TUE Advisory Group in compliance with the
International Standard for Therapeutic Use Exemptions and will be
published in the FIFA TUE policy:

a) The Player shall submit an application for a TUE within the time limit
stipulated in the published FIFA TUE policy in force.

b) The Prohibited Substance or Prohibited Method in question is needed

to treat a diagnosed medical condition supported by relevant clinical
evidence;

c) The therapeutic Use of the Prohibited Substance or Prohibited Method

will not, on the balance of probabilities, produce any additional
enhancement of performance beyond what might be anticipated by a
return to the Player’s normal state of health following the treatment of
the medical condition;

d) The Prohibited Substance or Prohibited Method is an indicated

treatment for the medical condition, and there is no reasonable permitted
therapeutic alternative;

e) The necessity for the Use of the Prohibited Substance or Prohibited

Method is not a consequence, wholly or in part, of the prior Use
(without a TUE) of a substance or method which was prohibited at the
time of such Use.

3.
The TUE will be cancelled by the FIFA TUE Advisory Group if:

a) the Player does not promptly comply with any requirements or

conditions imposed by the FIFA TUE Advisory Group;

b) the term for which the TUE was granted has expired;
108 Annexe B: Therapeutic use exemption (TUE)

c) the Player is advised that the TUE has been withdrawn by the FIFA TUE
Advisory Group; or

d) a decision granting a TUE has been reversed by WADA or CAS.

4.
A Player who needs a TUE should apply as soon as possible. For substances
prohibited In-Competition only, the Player should apply for a TUE at least
30 days before his next Competition, unless it is an emergency or there are
exceptional circumstances as described in this Annexe. The Player should
make the TUE application, using the TUE application form provided by
FIFA. He should submit the TUE application form in the manner described
in the FIFA TUE policy. The form must be signed by the treating doctor and
accompanied by a comprehensive medical history, including documentation
from the original diagnosing doctor(s) and the results of all examinations,
laboratory investigations and imaging studies relevant to the application.

5.
An application for a TUE will not be considered for retroactive approval,
except in cases where:

a) emergency or urgent treatment of a medical condition was necessary;

or

b) there was insufficient time or opportunity or there were other exceptional

circumstances that prevented the Player from submitting or the FIFA TUE
Advisory Group from considering, an application prior to Doping Control;

c) the Player Used Out-of-Competition, for therapeutic reasons, a

Prohibited Substance that is only prohibited In-Competition;

6.
In exceptional circumstances and notwithstanding any other provision in
this Annexe B, a Player may apply for and be granted retroactive approval
for his therapeutic Use of a Prohibited Substance or Prohibited Method if
it would be manifestly unfair not to grant a retroactive TUE, considering
the purpose of these Regulations and the Code and notwithstanding any
provisions herein or in the International Standard for Therapeutic Use
Exemptions.
 Annexe B: Therapeutic use exemption (TUE) 109

7.
Confidentiality of information
a) The collection, storage, processing, disclosure and retention of personal
information by FIFA in the TUE process complies with the International
Standard for the Protection of Privacy and Personal Information.

b) A Player applying for a TUE shall provide written consent for the
transmission of all information pertaining to the application to
members of all therapeutic use exemption committees with authority
under the World Anti-Doping Code to review the file and, as required,
other independent medical or scientific experts, and to all necessary
staff involved in the management, review or appeal of TUEs, and
WADA. In accordance with the provisions of the World Anti-Doping
Code, the applicant shall also provide written consent for the decision
of the FIFA TUE Advisory Group to be distributed to other relevant
Anti-Doping Organisations and Member Associations.

c) Should the assistance of external, independent experts be required,

all details of the application shall be circulated without identifying the
Player concerned.

d) The members of the FIFA TUE Advisory Group, all independent experts
and the staff of the FIFA Medical Office and Anti-Doping Unit involved
will conduct all of their activities in strict confidence and will sign
confidentiality agreements. In particular, they shall keep the following
information confidential:

i. All medical information and data provided by the Player and

doctor(s) involved in the Player’s care.

ii. All details of the application, including the name of the doctor(s)
involved in the process.

e) Should the Player wish to revoke the right of the FIFA TUE Advisory
Group or any therapeutic use exemption committee to obtain any
health information on his behalf, the Player must notify his medical
practitioner in writing of the fact. As a consequence of such a decision,
the Player will not receive approval for a TUE or renewal of an existing
TUE.
110 Annexe B: Therapeutic use exemption (TUE)

8.
Where the Player already has a TUE granted by his NADO for the
substance or method in question, if that TUE meets the criteria set out
in the International Standard for Therapeutic Use Exemptions, FIFA shall
recognise it. If FIFA considers that the TUE does not meet those criteria
and so refuses to recognise it, it must notify the Player and his NADO
promptly, with reasons. The Player or the NADO shall have 21 days from
such notification to refer the matter to WADA for review. If the matter
is referred to WADA for review, the TUE granted by the NADO remains
valid for National Competition and Out-of-Competition Testing (but is
not valid for International Competition) pending WADA’s decision. If the
matter is not referred to WADA for review within the 21-day deadline, the
Player’s NADO must determine whether the original TUE granted by that
NADO should nevertheless remain valid for national-level Competition
and Out-of-Competition Testing (provided that the Player ceases to be
an International-Level Player and does not participate in International
Competition). Pending the NADO’s decision, the TUE remains valid for
National Competition and Out-of-Competition Testing (but is not valid for
International Competition).

9.
If FIFA grants the Player’s application, it shall notify not only the Player
but also his NADO, and if the NADO considers that the TUE does not meet
the criteria set out in the International Standard for Therapeutic Use
Exemptions, it has 21 days from such notification to refer the matter to
WADA for review. If the NADO refers the matter to WADA for review,
the TUE granted by FIFA remains valid for International Competition and
Out-of-Competition Testing (but is not valid for National Competition)
pending WADA’s decision. If the NADO does not refer the matter to
WADA for review, the TUE granted by FIFA becomes valid for National
Competition as well when the 21-day review deadline expires.
 Annexe C: Whereabouts 111

1 Registered Testing Pool and Testing Pools

1.
FIFA shall establish a Registered Testing Pool and Testing Pools at
international level. The responsibility for setting up a Registered Testing
Pool at national level rests with the NADO/Association concerned.

2.
The FIFA International Registered Testing Pool (IRTP) includes individual
International-Level Players who are Ineligible following a decision by a
FIFA body or who are categorised as being high-risk Players or who have
been designated by the FIFA Anti-Doping Unit for any other reason. Those
Players will be designated individually by the FIFA Anti-Doping Unit and
notified via the Association concerned. An explanation for the designation
is not required.

In addition to the IRTP, FIFA has established two additional Testing Pools:

a) The elite testing pool (ETP) includes the Players of the clubs/
representative teams participating at an elite Confederation level to be
defined by the Confederations. The Testing and results management
of this testing pool is delegated to the Confederation concerned.
Consequently, the Confederation’s anti-doping regulations are
applicable in respect of the ETP, with articles of this Annexe dealing
with the PCTP (see below) being applicable in a subsidiary way.

b) The FIFA pre-Competition testing pool (PCTP) includes the Players of

the representative teams participating in the Competition(s) selected by
FIFA during the preparation phase prior to that (those) Competition(s).
The relevant representative teams will be informed of their selection.

3.
Each Association concerned must inform the Players who have been
included by FIFA in the IRTP and the Players/clubs and the Players/
representative teams that have been included in the ETP or PCTP
immediately in writing of:

a) their inclusion in the IRTP, ETP or PCTP (as applicable) with effect from a
specified date in the future;
112 Annexe C: Whereabouts

b) the consequent requirement to file accurate and complete whereabouts

information for each respective pool;

c) the consequences of any failure to comply with that requirement;

d) confirmation that they may also be tested by other Anti-Doping

Organisations with Testing authority over them.

Each Association concerned is required to ensure that its respective Players

or teams file complete and accurate whereabouts information as set forth
in these Regulations.

4.
Players who have announced their retirement and are no longer in the IRTP
or ETP may not resume competing unless they:

a) notify the Association concerned at least six months before they expect
to return to competition;

b) fulfil the same whereabouts requirements as Players in the IRTP or ETP;

and

c) are available for no-advance-notice Out-of-Competition Testing at any

time during the period before their actual return to competition.

5.
Players who are injured and unable to play will remain in the relevant
testing pool and might be subject to Target Testing, unless they are
designated for inclusion in the IRTP.

6.
FIFA shall periodically review and update as necessary its criteria for including
Players, clubs and representative teams in the testing pools. The Players (in
the case of the IRTP), Players/clubs and Players/teams (in the case of the ETP
and PCTP) concerned must be informed in writing of any changes to the
list of Persons included in the pools that are made via their Association or
Confederation respectively.
 Annexe C: Whereabouts 113

2 Filing obligations

1.
Each Player (IRTP) or Player/representative team (PCTP) that is included
in the respective testing pool is required to file accurate and complete
whereabouts information in the manner set forth under art. 3 of this
Annexe.

2.
A Player (IRTP) or a Player/representative team (PCTP) may delegate the
task of making some or all of the whereabouts filings required herein
under art. 3 of this Annexe to his Association, to be carried out e.g. by a
coach or manager. It is assumed that a valid delegation has been made
for all of the relevant whereabouts filings, unless otherwise determined
by the Player or as stipulated under par. 3 of this article. Irrespective of
such delegation, a Player (IRTP) or Player/representative team (PCTP), shall,
together with the Association, remain jointly liable for complying with the
whereabouts requirements set out in this Annexe.

3 Whereabouts requirements
1.
a) IRTP:
Using the form provided by FIFA, each Player has to file his whereabouts
information with the Association concerned for the remaining days
of the current quarter within ten days of receiving notification of his
designation, and afterwards for all days on a quarterly basis by 25
December, 25 March, 25 June and 25 September. The Association has to
submit the quarterly reports and their updates to the FIFA Anti-Doping
Unit by 30 December, 30 March, 30 June and 30 September at the latest.

b) PCTP:
Using the form provided by FIFA, each Player of the representative team
concerned has to file whereabouts information with the Association
concerned for all of the Team Activity days of its representative team
prior to the designated Competition. The Association shall submit that
information to the FIFA Anti-Doping Unit.
114 Annexe C: Whereabouts

2.
At a minimum, the following information shall be provided:

IRTP:

a) name of the Player and the relevant team;

b) full mailing address and electronic mail address for formal notice
purposes;

c) specific confirmation of the Player’s understanding that his whereabouts

filing will be shared with other Anti-Doping Organisations having
authority to test him;

d) for each day during the respective period, the full address of the place
where the Player will be residing (e.g. home, temporary lodgings, hotel,
etc.);

e) for each day during the respective period, the time(s) each day of any
regular activity, along with the venue and any other details required in
order for the Player to be located during the time(s) in question;

f) the Player’s Match/Competition schedule for the respective period,

including the name and address of each location where the Player is
scheduled to compete during the respective period and the date(s) and
time(s) at which he is scheduled to compete at such locations; and

g) for each day during the respective period, one specific 60-minute time
slot between 05:00 and 23:00 (local time) where the Player will be
available and accessible for Testing at a specific location.

PCTP:

a) name of the Player and his relevant representative team;

b) full mailing address and electronic mail address for formal notice
purposes;

c) specific confirmation of the Player’s understanding that his whereabouts

filing will be shared with other Anti-Doping Organisations having
authority to test them;
 Annexe C: Whereabouts 115

d) for each day of any Team Activity during the respective period in
question, the full address of the place where the team will be residing
(e.g. temporary lodgings, hotel, etc.);

e) the team’s Competition schedule for the respective period in question,

including the name and address of each location where the team is
scheduled to compete during this time and the date(s) on which it is
scheduled to compete at such locations; and

f) for each day of any Team Activity during the respective period in
question, the time(s) of any collective activity (e.g. training) or individual
activity under the supervision of the team (e.g. medical treatment), and
other regular activities, if applicable, along with the venue and any
other details required in order for the team to be located during the
time(s) in question.

g) If a Player is to be absent from a team activity as stated in the team’s

whereabouts filings, the association shall:

- provide FIFA with accurate details of the Player’s full name, date of
birth and the complete whereabouts location during the entire time
of his absence;

- provide a specific 60-minute time slot, during which the Player must
be available and accessible for testing at a specific location. The time
slots shall be between 05:00 and 23.00 (local time), with the starting
time clearly indicated and shall not start until at least two hours
after notification have elapsed;

- submit the whereabouts information for the absent Player 24 hours

at the latest before the start of the team activity to which the
absence relates and provide immediate updates if the time slot or
the location of the absent Player changes.

3.
IRTP:
It is the Player’s responsibility to ensure that all of the information provided
in his whereabouts filing is accurate and sufficiently detailed to enable the
FIFA Anti-Doping Unit to locate him for Testing on any given day during
the respective period, including but not limited to the 60-minute time slot
specified for that day in his whereabouts filing.
116 Annexe C: Whereabouts

PCTP:
It is the Player’s and the Association’s joint responsibility to ensure that all
whereabouts information provided in its whereabouts filing is accurate
and sufficiently detailed to enable the FIFA Anti-Doping Unit to locate the
representative team for Testing on each day of any Team Activity during
the respective period.

4.
Where any change in circumstances means that the information previously
provided by the Player/team is no longer accurate or complete, the
whereabouts filing must be updated so that the information on file is
again accurate and complete.

Such update must be made as soon as possible, and, in the case of the IRTP,
in any event prior to the 60-minute time slot specified in the filing for that
day. Failure to do so shall have the consequences set forth below.

4 Availability for Testing

1.
A Player in the IRTP must specifically be present and available for Testing on
any given day in the relevant period for the 60-minute time slot specified
for that day in his whereabouts filing, at the location he has specified for
that time slot in such filing.

2.
The Players of a representative team in the PCTP must be present and
available for Testing on any given Team Activity day in the relevant
period at the time and location it has specified for the Team Activity in its
whereabouts filing. If located for Testing, the whole team must remain
until the Sample collection has been completed.

5 Liability for non-compliance with whereabouts requirements

1.
Each Player in the IRTP remains ultimately responsible at all times for
providing accurate and complete whereabouts filings as required in these
Regulations.
 Annexe C: Whereabouts 117

2.
Each Player in the IRTP is responsible for ensuring his availability for Testing
at the given location during the 60-minute time slot specified for that day
in his whereabouts filing. If an Attempt to test the Player during the 60
minute time slot is unsuccessful, the Player will be liable for a missed test
under art. 9 (Whereabouts failures) of the FIFA Anti-Doping Regulations,
subject to the requirements set forth under art. 8 par. 2 of this Annexe.

3.
If any of the required information changes after a whereabouts filing is
made, then, in accordance with the provisions set forth under art. 3 par.
4 of this Annexe, an update must be filed so that the whereabouts filing
remains accurate at all times. If an update is not filed, and as a result an
Attempt to test the Player during the 60-minute time slot is unsuccessful,
the Player will be liable for a missed test under art. 9 (Whereabouts
failures) of the FIFA Anti- Doping Regulations, subject to the requirements
set forth under art. 8 par. 2 of this Annexe.

4.
Each Player of a representative team in the PCTP and its Association are
responsible for providing accurate and complete whereabouts filings as
required in these Regulations and for ensuring that its representative team
is available for Testing at the time and location specified for Team Activity
in its whereabouts filing.

6 Anti-doping rule violation

1.
A Player in the IRTP shall be deemed to have committed an anti-doping
rule violation under art. 9 (Whereabouts failures) of the FIFA Anti-Doping
Regulations if he commits a total of three whereabouts failures (which may
be any combination of filing failures and/or missed tests adding up to three
in total) within any 12-month period, irrespective of which Anti-Doping
Organisation(s) has/have declared the whereabouts failures in question.

2.
The 12-month period referred to in art. 9 (Whereabouts failures) begins on
the date that a Player commits his first whereabouts failure that is being
relied upon in support of the allegation of violation of art. 9 (Whereabouts
failure). It is not affected by any successful Sample collection conducted
with respect to the Player during the 12-month period.
118 Annexe C: Whereabouts

However, if a Player who has committed one whereabouts failure does

not commit a further two whereabouts failures within 12 months of the
first one, at the end of that 12-month period the first whereabouts failure
“expires” for the purposes set forth under art. 8 of this Annexe.

3.
To ensure fairness to the Player in the IRTP, where an unsuccessful Attempt
has been made to test a Player during one of the 60-minute time slots
specified in their whereabouts filing, any subsequent unsuccessful Attempt
to test that Player (by FIFA or any other Anti-Doping Organisation) during
one of the 60-minute time slots specified in their whereabouts filing
may only be counted as a missed test (or, if the unsuccessful Attempt was
because the information filed was insufficient to find the Player during the
time slot, as a filing failure) against that Player if that subsequent Attempt
takes place after the Player has received notice, in accordance with arts 7
and 8 of this Annexe, of the original unsuccessful Attempt.

4.
Where a Player retires from but then returns to competition, his period of
non-availability for Out-of-Competition Testing shall be disregarded for the
purposes of calculating the 12-month period.

5.
Any Player who provides fraudulent information in his whereabouts filing,
whether in relation to his location during the specified daily 60-minute
time slot, or in relation to his whereabouts outside that time slot, or
otherwise, thereby commits an anti-doping rule violation under art. 8
(Evading, refusing or failing to submit to Sample collection) and art. 10
(Tampering or Attempted Tampering with any part of Doping Control by a
Player or other Person) of the FIFA Anti-Doping Regulations. Sanctions may
be imposed by the FIFA Disciplinary Committee.

7 Failure to provide timely and accurate whereabouts

information by Players or Associations/clubs in the PCTP
If the Player, or the Association/club on behalf of the Player, does not file
whereabouts information as required in these Regulations, or such filing
is late and/or inaccurate, the Player and/or the Association or club will be
subject to disciplinary measures under the FIFA Disciplinary Code.
 Annexe C: Whereabouts 119

8 Results Management in respect of a filing failure by the

Player in the IRTP

The Results Management process in respect of an apparent filing failure

shall be as follows:

1.
A Player may only be declared to have committed a filing failure where the
FIFA Anti-Doping Unit, following the Results Management procedure set
forth below, can establish each of the following:

a) that the Player was duly notified:

i. that he had been designated for inclusion in the IRTP;

ii. of the consequent requirement to make accurate and complete

whereabouts filings; and

iii. of the consequences of any failure to comply with that requirement.

b) that he failed to comply with that requirement by the applicable

deadline;

c) that, in case of a second or third filing failure, he was given notice of

the previous filing failure in accordance with the provision set forth
under art. 8 par. 2 of this Annexe and failed to rectify that filing failure
by the deadline specified in that notice; and

d) that his failure to file was at least negligent. For these purposes, the
Player will be presumed to have committed the failure negligently upon
proof that he was notified of the requirement yet failed to comply with
it. That presumption may only be rebutted by the Player establishing that
no negligent behaviour on his part caused or contributed to the failure.

2.
If it appears that all of the requirements set forth under art. 8 par. 1 of this
Annexe have been met, then, no later than 14 days after the date of discovery
of the apparent filing failure, the FIFA Anti-Doping Unit must send notice to
the Player concerned in the manner set forth in chapter X section 1 (General
provisions), inviting a response within 14 days of receipt of the notice. In the
notice, the FIFA Anti-Doping Unit should inform the Player:
120 Annexe C: Whereabouts

a) that, in order to avoid a further filing failure, he must make

the required whereabouts filing within a deadline set by the FIFA
Anti-Doping Unit; the deadline shall be set at least 24 hours after
receipt of the notice and no later than 48 hours after the notice is
received;

b) that, unless the Player persuades the FIFA Anti-Doping Unit that there
has not been any filing failure, an alleged whereabouts failure will be
recorded against the Player;

c) whether any other whereabouts failures have been alleged against the
Player in the 12-month period prior to this alleged whereabouts failure;
and

d) of the consequences to the Player if a hearing panel upholds the

alleged whereabouts failure.

3.
Where the Player disputes the apparent filing failure, the FIFA Anti-Doping
Unit must reassess whether all of the requirements set forth under par. 1
of this article have been met. The FIFA Anti-Doping Unit must advise the
Player, by letter sent no later than 14 days after receipt of the Player’s
response, whether or not it maintains that there has been a filing failure.

4.
If no response is received from the Player by the relevant deadline, or if the
FIFA Anti-Doping Unit maintains that there has been a filing failure, the
FIFA Anti-Doping Unit shall send notice to the Player that an alleged filing
failure is to be recorded against him. The FIFA Anti-Doping Unit shall at
the same time advise the Player that he has the right to an administrative
review of that decision.

5.
Where requested by the Player, such administrative review shall be
conducted by a designee of the FIFA Anti-Doping Unit who was not
involved in the previous assessment of the alleged filing failure. The review
shall be based on written submissions only, and shall consider whether all
of the requirements set forth herein under par. 1 of this article have been
met. The review shall be completed within 14 days of receipt of the Player’s
request and the decision shall be communicated to the Player by letter sent
no more than seven days after the decision is made.
 Annexe C: Whereabouts 121

6.
If it appears, upon such review, that the requirements set forth under par.
1 of this article have not been met, the alleged filing failure shall not be
treated as a whereabouts failure for any purpose. The Player, WADA and all
other relevant Anti-Doping Organisations shall be notified accordingly.

7.
If the Player does not request an administrative review of the alleged filing
failure by the relevant deadline, or if the administrative review leads to the
conclusion that all of the requirements set forth under par. 1 of this article
have been met, the FIFA Anti-Doping Unit shall record an alleged filing
failure against the Player and shall notify the Player, WADA and all other
relevant Anti-Doping Organisations of that alleged filing failure and the
date of its occurrence in the manner set forth under art. 70 par. 7 of the
FIFA Anti-Doping Regulations.

8.
Any notice sent to a Player pursuant to this article, informing him of the
decision that there has been no filing failure, shall also be sent to WADA
and any other party/ies with a right of appeal under chapter X of the FIFA
Anti-Doping Regulations. This decision may be appealed by WADA and/or
such party/ies in accordance with that chapter.

9 Results management in respect of a missed test by the Player

in the IRTP
The Results Management process in the case of an apparent missed test
shall be as follows:

1.
The FIFA Doping Control Officer shall file an Unsuccessful Attempt Report
on any unsuccessful Attempt with the FIFA Anti-Doping Unit, setting out
the details of the Attempted Sample collection, including the date of the
Attempt, the location visited, the exact arrival and departure times at the
location, the step(s) taken at the location to try to find the Player, including
details of any contact made with third parties, and any other relevant
details about the Attempted Sample collection.

2.
A Player may only be declared to have missed a test where the FIFA
Anti-Doping Unit can establish each of the following:
122 Annexe C: Whereabouts

a) that when the Player was given notice that he had been included
in the IRTP, he was advised of his liability for a missed test if he was
unavailable for Testing during the 60-minute time slot specified in his
whereabouts filing at the location specified for that time slot;

b) that a FIFA Doping Control Officer Attempted to test the Player on a

given day in the quarter, during the 60-minute time slot specified in
the Player’s whereabouts filing for that day, by visiting the location
specified for that time slot;

c) that during that specified 60-minute time slot, the FIFA Doping Control
Officer did all that was reasonable (i.e. given the nature of the specified
location) in the circumstances to try to locate the Player, short of giving
the Player any advance notice of the test;

d) that the provisions set forth herein under par. 3 of this article have been
met, if applicable; and

e) that the Player’s failure to be available for Testing at the specified

location during the specified 60-minute time slot was at least negligent.
For these purposes, the Player will be presumed to have been negligent
upon proof of the matters set forth under this paragraph. That
presumption may only be rebutted by the Player establishing that no
negligent behaviour on his part caused or contributed to him:

– being unavailable for Testing at such location during such time slot;
and
– failing to update his most recent whereabouts filing to give notice
of a different location where he would instead be available for
Testing during a specified 60-minute time slot on the relevant day.

3.
To ensure fairness to the Player, where an unsuccessful Attempt has been
made to test a Player during one of the 60-minute time slots specified in his
whereabouts filing, any subsequent Attempt to test that Player may only
be counted as a missed test against that Player if that subsequent Attempt
takes place after the Player has received notice, in accordance with par. 4 of
this article, of the original unsuccessful Attempt.

4.
If it appears that all of the requirements set forth under par. 2 of this
article have been met, then, no later than 14 days after the date of the
 Annexe C: Whereabouts 123

unsuccessful Attempt, the FIFA Anti-Doping Unit must send notice to the
Player of the unsuccessful Attempt in the manner set forth in chapter X
section 1 (General provisions) of the FIFA Anti-Doping Regulations, inviting
a response within 14 days of receipt of the notice. In the notice, the FIFA
Anti-Doping Unit should inform the Player:

a) that, unless the Player persuades the FIFA Anti-Doping Unit that there
has not been any missed test, an alleged missed test will be recorded
against the Player;

b) whether any other whereabouts failures have been declared against

him in the 12-month period prior to this alleged missed test; and

c) of the consequences to the Player if a hearing panel upholds the

alleged missed test.

5.
Where the Player disputes the apparent missed test, the FIFA Anti-Doping
Unit must reassess whether all of the requirements set forth under par. 2
of this article have been met. The FIFA Anti-Doping Unit must advise the
Player, by letter sent no later than 14 days after receipt of the Player’s
response, whether or not it maintains that there has been a missed test.

6.
If no response is received from the Player by the relevant deadline, or if the
FIFA Anti-Doping Unit maintains that there has been a missed test, the FIFA
Anti-Doping Unit shall send notice to the Player that an alleged missed test
is to be recorded against him. The FIFA Anti-Doping Unit shall at the same
time advise the Player that he has the right to request an administrative
review of the alleged missed test. The Unsuccessful Attempt Report on the
unsuccessful Attempt must be provided to the Player at this point if it has
not been provided earlier in the process.

7.
Where requested, such administrative review shall be conducted by
a designee of the FIFA Anti-Doping Unit who was not involved in the
previous assessment of the alleged missed test. The review shall be
based on written submissions only, and shall consider whether all of the
requirements set forth under par. 2 of this article have been met.
If necessary, the relevant FIFA Doping Control Officer may be asked to
provide further information to the designee. The review shall be completed
within 14 days of receipt of the Player’s request and the decision shall be
124 Annexe C: Whereabouts

communicated to the Player by letter sent no more than seven days after
the decision is made.

8.
If it appears, upon such review, that the requirements set forth under par.
2 of this article have not been met, the unsuccessful Attempt to test the
Player shall not be treated as a missed test for any purpose. The Player,
WADA and all other relevant Anti-Doping Organisations shall be notified
accordingly.

9.
If the Player does not request an administrative review of the alleged
missed test by the relevant deadline, or if the administrative review leads
to the conclusion that all of the requirements set forth under par. 2 of this
article have been met, the FIFA Anti-Doping Unit shall record an alleged
missed test against the Player and shall notify the Player and WADA and all
other relevant Anti-Doping Organisations of that alleged missed test and
the date of its occurrence in the manner set forth under art. art. 70 par. 7
(Information concerning asserted anti-doping rule violations) of the FIFA
Anti-Doping Regulations.

10.
Any notice sent to a Player pursuant to this article, agreeing that there
has been no missed test, shall also be sent to WADA and any other
party/ies with a right of appeal under chapter X (Procedural rules) of
the FIFA Anti-Doping Regulations, and may be appealed by WADA
and/or such party/ies in accordance with that chapter.

10 Results Management in respect of failure to provide

timely and accurate whereabouts information by Players
or Associations/clubs in the PCTP
The Results Management process in the cases described in art. 7 of this
Annexe shall be as follows:

1.
A Player and an Association/club may only be declared to have committed
a failure to provide timely and accurate whereabouts information where
the FIFA Anti-Doping Unit, following the results management procedure set
forth below, can establish each of the following:
 Annexe C: Whereabouts 125

a) that the Player and Association’s/clubs team were included in the PCTP
(as applicable) with effect from a specified date;

b) the consequent requirement to file timely and accurate whereabouts

information and details of such information for the PCTP;

c) that the consequences of any failure to comply with that requirement

are established under the FIFA Disciplinary Code;

d) that each Association/club concerned was required to ensure that its

respective Players and teams were jointly responsible for filing timely
and accurate whereabouts information as per these Regulations.

2.
If it appears that all of the requirements set forth under art. 10 par. 1 of
this Annexe have been met, then, no later than 14 days after the date
of discovery of the apparent failure to provide timely and/or accurate
whereabouts information, the FIFA Anti-Doping Unit shall send notice to
the Player and Association concerned in the manner set forth in chapter X
section 1 (General provisions), inviting a response within 14 days of receipt
of the notice. In the notice, the FIFA Anti-Doping Unit shall inform the
Player and the Association:

a) that, in order to avoid a further failure to provide timely and accurate

whereabouts information, they must make the required whereabouts
information filing within a deadline set by the FIFA Anti-Doping Unit;
the deadline shall be set at least 24 hours after receipt of the notice and
no later than 48 hours after the end of the month in which the notice is
received;

b) that, unless the Player and/or Association/club can prove to the FIFA
Anti-Doping Unit that there has not been any failure to provide
timely and/or accurate whereabouts information, the Player and the
Association will be charged with an alleged failure to provide timely
and/or accurate whereabouts information;

c) of the consequences to the Player and/or the Association/club if a

hearing panel upholds the alleged failure to provide whereabouts
information under the FIFA Disciplinary Code.
126 Annexe C: Whereabouts

3.
If the Player and/or the Association/club disputes the alleged failure
to provide timely and/or accurate whereabouts information, the FIFA
Anti-Doping Unit shall reassess whether all of the requirements set forth
under par. 1 of this article have been met. If it appears, upon such review,
that the requirements set forth under par. 1 of this article have not been
met, the intended charge of failure to provide timely and/or accurate
whereabouts information shall be dropped. The Player and the Association
shall be notified accordingly.

4.
If no response is received from the Player and/or the Association/club
by the relevant deadline, or if the FIFA Anti-Doping Unit maintains that
there has been a failure to provide timely and/or accurate whereabouts
information, the FIFA Anti-Doping Unit shall send notice to the Player
and the Association/club that the FIFA Anti-Doping Unit intends to
charge them with failure to provide timely and/or accurate whereabouts
information and shall submit the case to the FIFA Disciplinary Committee
for adjudication.

5.
If the reassessment by the FIFA Anti-Doping Unit leads to the conclusion
that all of the requirements set forth under par. 1 of this article have
been met, the FIFA Anti-Doping Unit shall inform the Player and/or the
Association/club of the intention to charge them with a failure to provide
whereabouts information and shall submit the case to the FIFA Disciplinary
Committee for adjudication.

11 Responsibility for conducting proceedings

1.
The FIFA Anti-Doping Unit shall keep a record of all whereabouts failures
alleged in respect of each Player in its IRTP. Where it is alleged that such
a Player has committed three whereabouts failures within any 12-month
period, the responsibility for bringing proceedings against the Player under
art. 9 (Whereabouts failures) of the FIFA Anti-Doping Regulations shall be as
follows:

a) FIFA shall be responsible if two or more of those whereabouts failures

were alleged by FIFA or, if the whereabouts failures were alleged by
 Annexe C: Whereabouts 127

three different Anti-Doping Organisations, the Player concerned was

included in the IRTP as of the date of the third whereabouts failure;

b) the Association or NADO concerned shall be responsible if two or more

of those whereabouts failures were alleged by it or, if the whereabouts
failures were alleged by three different Anti-Doping Organisations, the
Player concerned was included in the national Registered Testing Pool
as of the date of the third whereabouts failure. In this case, references
to FIFA or the FIFA Disciplinary Committee shall, where appropriate, be
understood as meaning the Association/NADO or the relevant hearing
panel.

2.
FIFA shall have the right to receive such further information about that
alleged whereabouts failure from any other Anti-Doping Organisation in
order to assess the strength of the evidence of such alleged whereabouts
failure and to bring proceedings under art. 9 (Whereabouts failures) of
the FIFA Anti-Doping Regulations in reliance thereon. If FIFA decides in
good faith that the evidence in relation to such alleged whereabouts
failure(s) is insufficient to support such proceedings under art. 9 of the
FIFA Anti Doping Regulations, it may decline to bring proceedings based
on such alleged whereabouts failure(s). Any decision by the Anti-Doping
Organisation responsible that a declared whereabouts failure should
be disregarded for lack of sufficient evidence shall be communicated to
the other Anti-Doping Organisations and to WADA, shall be without
prejudice to WADA’s right of appeal under chapter X (Procedural rules)
of the FIFA Anti-Doping Regulations, and in any event shall not affect the
validity of the other whereabouts failures alleged against the Player in
question.

3.
FIFA should also consider in good faith whether or not a Provisional
Suspension should be imposed on the Player pending determination of the
proceedings, in accordance with chapter VII (Provisional Suspension) of the
FIFA Anti-Doping Regulations.

4.
A Player alleged to have committed an anti-doping rule violation under
art. 9 (Whereabouts failures) of the FIFA Anti-Doping Regulations shall
have the right to have such allegation determined at a full evidentiary
hearing in accordance with chapter X, section 2 (Fair hearing) of the FIFA
Anti-Doping Regulations.
128 Annexe C: Whereabouts

5.
The FIFA Disciplinary Committee shall not be bound by any determination
made during the Results Management process, whether as to the adequacy
of any explanation offered for a whereabouts failure or otherwise. Instead,
the burden shall be on the Anti-Doping Organisation responsible for
bringing the proceedings to establish all of the requisite elements of each
alleged whereabouts failure.

6.
If the FIFA Disciplinary Committee decides that one or two alleged
whereabouts failures have been established to the required standard,
but that the third alleged whereabouts failure has not, no violation of
art. 9 (Whereabouts failures) of the FIFA Anti-Doping Regulations shall be
found to have occurred. However, if the Player then commits one or two
further whereabouts failures within the relevant 12-month period, new
proceedings may be brought based on a combination of the whereabouts
failure(s) established to the satisfaction of the hearing panel in the previous
proceedings (in accordance with art. 70 par. 7 (Information concerning
asserted anti-doping rule violations) and the whereabouts failure(s)
subsequently committed by the Player.

7.
Where FIFA fails to bring proceedings against a Player under art. 9
(Whereabouts failures) of the FIFA Anti-Doping Regulations within 30
days of WADA receiving notice of that Player’s third alleged whereabouts
failure in any 12-month period, it shall be deemed that FIFA has decided
that no anti-doping rule violation was committed, for the purpose of
triggering the appeal rights set forth in chapter X (Procedural rules) of
the FIFA Anti-Doping Regulations.
 Annexe D: Testing procedure 129

1 Requirements for notification of Players

1.
When initial contact is made with the selected Player, FIFA, the FIFA Doping
Control Officer and/or the Chaperone, as applicable, shall ensure that the
Player and/or a third party (if required in accordance with art. 4 par. 3 of
this Annexe) is informed:

a) that the Player is required to undergo a Sample collection;

b) that FIFA is the Sample collection authority;

c) of the type of Sample collection and any conditions that need to be

adhered to prior to the Sample collection;

d) of the Player’s rights, including the right to:

i. have a representative present and, if available, an interpreter to

accompany him;

ii. ask for additional information about the Sample collection process;

iii. request a delay in reporting to the Doping Control room for valid
reasons;

iv. request modifications because of disabilities.

e) of the Player’s responsibilities, including the requirement to:

i. remain within direct observation of the FIFA Doping Control Officer

and/or the Chaperone at all times from the time the initial contact
is made with the Player until completion of the Sample Collection
Session;

ii. provide adequate identification;

iii. comply with Sample collection procedures (and the Player should
be advised of the possible consequences of failure to comply in
accordance with art. 45 of the FIFA Anti-Doping Regulations); and
130 Annexe D: Testing procedure

iv. report immediately for Sample collection, unless there are valid
reasons for a delay.

f) of the location of the Doping Control room;

g) that should the Player choose to consume food or fluids prior to

providing a Sample, he does so at his own risk;

h) not to hydrate excessively, since this may delay the production of a

suitable Sample; and

i) that any urine Sample provided by the Player to the Sample collection
personnel should be the first urine passed by the Player subsequent to
notification, i.e. he should not pass urine in the shower or otherwise
prior to providing a Sample to the Sample collection personnel.

2.
When contact is made with the selected Player, the FIFA Doping Control
Officer and/or the Chaperone, as applicable, shall:

a) keep the Player under constant observation, from the time that
initial contact is made with the Player until completion of the Sample
Collection Session;

b) identify himself to the Player using official documentation provided

by FIFA (e.g. FIFA Doping Control Officer card, assignment letter or the
like) evidencing his authority to collect a Sample from the Player; and

c) ask the Player to produce identification and confirm the Player’s identity
to ensure that the Player who is to be notified is the same Player who
has been selected for Doping Control. The method of identification
of the Player or the failure by the Player to confirm his identity shall
be documented and reported to the FIFA Anti-Doping Unit. In such
cases, the FIFA Anti-Doping Unit shall decide whether it is appropriate
to report the situation as a failure to comply as set forth under art.
45 (Failure to comply with Doping Control) of the FIFA Anti-Doping
Regulations.

3.
The FIFA Doping Control Officer and/or Chaperone shall have the Player
sign the relevant section of the Doping Control Form to acknowledge and
 Annexe D: Testing procedure 131

accept the notification. If the Player refuses to sign the Doping Control
Form to confirm that he has been notified, or evades notification, the FIFA
Doping Control Officer and/or Chaperone shall, if possible, inform the
Player of the consequences of refusing or failing to comply. If it is the
Chaperone who has dealt with the matter and not the FIFA Doping Control
Officer, he shall immediately report all relevant facts to the FIFA Doping
Control Officer, who in turn shall report the facts to the FIFA Anti-Doping
Unit. Where possible, the FIFA Doping Control Officer shall proceed to
collect a Sample. The FIFA Doping Control Officer shall document the facts
and report the circumstances to the FIFA Anti-Doping Unit. FIFA shall follow
the steps prescribed in art. 45 (Failure to comply with Doping Control) of
the FIFA Anti-Doping Regulations.

4.
The process set out in this Annexe may be adapted by FIFA to fit the
particular requirements of each specific Competition and football discipline,
particularly for beach soccer, futsal and the FIFA eWorld Cup™.

2 Procedure for In-Competition no-advance-notice tests

1.
In principle, two Players from each team are selected for Testing either
via random or target methods by the FIFA Anti-Doping Unit. Additional
Players may be summoned for Sample collection (in accordance with art. 2
pars 3 and 4 of this Annexe). In the case of Competitions with lower Player
numbers, e.g. beach soccer or futsal, in principle one Player per team may
be tested.

2.
Players shall be notified with no advance notice except where art. 4 par. 3
of this Annexe is applicable.

Procedure regarding injured Players

3.
If either of these two Players is injured before the Match is over, the FIFA
Doping Control Officer shall decide whether or not the injury is severe
enough to prevent the Player from undergoing a doping test. If he decides
the injury is severe enough, the FIFA Doping Control Officer shall perform a
draw in order to replace the injured player for the doping test.
132 Annexe D: Testing procedure

4.
In addition, the FIFA Doping Control Officer is entitled to appoint
additional Players to be tested at any time prior to, during or after the
Match. An explanation for the appointment is not required.

Procedure for notifying Players who have received a red card

5.
If a Player is shown the red card at any time of the Match, the FIFA Doping
Control Officer shall decide whether the Player is to be escorted by the
Chaperones to the Doping Control room, his team’s changing room or the
area of the stand allocated to his team to watch the Match from there until
the names of the Players selected for the doping test are known, so that he
is available to undergo the test immediately after the Match, if necessary.
The Player may propose to voluntarily provide a Sample in order to be
released after the procedure. However, the FIFA Doping Control Officer
may accept or decline the Player’s proposal without giving any justification.

3 Procedure for Out-of-Competition no-advance-notice tests

during team activities
Preparing for the Sample Collection Session
1.
FIFA or the respective Confederation conducts no-advance-notice doping
tests based on the whereabouts of Players of the teams in the elite testing
pool (ETP) and pre-Competition testing pool (PCTP). In accordance with the
test distribution plan, the FIFA Anti-Doping Unit selects teams for Testing.

2.
If the Players of the team cannot be contacted by the FIFA Doping Control
Officer after reasonable Attempts have been made using the whereabouts
information provided, the matter shall be reported to the FIFA Anti-Doping
Unit as soon as possible, as set forth in Annexe C. The FIFA Anti-Doping
Unit shall then proceed to evaluate whether there has been a whereabouts
filing failure (for Players in the IRTP) or a failure to provide timely and/or
accurate whereabouts information (for Players/Associations in the PCTP) in
accordance with Annexe C.

3.
If the FIFA Doping Control Officer has located the Players of the team,
he shall identify himself to the head of the delegation or the relevant
representative of the team or club concerned by presenting his
 Annexe D: Testing procedure 133

authorisation as a FIFA Doping Control Officer and the assignment for the
respective control, and discuss the procedure for the doping test with that
person and the team doctor if applicable.

4.
The head of the delegation or the relevant representative of the team or
club concerned shall give the FIFA Doping Control Officer an up-to-date
list of the Players of the team, including any absent Players at the time the
doping test is undertaken. The reasons for any such absences shall be given
to the FIFA Doping Control Officer, as well as the scheduled time of arrival
at or return to the location of the Team Activities for these Players. If there
is to be a random selection, the FIFA Doping Control Officer shall decide
whether these Players are to be included in the random selection procedure
for Players having to undergo a doping test. He shall further notify the FIFA
Anti-Doping Unit, who shall proceed to evaluate whether there has been
a whereabouts filing failure (for Players in the IRTP) or a failure to provide
timely and/or accurate whereabouts information (for Players/Associations in
the PCTP) in accordance with Annexe C.

5.
Players to undergo Sample collection are either randomly selected by the
FIFA Doping Control Officer or targeted by the FIFA Anti-Doping Unit.

Notification of Players
6.
The FIFA Doping Control Officer and the team official/team doctor present
shall sign the Doping Control Form. The FIFA Doping Control Officer shall
notify the Player. The FIFA Doping Control Officer shall:

a) identify himself to the Player using the official documentation provided

by FIFA (e.g. FIFA Doping Control Officer card, assignment letter or the
like) evidencing his authority to collect a Sample from the Player;

b) ask the Player to produce identification and confirm the Player’s identity
to ensure that the Player who is to be notified is the same Player who
has been selected for Doping Control. The method of identification
of the Player or the failure by the Player to confirm his identity shall
be documented and reported to the FIFA Anti-Doping Unit. In such
cases, the FIFA Anti-Doping Unit shall decide whether it is appropriate
to report the situation as a failure to comply as set forth under art.
45 (Failure to comply with Doping Control) of the FIFA Anti-Doping
Regulations.
134 Annexe D: Testing procedure

4 Procedure for Out-of-Competition no-advance-notice tests

on individual Players

1.
FIFA conducts no-advance-notice doping tests based on the individual
whereabouts of Players in the IRTP. In accordance with the test distribution
plan, the FIFA Anti-Doping Unit selects individual Players for Testing via
random or target methods.

2.
For no-advance-notice Out-of-Competition Sample collection, reasonable
Attempts should be made to notify Players of their selection for Sample
collection. The FIFA Doping Control Officer shall record all notification
Attempts that were made during such period.

3.
When the Player is a Minor or Protected Person, or in situations where an
interpreter is required and available, the FIFA Doping Control Officer shall
consider whether a third party must be notified prior to notification of the
Player. Should the circumstances so require, the FIFA Doping Control Officer
may request the assistance of a third party in notifying the Player.

4.
The identification procedure set forth under art. 3 par. 6 of this Annexe
shall be followed. The FIFA Doping Control Officer shall also inform the
Player of his rights, including his right:

a) to have a representative and, if available, an interpreter to accompany

him;

b) to ask for additional information about the Sample collection process;

c) to request a delay in reporting to the Doping Control room for valid

reasons (as set forth herein under art. 5 of this Annexe); and

d) to request modifications because of disabilities.

In addition, the FIFA Doping Control Officer shall also inform the Player of
his responsibilities, including the requirement:

a) to report immediately for Sample collection unless there are valid

reasons for a delay as specified in art. 5 par. 3 of this Annexe;
 Annexe D: Testing procedure 135

b) to produce adequate identification;

c) to remain within direct observation, as set forth under art. 5 of this

Annexe; and

d) to comply with the Sample collection procedure set forth in this

Annexe.

5.
If the Player cannot be contacted by the FIFA Doping Control Officer after
reasonable attempts have been made using the whereabouts information
provided by the Player, the matter shall be reported to the FIFA Anti-Doping
Unit as soon as possible, as set forth in Annexe C (art. 9 par. 1 (Results
management in respect of a missed test by the Player in the IRTP)). The FIFA
Anti-Doping Unit shall then proceed to evaluate whether there has been a
whereabouts failure in accordance with Annexe C.

5 Reporting time
1.
From the time of notification until the Player leaves the Doping Control
room at the end of his Sample Collection Session, he shall be kept under
observation at all times.

2.
For In-Competition controls, each Association and/or team concerned shall
ensure that Players selected to undergo a doping test follow the Chaperone
to the Doping Control room straight from the pitch as soon as the Match
is over. For no-advance-notice tests on Players in the IRTP or PCTP, once the
Player has been notified, he must report to the room assigned for Doping
Control immediately for Sample collection unless there are valid reasons for
delay as stated below.

3.
The FIFA Doping Control Officer may at his discretion consider any
reasonable third party request or any request by the Player for permission
to delay reporting to the Doping Control room following acknowledgment
and acceptance of notification, and/or to temporarily leave the Doping
Control room after arrival, and may grant such permission if the Player can
be continuously chaperoned and kept under direct observation during the
136 Annexe D: Testing procedure

delay. For example, delayed reporting to and/or temporary departure from

the Doping Control room may be permitted for the activities listed below.
For In-Competition Testing:

a) participation in a presentation ceremony;

b) fulfilment of media commitments (e.g. flash interviews, but not press

conferences);

c) obtaining necessary medical treatment;

d) locating a representative and/or interpreter;

e) obtaining photo identification; or

f) any other reasonable circumstances, as determined by the FIFA Doping

Control Officer, taking into account any instructions given by FIFA.

For Out-of-Competition Testing:

a) locating a representative and/or interpreter;

b) completing a training session;

c) receiving necessary medical treatment;

d) obtaining photo identification; or

e) any other reasonable circumstances, as determined by the FIFA Doping

Control Officer, taking into account any instructions given by FIFA.

4.
The FIFA Doping Control Officer shall document any reasons for delay in
reporting to the Doping Control room and/or reasons for leaving the
Doping Control room that may require further investigation by FIFA. Any
failure of the Player to remain under constant observation should also
be recorded and may be further investigated as a failure to comply in
accordance with art. 45 of the FIFA Anti-Doping Regulations.

5.
The FIFA Doping Control Officer shall reject a request for delay from a
Player if it is not possible for the Player to be continuously chaperoned.
 Annexe D: Testing procedure 137

6.
If, while keeping the Player under observation, the FIFA Doping Control
Officer observes any matter with potential to compromise the test, he shall
report and document the circumstances. If deemed appropriate by the FIFA
Doping Control Officer, he shall follow the requirements of art. 45 (Failure
to comply with Doping Control) of the FIFA Anti-Doping Regulations, and/or
consider if it is appropriate to collect an additional Sample from the Player.

6 Doping Control room

1.
The Doping Control room shall ensure the Player’s privacy. For Testing, it
shall be used solely as a Doping Control room for the duration of Sample
collection. The FIFA Doping Control Officer shall record any significant
deviations from these criteria.

2.
In the case of In-Competition Doping Controls, only the following people
are allowed into the Doping Control room:

a) the Players who have been selected for Testing;

b) the Player’s representative;

c) if the Player is a Minor, a Minor Player’s representative observing the

witnessing FIFA Doping Control Officer or Chaperone when the Minor
Player is passing a urine Sample, but without the representative directly
observing the passing of the Sample unless requested to do so by the
Minor Player;

d) the FIFA Doping Control Officer;

e) the accredited assistant(s) of the FIFA Doping Control Officer;

f) an authorised Person who is involved in the training of a Doping

Control Officer or the auditing of the FIFA Doping Control Officers;

g) a local official, if requested;

h) the FIFA Match Commissioner, if requested;

138 Annexe D: Testing procedure

i) the FIFA General Coordinator, if requested;

j) an interpreter approved by FIFA, if requested;

k) a WADA-appointed observer under the WADA Independent Observer

Programme or a WADA auditor as defined in the International Standard
for Testing and Investigations;

l) an independent observer who must be a doctor according to FIFA’s

requirements.

3.
In the case of Out-of-Competition tests during Team Activities, only the
following people are allowed into the Doping Control room:

a) the Player(s) who has/have been selected for Testing;

b) the Player’s representative;

c) if the Player is a Minor, a Minor Player’s representative observing the

witnessing FIFA Doping Control Officer or Chaperone when the Minor
Player is passing a urine Sample, but without the representative directly
observing the passing of the Sample unless requested to do so by the
Minor Player;

d) the FIFA Doping Control Officer;

e) the accredited assistant(s) of the FIFA Doping Control Officer;

f) an authorised Person who is involved in the training of a FIFA Doping

Control Officer or the auditing of the FIFA Doping Control Officers;

g) an interpreter approved by FIFA, if requested;

h) a WADA-appointed observer under the WADA Independent Observer

Programme or a WADA auditor as defined in the International Standard
for Testing and Investigations;

4.
In the case of Out-of-Competition tests on individual Players, only the
following people are allowed into the Doping Control room:
 Annexe D: Testing procedure 139

a) the Player who has been selected for Testing;

b) the Player’s representative;

c) if the Player is a Minor, a Minor Player’s representative observing the

witnessing FIFA Doping Control Officer or Chaperone when the Minor
Player is passing a urine Sample, but without the representative directly
observing the passing of the Sample unless requested to do so by the
Minor Player;

d) the FIFA Doping Control Officer;

e) the accredited assistant(s) of the FIFA Doping Control Officer;

f) an authorised Person who is involved in the training of a FIFA Doping

Control Officer or the auditing of the FIFA Doping Control Officers;

g) an interpreter approved by FIFA, if requested;

h) a WADA-appointed observer under the WADA Independent Observer

Programme or WADA auditor as defined in the International Standard
for Testing and Investigations.

5.
The Players selected for Testing shall remain in the waiting area of the
Doping Control room until they are ready to give Samples. In-Competition,
non-alcoholic drinks shall be made available to the Players in the form
of unopened and sealed plastic bottles, some of which are placed in a
refrigerator in the Doping Control room.

6.
For In-Competition Testing, the local security bodies shall take the necessary
measures to ensure that no Persons other than those authorised under par.
2 of this article enter the Doping Control room. The entrance to the Doping
Control room shall be constantly guarded. Responsibility for security during
Out-of-Competition tests shall be borne by the relevant team delegations.
The FIFA Doping Control Officer is entitled to refuse unauthorised Persons
access to the Doping Control room.

7.
In exceptional circumstances, the FIFA Doping Control Officer may give
approval for a Player to leave the Doping Control room, provided that he
has agreed the following conditions of leave with the Player:
140 Annexe D: Testing procedure

a) the purpose of the Player leaving the Doping Control room;

b) the time of return (or return upon completion of an agreed activity);

c) that the Player must remain under observation at all times.

d) that the Player shall not pass urine until he gets back to the Doping
Control room.

The FIFA Doping Control Officer shall document the actual time of the
Player’s departure and return to the Doping Control room.

7 Conducting the Sample Collection Sessions

The collection of urine and blood Samples shall be conducted in accordance
with WADA’s regulations, in particular with WADA’s International Standard
for Testing and Investigations.

8 Requirements for Sample collection

1.
Any behaviour by the Player and/or Persons associated with the Player or
anomalies with potential to compromise the Sample collection shall be
recorded by the FIFA Doping Control Officer on the Doping Control Form.
If appropriate, the FIFA Anti-Doping Unit shall investigate a possible failure
to comply as set forth under art. 45 (Failure to comply with Doping Control)
of the FIFA Anti-Doping Regulations.

2.
The FIFA Doping Control Officer shall provide the Player with the opportunity
to document any concerns he may have about how the Sample Collection
Session was conducted.

3.
In conducting the Sample Collection Session, the following information
shall be recorded as a minimum:
 Annexe D: Testing procedure 141

a) the date and time of notification, and the name and signature of the
notifying FIFA Doping Control Officer or Chaperone;

b) the arrival time of the Player at the Doping Control room and the times
of any temporary departures and returns;

c) the date and time of sealing of each Sample collected and the date and
time of completion of the entire Sample Collection process;

d) the names of the Testing authority, Sample Collection authority,

Results Management authority and the Doping Control Coordinator (if
applicable);

e) the Competition/location, date and time of Sample provision;

f) the Player’s name, date of birth, gender, home address, email address,
phone number and shirt number;

g) the Player’s sport and discipline;

h) the name of the Player’s team;

i) the means by which the Player’s identity is validated (e.g. passport,

driver’s licence or Player’s accreditation);

j) the name of the Player’s coach and doctor and/or Person accompanying
the Player (during Team Activities);

k) the Sample code number and name of the equipment manufacturer;

l) the type of Sample (urine, blood, etc.);

m) the type of test (In-Competition or Out-of-Competition);

n) the name and signature of the witnessing FIFA Doping Control

Officer/Chaperone;

o) the name and signature of the blood collection officer (if applicable);

p) partial Sample information;

q) the required laboratory information on the Sample;

142 Annexe D: Testing procedure

r) the medications and supplements taken and recent blood transfusion

details (if applicable) as declared by the team doctor/Player;

s) for an Athlete Biological Passport blood Sample, information as

out-lined in Annex I of the International Standard for Testing and
Investigations;

t) any irregularities in procedures;

u) the Player’s comments or concerns regarding the conduct of the Sample

Collection Session, if provided;

v) the Player’s acknowledgement of the processing of Sample Collection

data and a description of such processing in accordance with
International Standard for the Protection of Privacy and Personal
Information;

w) the Player’s consent or otherwise for the use of the Sample(s) for
research purposes;

x) the name and signature of the Player’s doctor and/or Person

accompanying the Player (if applicable);

y) the name and signature of the Player;

z) the name and signature of the FIFA Doping Control Officer.

4.
At the conclusion of the Sample Collection Session, the Player and FIFA
Doping Control Officer shall sign appropriate documentation to indicate
their satisfaction that the documentation accurately reflects the details of
the Player’s Sample Collection Session, including any concerns recorded
by the Player. During Team Activities, the Player’s doctor and/or Person
accompanying the Player shall sign the documentation as a witness of the
proceedings. In individual Testing, the Person accompanying the Player or
witness, if applicable, shall sign the documentation.

5.
The FIFA Doping Control Officer shall provide the Player with a copy of the
Doping Control Form of the Sample Collection Session that has been signed
by the Player.
 Annexe D: Testing procedure 143

9 Post-test administration

1.
The FIFA Anti-Doping Unit shall ensure that all Samples collected are stored
in a manner that protects their integrity, identity and security prior to
transport from the Doping Control room. The FIFA Doping Control Officer
shall record the Chain of Custody of the Samples and Sample collection
documentation to ensure that the complete documentation for each
Sample is completed and securely handled. The FIFA Anti-Doping Unit shall
confirm that both the Samples and the Sample collection documentation
have arrived at their intended destinations. The laboratory shall report any
irregularities the condition of the Samples upon their arrival at the FIFA
Anti-Doping Unit in line with the International Standard for Laboratories.

2.
The FIFA Anti-Doping Unit shall ensure that instructions for the type of
analysis to be conducted are laid down in the agreement with the laboratory
chosen in accordance with chapter IX, section 2 (Analysis of Samples) of the
FIFA Anti-Doping Regulations.

10 Transport of Samples and documentation

1.
The FIFA Anti-Doping Unit shall authorise a transport system that ensures
that Samples and documentation will be transported in a manner that
protects their integrity, identity and security.

2.
Samples shall always be transported to the laboratory chosen in accordance
with chapter IX, section 2 (Analysis of Samples) of the FIFA Anti-Doping
Regulations, using FIFA’s authorised Sample transport method, as soon as
practicable after the completion of the Sample Collection Session. Samples
shall be transported in a manner that minimises the potential for Sample
degradation due to factors such as time delays and extreme temperature
variations.

3.
Documentation identifying the Player shall not be included with the
Samples or documentation sent to the laboratory chosen in accordance
144 Annexe D: Testing procedure

with chapter IX, section 2 (Analysis of Samples) of the FIFA Anti-Doping

Regulations.

4.
The FIFA Doping Control Officer shall send all relevant Sample Collection
Session documentation to the FIFA Anti-Doping Unit using FIFA’s authorised
transport method as soon as practicable after the completion of the Sample
Collection Session.

5.
The Chain of Custody shall be checked by the FIFA Anti-Doping Unit
if receipt of either of the Samples with accompanying documentation
or Sample Collection Session documentation is not confirmed at its
intended destination or if a Sample’s integrity or identity may have been
compromised during transport. In this instance, the FIFA Anti-Doping Unit
shall consider whether the Sample should be voided.

6.
Documentation relating to a Sample Collection Session and/or an anti-doping
rule violation shall be stored by FIFA for a minimum of ten years as per the
requirements of the International Standard for the Protection of Privacy and
Personal Information.
 Annexe E: Forms 145

Doping Control Form

DOPING CONTROL FORM

Test authorised by: FIFA · Sample collection agency: FIFA · Results management authority: FIFA

FIFA COMPETITION:
1. PLAYER NOTIFICATION
Player’s name: Shirt no.: Date of birth: D D MM Y Y
Match/venue: Match no.: Team:

The above-named player has been selected to undergo a doping test and
Type of identification: Accreditation ID / Passport Driver‘s license
is requested to report immediately after the match to the doping control
room. He may be accompanied by one representative (doctor, coach
Urine Blood Date: D D MM Y Y Time of notification: : or team official). I hereby acknowledge that I have received and read
this notice, including the player‘s rights and responsibilities listed on the
reverse side of copy 1, and I consent to provide sample(s) as requested. I
DCO/Chaperone name: understand that failure or refusal to provide a sample may constitute an
anti-doping rule violation.
DCO/Chaperone Signature: Player‘s signature:

2. PLAYER INFORMATION
Time of temporary departures and returns:
: : :
Time of arrival in doping control room: arrival: return: Doctor‘s Name

Adress:
Number/Street City/Town State Coach‘s Name

( )
Country Contact Tel (incl. Country Code) E-Mail Accompanying Person‘s Name

3a. INFORMATION FOR ANALYSIS

In-competition Out-of-competition Sample collection date: D D MM Y Y Gender: m f Equipment manufacturer

Blood serum A/B: Time: :

Name of FIFA BCO Signature of FIFA BCO

Whole blood A/B: Time: :

Name of FIFA BCO Signature of FIFA BCO

Urine A/B: ml S/G 1 0 Time: :

Player‘s Name of the witnessing FIFA DCO/Chaperone

Partial urine No.: ml initials

sample: Player‘s Signature of the witnessing FIFA DCO/Chaperone
No.: ml initials

Additional sample
Name of the witnessing FIFA DCO/Chaperone
A/B: ml S/G 1 0 Time: :
Signature of the witnessing FIFA DCO/Chaperone

3b. DECLARATION OF MEDICATION List all medications or supplements taken during the past 7 days and any blood transfusions received during the past three months
Diagnosis Substance Dosage Method of application Start and duration of treatment

Consent for research: in order to help combat doping in sport, by signing below, I agree that my sample may be used for anti-doping research purposes.
When all analyses have been completed and my sample would otherwise be discarded, it may then be used by any WADA-accredited laboratory for
anti-doping research of any type, provided it can no longer be identified as my sample. I accept I refuse
4. CONFIRMATION OF PROCEDURE FOR URINE AND/OR BLOOD TESTING
Remarks:

Supplementary form used

Doping Collection Officer‘s name: Doping Collection Officer‘s signature:

Team representative‘s/player representative‘s name: Team representative‘s/player representative‘s signature:

Player‘s signature:
I declare that the information given on this form is correct and confirm that the sample collection
was conducted in accordance with the relevant procedures. Furthermore, I accept that all information
related to the doping control, including but not limited to laboratory results and possible sanctions, shall
be shared with the relevant bodies (for instance WADA, international, continental or national sports Place:
federations) in accordance with the relevant regulations, including the FIFA Anti-Doping Regulations.
I have read and understood the text overleaf and I consent to the processing of my doping control-related
08.20 ALP 200 mok

data through ADAMS or any other reliable means or measures.

Time: : Date: D D MM Y Y
Original: FIFA Anti-Doping Unit (white) Copy 1: Player’s copy (pink) Copy 2: Player’s copy (pink) Copy 3: Laboratory (blue)

Fédération Internationale de Football Association FIFA-Strasse 20 P.O. Box CH-8044 Zurich Switzerland Tel.: +41 (0)43 222 7777 www.FIFA.com

Annexe E may be amended by the FIFA administration from time to time.

146 Annexe E: Forms

Doping Control Form – Supplementary

PLAYER INFORMATION FORM

I have been asked by the Fédération Internationale de Football Association (FIFA), ADOs and service providers to access some of my information appearing in ADAMS to enable
headquartered in Zurich, Switzerland, to read the following form to ensure that I am aware them to administer anti-doping programmes. In addition, WADA may access and process
that my doping control-related data, including but not limited to personal information and some of my data in ADAMS (i.e. TUE data, laboratory results, the athlete biological passport,
the athlete biological passport and all data related to the process, including test distribution sanctions and whereabouts data) to fulfil its responsibilities under the Code. FIFA, WADA and
planning, sample collection and handling, laboratory analysis, results management and the organisations listed above will not disclose any of my data other than to authorised persons
sanctions, will be processed and stored in accordance with this form and used in anti-doping within their organisations on a “need-to-know” basis; each of the organisations accessing
programmes for the detection, deterrence and prevention of doping according to the FIFA and using ADAMS may only do so in order to fulfil their responsibilities and obligations
Anti-Doping Regulations, the World Anti-Doping Code (“Code”) and the WADA (World Anti- arising under the FIFA Anti-Doping Regulations and the Code, which primarily involve the
Doping Agency) International Standards. establishment of anti-doping programmes and ensuring appropriate information-sharing as
provided for under the FIFA Anti-Doping Regulations and the Code.
CONFIRMATION
By signing this form, I confirm that I have been informed accordingly and that I acknowledge INTERNATIONAL TRANSFERS
that: My data may be made available through ADAMS to persons or parties located outside the
• I am bound by and shall comply with the provisions of the FIFA Anti-Doping Regulations, the country where I reside since my information is to be shared with WADA, established in
Code and the International Standards issued by WADA, as amended from time to time; Switzerland and Canada, and may be shared with the ADO in the country where my national
• My doping control-related data as further specified in this information form will be used in association is registered and with my relevant confederation in order to allow them to perform
the context of anti-doping programmes indicated in the FIFA Anti-Doping Regulations and their anti-doping programmes and to comply with their obligations under the Code. The data
the Code. FIFA may also use my data for research purposes, in which case any personal protection and privacy laws of these countries may not always be equivalent to those in my
information that could identify me will be removed or changed before data is shared with own country. In any case, ADOs must comply with WADA‘s International Standard for the
other researchers or results are made public; Protection of Privacy and Personal Information.
• FIFA shall be principally responsible for ensuring the protection of my data, and is committed
to complying with the International Standard for the Protection of Privacy and Personal MY RIGHTS
Information issued by WADA; I have certain rights under applicable laws and under WADA‘s International Standard for the
• Pursuant to the above-mentioned International Standard and under the applicable law, I Protection of Privacy and Personal Information. Subject to the relevant legal conditions being
have certain rights in relation to my doping control-related data, including rights to access fulfilled, these rights include: (a) the right to be informed about the processing of my personal
and/or correct any inaccurate data and remedies with respect to any unlawful processing of data; (b) the right of access to and receipt of a copy of my personal data processed within
data as further specified below; ADAMS; (c) the right to rectification if any of my personal data that is processed within ADAMS
• FIFA will use, process and store my doping control-related data via the WADA Anti-Doping is inaccurate or incomplete; (d) the right to erasure – i.e. the right to request deletion of any
Administration and Management System (“ADAMS”) and/or other internal FIFA means (“the of my personal data that is processed in ADAMS and is no longer required for the relevant
FIFA System”). FIFA will disclose and transfer my doping control-related data via ADAMS to purposes; (e) the right to restrict or prevent the processing of my personal data if, for example,
recipients authorised to receive the information in accordance with the FIFA Anti-Doping I want to contest the accuracy of the personal data or my personal data is no longer needed;
Regulations and the Code (for instance, designated anti-doping organisations (“ADOs”), (f) the right to obtain a copy of my personal data processed in ADAMS; (g) the right to object
national ADOs, international and national sports federations, major competition organisers to FIFA processing the personal data for particular purposes if FIFA cannot provide compelling
and WADA), which may include the creation of personal online profiles and the entry of legitimate grounds for its processing. I further take note that the personal data processed by
information regarding doping controls, whereabouts and therapeutic use exemptions FIFA is not subject to automated decision-making, including profiling.
(“TUEs”) in any other similar, WADA-authorised national system used by an ADO for sharing
information; I acknowledge that according to the Code, FIFA has limited competence to erase or amend my
• I am responsible for ensuring that all information that I enter (or that is entered on my behalf) personal data. Should FIFA, despite using its reasonable efforts, fail to comply with my request,
into ADAMS is accurate and up to date; I will have to exercise my rights before WADA and/or the ADO of my national association.
• FIFA only uses WADA-accredited laboratories as well as laboratories that have been approved
by WADA and that will also use and process my laboratory test results, but shall only have CONTACT
access to the anonymised, key-coded data; In the event of any cause for complaint about the use of my personal data or if I have any
• Persons or parties receiving my information may be located outside my country of residence, questions relating to the processing of my personal data, I may contact FIFA (antidoping@fifa.
including Switzerland and Canada. In some countries, data protection and privacy laws may org). In the event of any such complaint or question, FIFA shall use its reasonable efforts to
not be equivalent to those in my own country; best resolve the matter. If I am not satisfied with FIFA‘s response, I may contact WADA and/
• Subject to applicable local laws, any dispute arising from this form or a decision made or the ADO of the country of my national association. For further details, I may also consult
pursuant to the FIFA Anti-Doping Regulations may be appealed exclusively before the bodies the athlete information notice, which is subject to change without notice, as found on the
stipulated in the FIFA Anti-Doping Regulations, including the Court of Arbitration for Sport WADA website.
(CAS).
DISPUTES
I further acknowledge the following: If the matter cannot be resolved, I have the right to lodge a complaint with the competent data
protection supervisory authority in accordance with data protection laws applicable to me.
PURPOSE OF ADAMS
ADAMS enables ADOs, such as FIFA and WADA, to conduct harmonised, coordinated and SECURITY
effective anti-doping programmes and to fulfil their respective responsibilities arising under I have taken note that ADAMS is securely maintained in Switzerland and Canada. Stringent
the Code. ADAMS and the FIFA System may be used for scheduling in and out-of-competition technological, organisational and other security measures have been applied to ADAMS to
doping tests and managing related information, including TUEs, whereabouts information, maintain the security of the data entered in it. In addition, FIFA, WADA and ADOs have put
information about the results of anti-doping tests, information relating to the athlete biological in place internal and contractual guarantees to ensure that my data remains confidential and
passport, and sanctions-related information relevant to individual athletes. WADA and FIFA secure.
rely upon ADAMS and the FIFA System to fulfil their responsibilities under the Code, including
the performance of out-of-competition testing, the review of TUEs and its implications for DATA RETENTION
anti-doping rule violation procedures. I understand that it may be necessary to retain my data in ADAMS or the FIFA System for a
minimum period of ten years. For instance, if ADAMS is used for TUEs and I am granted a TUE,
LAWFULNESS OF THE PROCESSING the TUE approval forms will be stored electronically in ADAMS for a minimum period of ten
The fight against doping in sport is supported by the international community, and more than years. The period of ten years represents the period during which an action may be commenced
180 countries have ratified the 2005 UNESCO International Convention against Doping in Sport for an anti-doping violation under the Code. Where the relevant anti-doping rules do not
(“Convention”), which endorses the work of WADA and aims at ensuring the effectiveness of require my data to be retained for ten years, the data will be deleted after an appropriately
the implementation of the Code. The worldwide anti-doping system pursuant to the Code, shorter period. For more information on data retention, I may consult the Annexe to WADA‘s
as further reflected in the FIFA Anti-Doping Regulations, is necessary for the protection of International Standard for the Protection of Privacy and Personal Information.
health, for moral, cultural and physical education and for the principle of fair play, as well as to
eliminate cheating in sport and to protect its future. The anti-doping measures undertaken by RELEASE
FIFA and the processing of my data form part of the worldwide fight against doping in sport in I hereby release FIFA and the accredited laboratories from all claims, demands, liabilities,
furtherance of the aforementioned goals and are justified to carry out an important task in the damages, costs and expenses that may arise in connection with the processing of my doping
public interest and to pursue important and legitimate interests as set out in the Convention, control-related data through ADAMS and other means such as the FIFA System.
the Code and the FIFA Anti-Doping Regulations.
REFUSAL
CATEGORIES OF DATA CONCERNED I understand that my participation in association football is contingent upon my voluntary
ADAMS and the FIFA System may contain the following categories of data: my unique ADAMS participation in anti-doping procedures as set forth in the relevant regulations, including the
profile, consisting of data relating to my identity (name, nationality, date of birth, gender, FIFA Anti-Doping Regulations, and thus the processing of my doping control-related data as
the sport(s) and discipline(s) in which I compete, organisations and/or sports federations to described in this form.
which I belong, an indication of whether I compete at international or national level, and I understand that any refusal on my part to undergo anti-doping procedures and to have
whether I am considered to be a national or international-level athlete in accordance with my doping control-related data processed will be construed as a violation of the relevant
the rules of FIFA, my confederation and/or national ADO); data relating to my whereabouts, regulations, including the Code and FIFA Anti-Doping Regulations, and may result in disciplinary
to test distribution planning (for the testing pools in which I am included); data relating to my and other sanctions being imposed upon me, such as disqualification from competitions, the
TUEs, if any; data relating to doping control (test distribution planning, sample collection and invalidation of results arising from prior competitions and/or the imposition of a period of
handling, laboratory analysis, results management, hearings and appeals); and data relating ineligibility.
to the athlete biological passport. Some of the above data may constitute sensitive personal
data under national data protection or privacy laws where I reside and under the WADA DECLARATION
International Standards. By signing this form, I hereby declare that I am familiar with and agree to abide by the relevant
regulations, including the FIFA Anti-Doping Regulations and the Code.
DISCLOSURES
Part of my ADAMS profile may be shown to other ADOs using ADAMS to ensure that only a
single athlete profile is created for me. FIFA and WADA, where appropriate, may enable other
 Annexe F: List of WADA-accredited laboratories 147

Reference is made to the list of World Anti-Doping Agency

(WADA)-accredited laboratories published by WADA, which
is available at www.wada-ama.org.
148
Fédération Internationale de Football Association